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Preface 
The workshop on 'The role of private sector R&D in the catching up of the new Member States' was 
organized as part of the common activities of the Industrial Research and Innovation Action of the 
Knowledge for Growth Unit within the DG JRC-IPTS [Institute for Prospective Technological Studies]. 
Thus, the 'Focus on New Member States' Activity gathers and analyses information and offers key 
actors a platform to share knowledge and discuss (through regular seminars and workshops) 
challenges and opportunities in industrial research and innovation in the new Member States. In doing 
so it also addresses the role of private R&D in ‘catching up’ in light of the EU’s ambition of becoming a 
competitive knowledge-based economy (with a research intensity approaching 3% of GDP). 
The activity aims to fill this gap by studying private R&D patterns and trends at the sectoral level and 
their relation to policy influences and framework conditions in the new Member States. The research 
also includes the evaluation and comparison of R&D performance in selected sectors and the 
identification of good practice in this respect. 
A Steering Committee of users from new Member States has been set up to define their needs in this 
area, and to discuss, use and diffuse the results emerging from this activity. Within the JRC 
Enlargement and Integration Action, this is one of the four specific projects the IPTS is providing to 
support the integration of new Member States into the EU (see http://iri.jrc.es/nms.htm for further 
information).  
This report represents a synthesis of the work done so far in this Activity. It takes stock of a 
comprehensive study on state of the art and recent trends in terms of private sector R&D in the NMS 
(see Annex II: Final Report). For the future it is scheduled to continue with such empirical studies at 
various – mainly more disaggregated – levels and also to deepen further the analytical approach in 
order to provide the framework for sound and evidence based policy support.  
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Executive Summary 
 
While R&D1 is concentrated in advanced industrial economies and at favourable locations within the 
larger countries, the advantages of physical location (proximity) might be diminishing with the 
increasing speed and globalisation of information flows around the world and with easier access to 
the knowledge built up through R&D. This raises the question of whether policymakers would more 
usefully focus on making their country an attractive location for R&D, or promote easy access to, and 
absorption of, knowledge generated elsewhere. Related to this, the question of how to reap the 
benefits of R&D output generated by Foreign Direct Investment [FDI], either inward or outward, 
remains a major challenge. The latter holds in particular for the new Member States [NMS]2 as – after 
the former research and innovation capacities were widely abolished during the transition process – 
currently FDI in these countries seems to be the key in terms of any R&D activities.  
 
In general, the New Member States are still in a process of transition, industrial restructuring and 
integration into the EU economy. In fact, getting closer to the existing European frontiers in terms of 
technology, R&D and innovation is quite challenging and, therefore, is supposed to take some time. 
And the initial gap was evident. In 2003, right before entering the EU, the R&D intensities (Gross 
Expenditures on R&D [GERD] / Gross Domestic Product [GDP]) in all NMS were significantly below 
the EU-15 level, the public R&D systems appeared to be rather fragmented, and in terms of the 
expenditures of Business Enterprises on R&D [BERD] more than a doubling of the pre-accession 
levels would have been required just to catch up with the EU-15 average. Accordingly, policymakers 
put emphasis on leveraging the low R&D levels in the NMS in order to support the economic catching 
up and, by means of that, the integration of the NMS economies into the EU.  
 
Admittedly, the real challenge in this regard is to leverage the private sector R&D activities as this can 
be influenced by any policy measure only indirectly and reflects rather long-term aspects such as the 
macro-economic conditions, prosperity, quality of institutional environment, human resources and the 
science base of a certain country. Accordingly, focusing on corporate R&D appears to be crucial for 
analysing the NMSs' way towards achieving the objectives of the Lisbon strategy as well as the 
Barcelona target. The current situation and trajectories of the corresponding public sector R&D 
activities anticipating a common European Research Area [ERA] should however be taken into 
account too. Thus, monitoring these developments seems to be of outstanding importance since this 
may provide an early indication whether Europe is on the right track in terms of NMS integration and 
catching up to the world technological frontier. Therefore, this will remain to be a matter of interest 
also in the future.   
 
 
This report illustrates some recent trend patterns in the NMS concerning R&D intensity, taking the 3% 
Barcelona target and the EU average as a benchmark. For instance, the absolute R&D intensities in 
2005 are related to the corresponding annual changes per country. The image that emerged is 
heterogeneous. In general, there are large disparities among the EU-15 and the NMS, and the latter 
throughout can be found below the mean EU-27 R&D intensity.3 With respect to the 'technological 
output' of R&D activities, for instance approximated by European Patent Office [EPO] patent 
applications per capita, the same picture emerges: all NMS are (still) below the EU-27 average (year 
2003; EUROSTAT).  
 
Convergence in terms of R&D intensity, if at all, can be recognized only to a limited extent. Indeed, 
the majority of low R&D-intensive Member States (i.e. R&D intensity below 1.5%; namely all NMS) is 
                                                 
1  For a definition of R&D see e.g. UNCTAD: http://www.unctad.org/en/docs/wir2005ch3_en.pdf, Box III.1. 
2  NMS: Cyprus (CY), the Czech Republic (CZ), Estonia (EE), Hungary (HU), Latvia (LV), Lithuania (LT), Malta (MT), 
Poland (PL), the Slovak Republic (SK) and Slovenia (SI). 
3  EU average: 1.84% GERD as % of GDP in year 2005. Thus, among the NMS the highest R&D intensity is reported for 
the Czech Republic (1.42%) and the lowest (0.39%) for Romania. Data: EUROSTAT, OECD. 
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catching up with the remainder of the Union, albeit at different speeds. However, there are also some 
low R&D-intensive Member States (among them four NMS: Bulgaria, Poland, Malta and Slovakia), 
apparently falling further behind since 2000 (Source: EC (2007): Key Figures, p. 54)4.  
 
In general, common patterns in the NMS can be seen in their low R&D intensities as well as in the 
fact that the government sector (still) accounts for a very large share of the R&D funding.5 In other 
words, it seems that the pre-accession situation has not yet changed significantly: R&D sectors and 
the National Innovation Systems [NIS] appear to be still dominated by the public sector and the 
overall amount of investments in R&D remains comparably low. Hence, the efforts of the 
policymakers have not yet yield fruits and it seems that still a long way remains to go for the NMS in 
order to catch up with the remainder of the EU. 
 
Nevertheless, besides the statistics concerning R&D investments, looking at a number of structural 
and knowledge economy indicators, some NMS indeed seem to get closer to the position of older 
Member States. In fact, the picture is diverse: countries ahead in terms of R&D are not always the 
same as the ones showing fast growth; fast risers on the European innovation scoreboard do not 
necessarily generate/attract much R&D investment. This suggests, particularly for those NMS facing 
significantly rising GDP figures, there are a number of determinants – aside the performance of R&D 
activities – currently triggering the economic growth process in a more substantial way.  
 
However, according to an examination of R&D dynamics at country, sector, and partly company 
levels6 there is – at least currently – no common trend pattern uniformly evident in al NMS rather than 
a wide heterogeneity (at a commonly low amount of R&D activities); and this picture seems to 
become even more diversified as the focus of analysis shifts towards higher disaggregation (macro Æ 
sector Æ firm-level). Moreover, rising figures in terms of R&D are reported by few sectors only; 
particularly such sectors as pharmaceuticals or automotive, which are growing in many NMS but have 
not (yet) become substantial pillars of the national economies. Accordingly, these emerging sectors 
with dynamic R&D trajectories might be seen more as 'bright spots' than as being the heralds of a 
common catching up in terms of R&D activities in the NMS. 
 
The fact that aggregated country-level considerations related to sector studies may provide 
differentiated pictures calls for a complementary analytical focus on firm-level trajectories. In fact, 
such empirical studies indicated a number of companies in each analysed sector performing R&D 
quite successfully, setting its pace and its frontiers (even if these frontiers may refer to the production 
possibility set given the particular environment of a certain NMS only). However, a notable amount of 
companies lagging behind has been detected too. This implies that the most relevant aspects for the 
current development in the NMS are supposed to be the individual institutional framework conditions 
for a certain company and the management capacity and entrepreneurial competence rather than the 
amount of resources and/or support provided in terms of R&D activities.  
 
In general, evidence suggests that the current growth in the NMS seems to refer mainly to 
progressing structural changes, some emerging sectors, etc. and to an increasingly efficient allocation 
of production factors (decreasing inefficiencies) rather than to catching up in terms of R&D 
performance and getting closer to the technological frontier. With respect to the initially raised policy 
question this may imply a comparably marginal importance of policymaking in the field of the NMS' 
R&D capacity building. However, although the latter may currently appear to be only a minor source 
of economic growth in the NMS, with respect to the mid to long term perspectives of these countries 
the importance of R&D is supposed to be rising. Thus, R&D may emerge to be one of the main 
sources of growth given the further integration of the NMS into the EU economy and the 
correspondingly needed catching up in terms of the technological frontier.  
 
                                                 
4  The source mentioned identified also Slovenia as falling further behind the EU average. However, the data for 
Slovenia have been revised recently and accordingly Slovenia falls not in this category anymore (see Figure 1, below). 
5  In average in the EU-27, BERD refers to 54.5% of total R&D expenditure. The public sector contributes 34.8%. In 
most of the NMS this relation is vice-versa! 
6  See JRC Scientific and Technical Report: Private sector R&D in the NMS; forthcoming. 
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However, for anticipating future developments – and therefore also for current policy making – 
perhaps even more relevant than searching for convergence in terms of R&D are the relevant 
determinants and main drivers of the corresponding trajectories in the NMS. With respect to the latter, 
an empirically based study has identified FDI as quite eminent for the evolution of R&D in the NMS, 
implying a more or less tight embedding of the R&D investment in the overall R&D strategy of a multi-
national firm.7 Thus, due to the internal competition between R&D locations of a Multi-National 
Corporations [MNC], there is a non-negligible risk that these activities may move elsewhere if the 
conditions for R&D and/or the overall R&D strategy of the company change. The maintenance of 
private sector R&D activities by means of FDI thus comes at the price of uncertainty regarding the 
potential footloose characteristics of such investment. However, in the end, the extent to which R&D 
might become footloose depends on the attractiveness of a certain location and, accordingly, on the 
quality and evolution of those factors and conditions due to which R&D-investment were initially set 
up (and maintained!).8 This implicitly includes also the risk of a 'race-to-the-bottom' in terms of work-
safety, taxation, environmental regulations, etc. between locations competing for attracting and 
keeping such investment (as far as these factors are indeed representing investment decision criteria 
and may therefore favour one location over another). 
 
In this regard some individual sector case studies in the NMS9 have shown that the reasons for 
foreign investments in R&D can be manifold. Of outstanding importance for any investments in R&D 
in the NMS seems to be a combination of three factors: (1) the quality of the available human 
resources, (2) the labour costs, and (3) the access to local markets.  
 
In contrast to these evident key factors, it is difficult to assess the impact of a number of framework 
conditions supposed to be beneficial for performing R&D, like for example tax incentives. While they 
certainly matter for specific decisions, a corresponding survey conducted in course of the individual 
NMS analyses suggested that their importance might be over-estimated. If available, specific 
incentives are welcome, but the main determinants of investments in R&D apparently lie elsewhere 
(see key factors above). In fact, although R&D support measures as well as international technology 
and know-how transfers may bring important knowledge to an economy, that alone certainly is not 
enough. Using new technologies efficiently requires creating additional absorptive capacity, while a 
continuous effort has to be made to keep up with technical change. This is particularly true given the 
fact that wages tend to rise as a country develops, facilitating the entry of lower cost competitors in 
the market, both currently observable in the NMS.  
 
Given the direct and indirect linkages among all the issues mentioned above (many of them indeed 
are 'double edged'), there is no clear answer on the initially raised question concerning the 
appropriate emphasis of policymaking in terms of R&D in the NMS. In fact, how to cope with all this 
and what does it imply for policy making in the NMS obviously needs to be further studied, thus taking 
into account the individual characteristics of each NMS, the heterogeneity among them, the persisting 
vs. the emerging economic structures, and any possible path dependencies. However, there are 
some cross cutting issues arising as critical for the future and thus requiring particular attention (these 
points and potential future avenues of research in this regard have been the main subjects of the 
discussion during the workshop on 'The role of private R&D in the catching up of NMS', held 
December 13th-14th 2007 in Seville at the IPTS): 
 
                                                 
7  This development – while being generally perceived as very positive – has a number of double-edged impacts on the 
evolution of the R&D base in the NMS. On the one hand, foreign investments tend to contribute to the upgrading of 
the managerial knowledge and organisational competencies as well as diffusion of new technologies. On the other 
hand, the embedding in a global company's R&D strategy often entails a narrowing of the scope of the R&D 
performed in the country concerned. This, in turn, has consequences for the spectrum of R&D collaboration with 
domestic universities and research centres. 
8  In fact, the embedding of R&D might not always be sustainable in the case of FDI. Localised R&D could on the one 
hand lead to local value added. On the other hand, FDI might skim the cream of high-potential researchers in labs 
that produce footloose R&D for value added elsewhere in the world. In the NMS there is evidence for both.  
9  See JRC Scientific and Technical Report: Private sector R&D in the NMS; forthcoming. 
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 In general, improving the innovation climate by structural measures rather than by financial 
incentives.10 Rethinking the role of publicly funded innovation infrastructures for attracting and 
embedding private R&D investment. In fact, policy may – to a certain extent – leverage 
corporate R&D investment by upgrading the existing innovation infrastructure, i.e. creation of 
at least partly publicly funded research and research-facilitating organisations (technology 
transfer centres, competence centres, etc.). In a wider sense, investment in the university 
system also falls under this category, thus adding the educational and human resource 
dimension. Hence, a notable improvement of innovation infrastructures (universities, research 
centres, etc.) is supposed to be key for policymaking in the NMS, not only in order to provide 
sources of qualified R&D personnel, but also as potential partners for industrial R&D, both pre-
conditions for performing R&D and thus for attracting investment in R&D;  
 Consideration of the national/sectoral innovation systems ensuring the sustainable embedding 
of R&D investment in the NMS is crucial too. For instance, several NMS have implemented 
targeted measures (e.g. tax and investment incentives) in order to attract FDI.11 But, the 
individual impact of such targeted policy measures needs to be further analyzed. In fact, 
although such targeted measures have been quite successful e.g. in raising FDI, it is rather 
unclear whether these incentives are sufficient to ensure that the related investment will stay 
and not move elsewhere once the conditions may change. In general, rather than addressing 
specifically foreign firms, efforts should also strengthen domestic (private) investment in R&D 
and innovation, e.g. facilitating access to venture capital, supporting spin-offs, etc. 
 Bundling of national R&D capacities (e.g. through national technology platforms) and seeking 
a better coordination with European initiatives. For instance, as a co-ordination measure, 
building of sector or technology-specific platforms is about to be implemented in some NMS 
(e.g. in Poland). There are potential benefits to be reaped by these measures, e.g. in terms of 
international visibility, economies of scale, and influence on the agenda-setting at European 
level. But, suitable approaches for implementing these platforms still have to be developed. 
 Emphasising increasingly the role of services, either as stand-alone research-intensive 
activities (e.g. Knowledge Intensive Business Services [KIBS]) or as services supporting R&D 
performed in other sectors (e.g. standardisation, IT services);  
 
Summarizing these points from a policy perspective: Given the distance of the NMS to the 
technological frontier and also the gap in terms of R&D intensity (Barcelona target) compared to the 
remainder of the EU, emphasis might currently be more usefully on promoting easy access to, and 
absorption of, knowledge generated elsewhere accompanied with a sophisticated master plan for 
improving the existing R&D and innovation capacities systematically. In fact, making the NMS an 
attractive location for R&D appears to be a straightforward policy objective, but any corresponding 
measure should be embedded in an overall improvement of the institutional/environmental framework 
conditions in order to ensure sustainable investments in R&D in the NMS. 
 
From a techno-economic point of view, in general, further and more detailed analyses seem to be 
needed focusing on NMS individually, their key economic sectors and/or companies in order to 
substantiate the general impression arisen from the background study and the workshop. This may 
provide the base for a better understanding of the ongoing processes and also for sound policy 
support accordingly. In particular, studies are needed that fill the gap between the available empirical 
evidence from macro-level analyses and the anecdotal evidence from firm level case studies in the 
NMS. This is currently a matter of interest in a number of ongoing projects (e.g. analysing corporate 
R&D at firm level in different sectors comprising distinctive R&D intensities12) taking into account firm 
size patterns (e.g. SMEs), R&D environmental issues at certain regional levels,13 etc. Thus, it should 
be analysed what implications may have the above mentioned pitfalls and drawbacks in relation with 
the outlined favourable framework conditions for R&D in the NMS in a mid to a long term perspective.  
                                                 
10  This concerns, for instance, the strengthening of the relationships between private as well as public innovation actors. 
In fact, there are already some examples of private firms getting engaged in funding R&D centres or university 
institutes in the NMS. 
11  Thus, the major objective in most of the cases is not increasing the overall investment in R&D! 
12  See Sector Study: Framework Service Contract 150083-2005-02-BE; EC (2006c) 
13  See ERAWATCH project: http://cordis.europa.eu/erawatch.      
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Furthermore, the participants of the workshop also outlined the importance of studying potential cut-
off points of the structural funds applying suitable simulation/modelling techniques and taking stock of 
the experiences made elsewhere in the EU in this regard (Spain, Portugal, Greece, etc.). Crucial 
questions concern the cut-off levels, cut-off timing, and any post-cut-off adjustments. Blanc spots 
were also seen with respect to the consideration of the individual domestic markets in the NMS 
(entrepreneurial spirit, type of products/sectors, etc.), the role of macroeconomic stability as well as 
the particular framework conditions, and the development of comprehensive labour markets for 
researchers in NMS (wages, career possibilities, migration studies, mobility of workers, etc.). 
Analytically, the experts proposed a distinction of foreign vs. domestic R&D when considering R&D in 
NMS and, moreover, called for working out the particular differences of FP6 / FP7 programmes with 
respect to R&D in the NMS.  
 
Going ahead in terms of the above outlined avenues of research in the field certainly may help 
getting a clearer picture of R&D in the NMS. 
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Raising private sector R&D in the New Member States:  
Does it help their economies catching up? 
 
 
1 Introduction 
The new Member States [NMS]14 are in a process of transition, industrial restructuring and integration 
into the EU economy, which still has a long way to go. Nevertheless, on a number of structural and 
knowledge economy indicators, some countries are close to or even superseding the position of older 
Member States. The picture is diverse: countries ahead on R&D are not always the same as the ones 
showing fast growth; fast risers on the European innovation scoreboard do not necessarily 
generate/attract much R&D investment by companies. The overview provided by this report is a 
synthesis of the final project report of the ETEPS study 'Private Sector R&D in the NMS' (Specific 
Contract No. C150083.X7), updated with further corresponding material. Thus, the study seeks to 
analyze the situation of private sector R&D in the new Member States by comparing the available 
statistics. It also investigates the presence of these countries in key sectors relying on R&D, with a 
focus on company cases where sector data are missing or outdated.15 
The Member States are implementing "Lisbon Programmes" (almost all have set individual targets for 
R&D investment) in order to cope with the challenge of generating higher growth and employment. 
They strengthen the political accountability and allow for the assessment of the reform measures 
taken at country, region and/or sector level. For instance, the Czech Republic has released a (three-
year) National Reform Programme, representing an integrated and cohesive approach and targeting 
macroeconomic, microeconomic and employment policies, which can be revised in case of political 
changes and which has been elaborated on the basis of the Integrated Guidelines for Growth and 
Jobs (2005–2008), adopted by the European Council in June 2005. 
 
According to the final project report on Private Sector R&D in NMS (see Annex II) a number of cross-
cutting issues for policymaking on R&D and innovation can be identified:  
 Consideration of national and sectoral innovation systems to ensure the embedding of R&D;  
 Future development of the human resources base as a pre-condition for performing R&D and 
thus for attracting investment in R&D;  
 Continuous improvement of innovation infrastructures (universities, research centres, etc.), not 
only as sources of qualified R&D personnel, but also as potential partners for industrial R&D;  
 Emphasising increasingly the role of services, either as stand-alone research-intensive 
activities (e.g. KIBS) or as services supporting R&D performed in other sectors (e.g. 
standardisation, IT services);  
 Improving the innovation climate by structural measures rather than by financial incentives;16  
 Bundling of national R&D capacities (e.g. through national technology platforms) and seeking 
a better coordination with European initiatives.  
 
                                                 
14  NMS: Cyprus (CY), the Czech Republic (CZ), Estonia (EE), Hungary (HU), Latvia (LV), Lithuania (LT), Malta (MT), 
Poland (PL), the Slovak Republic (SK) and Slovenia (SI). 
15  This is consistent with recent trends in research and innovation policy research stressing the integration of RTDI-
policies into stronger industrial or sectoral policies (Malerba 2004). 
16  This concerns, for instance, the strengthening of the relationships between private as well as public innovation actors. 
In fact, there are already some examples of private firms getting engaged in funding R&D centres or university 
institutes. 
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Furthermore, from a policy perspective, there are a number of issues too that would require further 
investigation in order to be able to better assess the role and the impact of different types of policy 
measures in the new Member States: 
 The impact of targeted policy measures in terms of attracting and embedding foreign R&D 
investments. In fact, several NMS have implemented such targeted measures (e.g. tax and 
investment incentives). Thus, the major objective is increasing investment in R&D. But, 
although targeted measures have been quite successful in raising FDI, it is rather unclear 
whether these incentives are sufficient to ensure that this investment will stay and not move 
elsewhere once the conditions may change. In other words, the key question concerns the 
sustainable embedding of corporate R&D investment in the NMS innovation systems. 
 The impact of targeted measures on leveraging R&D funding: Rather than addressing 
specifically foreign firms, efforts should also stimulate domestic (private) investment in R&D 
and innovation, e.g. facilitating access to venture capital, supporting spin-offs, etc. 
 The role of publicly funded innovation infrastructures for attracting and embedding private 
R&D investment: Policy may – to a certain extent – leverage corporate R&D investment by 
upgrading the existing innovation infrastructure, i.e. creation of at least partly publicly funded 
research and research-facilitating organisations (technology transfer centres, competence 
centres, etc.). In a wider sense, investments in the HES also fall under this category, thus 
adding the educational and human resource dimension. 
 The role of national platforms and clusters: As a co-ordination measure, building of sector or 
technology-specific platforms is about to be implemented in some NMS (e.g. in Poland). There 
are potential benefits to be reaped by these measures, for instance in terms of international 
visibility, economies of scale, and influence on the agenda-setting at European level. But, 
suitable approaches for implementing these platforms still have to be developed.  
 
2 Bridging technological gaps and moving frontiers: Impetus R&D 
Closing any gap – namely realising convergence – in terms of R&D, technology, innovativeness or 
any other indicator implies achieving growth rates exceeding those of the corresponding leader who 
currently makes the pace and provides the benchmark accordingly. But, currently technology is 
advancing faster than ever which makes the benchmark – the technology frontier – permanently 
moving outwards, expanding the production possibility set.17 This is captured in the economic 
literature in comprehensive parametric or non-parametric models estimating the relevant isoquants 
and their changes in terms of shape or slope in time. In this study, we take a modest first step by 
investigating the R&D trajectories of the EU-25 countries trying to answer the question whether there 
is indeed empirical evidence of convergence in terms of R&D efforts and whether this is, however, a 
sign of economic and technological catching up.  
 
Assessing R&D growth rates and the trajectories in the NMS: What is the appropriate benchmark?  
 
No doubt, catching up with the global technological frontiers is a common target, also for NMS. But, 
considering the need of convergence and integration of NMS economies into the EU, benchmarking 
NMS and the EU-15 for the time being appears to be more appropriate. Hence, for this study the 
emphasis is on the latter. Nevertheless, it needs to be mentioned that the overall performance of R&D 
in Europe in recent years was lacking behind the development of the most relevant competitors (US, 
Japan, China, …). After evidence of slowly catching up, Europe as a whole again seems to fall further 
behind in terms of technology, approximated by R&D intensity.18 In this regard, Phillippe Aghion 
(2006) argues that R&D intensity systematically increases as industries are getting closer to the 
technological frontier and, since the EU-15 countries have moved closer to the world technological 
                                                 
17  In this context, the concept of technological frontiers refers to the efficient boundaries of the production possibility set 
(comprising all production possibilities technologically feasible), moved in- or outwards by technological change. See 
in this context e.g.: Solow (1957, p. 312), based on Cobb und Douglas (1928); Shepard (1953); Carlson (1939); 
Cassels (1936); Allen (1938) or also e.g. Chambers (1988) and Varian (1992). 
18  See e.g. European Commission (2006a and 2007a) for a general overview, and with particular respect to corporate 
R&D: European Commission (2006b): Analysis of the 2006 EU Industrial R&D investment Scoreboard.  
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frontier as an effect of a long period of catching up, they should invest even more in R&D. Moreover, 
within the EU, the most advanced countries should invest proportionally more since they benefit from 
a higher productivity of R&D. Thus, divergence between leading and lagging European countries 
might be explained.  
 
What about returns to scale in terms of R&D as a primer to innovation and growth?  
 
Certainly there is a positive marginal effect of R&D in case of the high-tech performers, and, as known 
from developing countries, a certain minimum capability is needed in order to achieve any positive 
returns to R&D investments at the lower end of the scale. Indeed, in low R&D intensive countries, 
initially government-funded R&D might be more important than business-funded R&D as it is critical 
for creating and developing Science and Technology [S&T] capabilities (a prerequisite for catching up 
with countries at the technology frontier) and for supporting research projects with expected high 
social benefits, which the private sector may not find sufficiently attractive. Hence, while investigating 
corporate R&D investments in the NMS one should also keep an eye on the public side.  
 
Why considering R&D and not other approximations of innovativeness, technological capability, etc.? 
 
In general, countries that failed to build capabilities enabling them to participate in the evolving global 
networks of knowledge creation risk falling further behind in terms of competitiveness as well as 
economic and social development.19 However, any leading position in terms of technology is 
supposed to be a result of accumulating know-how, performing R&D, creativity and the ability to 
transform the results into marketable products. There is no magic concerning the leadership, much of 
it reflects path dependence (the history of any economic system matters!).20 Outperforming of the 
frontier performers is only possible if sufficient and adequate efforts are made. In terms of the latter, 
investment in R&D appear to be the key21 and, therefore, the centre of the attention here.  
 
3 Reflection on R&D in the NMS before and after accession  
The transition from formerly planned to market economies in most of the NMS went hand in hand with 
significant structural changes. Accordingly, also the corresponding National Systems of Innovation 
[NIS]22 and the type of R&D, public as well as private, have changed considerably. In view of the 
challenge of integrating the NMS economies into the EU, this process of structural adjustment and 
evolution is likely to take some time. Hence, our search for evidence of converging R&D patterns in 
Europe is cast of a general reflection of what we know about the NMS in the pre-accession situation 
and what we expect to see happen there after EU accession? 
In the period right before accession, the amount of R&D performed was low. Nevertheless, it has to 
be mentioned that in some countries and in particular fields of science, noteworthy results were 
achieved, that proved to be competitive also at a global level.  
                                                 
19  See: UNCTAD (2005), chapter III: Innovation, R&D & Development 
(http://www.unctad.org/en/docs/wir2005ch3_en.pdf).  
20  As, on the one hand, accumulating knowledge and capabilities are core for achieving technological competence and, 
on the other, technological breakthroughs could make some knowledge and achievements obsolete there is always a 
certain path dependence apparent in setting the frontier or getting closer to it.   
21  In fact, empirical studies suggest a direct relationship between R&D and growth. For instance, Guellec and van 
Pottelsberghe (2004) found the long-term impacts on economic growth of public R&D and business R&D to be strong 
and significant. Business R&D undertaken in other countries apparently also plays an important role. Moreover, 
increased domestic business R&D accentuates the positive impact of both public and foreign business R&D. In other 
words, business R&D (either domestic or foreign-funded) has both a direct impact on a country’s economic growth as 
well as an indirect one through improved absorption of the results of public R&D and R&D performed in other 
countries. 
22  Enterprises are the principal agents of innovation today, but they do not innovate and learn in isolation. They rely on 
intricate (formal and informal) links with other firms and with public research institutions, universities and other 
knowledge creating bodies like standards and metrology institutes. In undertaking innovation, they react to 
government policies on trade, competition, investment and innovation. They seek human resources for innovation 
from the education and training system, and they draw upon the financial system for funding innovative efforts. The 
complex web within which innovation occurs is commonly referred to as the “national innovation system” or NIS 
(Nelson 1993, Lundvall 1992) 
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The pre-accession situation in terms of R&D in the formerly planned economies can be characterized 
as follows: R and D were performed separately and all in all not very well connected. Research was 
performed mainly in public institutions and the (mostly state owned) companies dominantly focused 
on 'development'. The lack of an integrated NIS with R&D performing private companies as the 
driving force of developing marketable products significantly hampered a full exploitation of the public 
research base. Although some NMS had a good reputation in science (more in basic than in applied 
research), these countries were not considered to be at the technology frontier and were competitive 
only in terms of niche markets/products.  
 
What about expectations with respect to the transition process and in terms of the EU accession? 
 
In fact, there are number of reasons why NMS could have faced significantly rising corporate R&D 
investments already before entering the EU. The main argument is rooted in the existence of 
developed public research systems and qualified human capital, together with emerging businesses.  
These prospects were further enhanced by the inflow of Foreign Direct Investment [FDI], the 
improvement of institutional conditions and local infrastructure as well as a rising domestic demand in 
response to the increase in per capita income.  
 
However, there are some counter-arguments… 
 
Any substantial change provides winners and losers. With respect to the Central and Eastern 
European (CEE) NMS there is evidence that some companies benefited from increasingly stable 
macro-economic circumstances. The initial undervaluation of the exchange rate enabled them to re-
orient their exports from collapsing Eastern markets to Western ones. In contrast, the diversification of 
the NMS industrial composition, the corresponding network cut offs and the devaluation of 
accumulated technological knowledge and capabilities negatively affected their R&D and innovation 
capacities. Furthermore, the predominantly rapid and extensive way of privatization of significantly 
undercapitalized companies brought about that larger (usually low tech) enterprises, like metallurgy, 
heavy machinery, coal mining, energy production, etc. could better face the constraints determined by 
economic reform than the middle and high-tech manufacturing.23 The total amount of corporate R&D 
dropped accordingly. For instance, in Czech Republic corporate R&D decreased by more than half in 
total – in some branches even more – and the profile of individual R&D units has shifted in favour of 
non-research activities. Right after the cutback, corporate R&D tended to remain low and the research 
infrastructure was adjusted to match the available knowledge and remaining science capacities. 
Also in terms of publicly financed R&D, the figures decreased (mainly affecting basic research) due to 
budget cuts during the transition process as well as the closure of R&D divisions of formerly state-
owned companies (mainly affecting applied research). The privatization process has triggered as well 
as hampered the R&D development in the CEE countries and public sector R&D capabilities tended 
to be diminishing in the pre-accession period which has further weakened the NIS. Hence, rising R&D 
trajectories are not as obvious as initially suggested and improving the R&D performance of entire 
economies indeed does not appear to be easy; also not in an environment of up-swinging economies 
like the NMS.  
 
4 R&D intensity in the NMS: Some empirical evidence 
Figure 1 shows the absolute R&D intensity in 2005, the corresponding change between 2000 and 
2005, as well as the main (%) sources of funds for R&D expenditures by country in 2005. The picture 
provided is heterogeneous. In general, there are large disparities within the EU-15 and the NMS-12. 
The latter throughout can be found below the mean EU-27 R&D intensity (1.84% GERD as % of GDP, 
year 2005); with Czech Republic the highest (1.42%) and 0.39% in Romania.24 Concerning the 
'technological output' of R&D activities, for instance approximated by EPO patent applications per 
capita, the same picture emerges: all NMS are below the EU-27 average (year 2003; EUROSTAT).  
                                                 
23  Middle-tech manufacturing used certain advantages of foreign capital and technology inflow as e.g. in the case of 
automotive production: SKODA/VW in Czech Republic. 
24  Data: EUROSTAT, OECD. 
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Figure 1: R&D intensity, 2005 and average annual growth, 2000-2005 
 
Figure 1 illustrates that the MS can be clustered as catching up, falling further behind, loosing 
momentum, and pulling further ahead. The NMS can be found in different clusters, meaning that there 
is no common pattern in terms of R&D trajectories aside from the fact that in all NMS the R&D 
intensity is low and that the government sector still accounts for a very large share of the entire R&D 
funding. In other words, it seems that the pre-accession situation has not yet changed significantly: 
R&D sectors and the NIS are dominated by the state sector.  
Further and more detailed analyses seem to be needed focusing on NMS individually and/or their key 
economic sectors in order to substantiate this first impression. A first investigation of the empirical 
evidence shows that the declining R&D intensity primarily resulted from reduced funding (particularly 
in Bulgaria and to a lesser extent in Poland), and in a few cases (Slovakia as an example) from a 
weakened contribution from the private sector. Table 1 below summarises these tendencies as 
stylised facts. 
5 Convergence vs. divergence in terms of R&D: Stylised Facts 
Convergence in terms of R&D intensity, if at all, can be recognised only to a limited extent. Indeed, 
the majority of low R&D-intensive MS (i.e. R&D intensity below 1.5%; namely all NMS) is catching up 
with the remainder of the Union, albeit at different speeds. However, as indicated above, there are 
also some low R&D-intensive MS (among them four NMS: Bulgaria, Poland, Malta and Slovakia), 
apparently falling further behind since 2000 (Source: EC (2007): Key Figures, p. 54. Note: revised 
EUROSTAT data considered for Slovenia). Table 1 summarises these R&D trend patterns.25  
                                                 
25  The stylized trend patters outlined hereinafter are derived from figures provided by EUROSTAT, DG Research, OECD 
as well as various statistical sources from the NMS according to the country studies on R&D in the NMS (EC (2006c)). 
A data availability matrix concerning relevant R&D figures in the NMS has been developed as part of the mentioned 
study, crossing data from various sources, like data from country's statistical offices, ministry information, and 
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Table 1: Trend patterns of GERD and BERD - Convergence in the EU? 
 GERD (as % of GDP)  BERD (as % of GDP) 
Country 
NMS vs. EU-27 
R&D intensity  
tendency 2000 – 2005 
public expenditures1  
average annual growth 
2000 – 2005 
business expenditures2 
average annual growth 
2000 – 2005 
Czech 
Republic catching up catching up catching up 
Slovakia falling further behind catching up falling further behind 
Slovenia catching up …?3) catching up 
Poland falling further behind falling further behind falling further behind 
Hungary catching up catching up catching up 
Latvia catching up catching up catching up 
Estonia catching up catching up catching up 
Lithuania catching up catching up catching up (if 2006 is considered too) 
Cyprus catching up catching up catching up 
Malta falling further behind  … … (falling further behind)  
Bulgaria falling further behind falling further behind falling further behind (little change) 
Romania catching up catching up falling further behind 
 
Note: 1) Estonia, Cyprus, Romania 200-2004, no (reliable) data for Malta 
 2) Romania 2000-2004, Malta 2004-2005 
 3) Decreasing until 2004, increasing thereafter (2005, 2006). No clear trend patterns. 
Source: EUROSTAT, DG Research, OECD, complemented with data from EC (2006c) country studies.26  
 
Splitting up GERD [Gross Expenditure on R&D] into financed by government and business sector 
suggests that the dynamics of BERD [Business Expenditure on R&D] determine the overall trend 
patterns. In fact, with the exception of Romania, those NMS that show convergence in terms of BERD 
as % of GDP also converge with respect to the average EU-27 R&D intensity. In other words: private 
sector R&D appears to be the key for catching up in terms of R&D figures in the NMS and this, as 
stated above, can be affected by policymaking only indirectly which gives reason to scrutinize the 
evidence more deeply.  
6 BERD in NMS: Evidence from sector studies 
Equivalent to GERD, there are also large disparities in terms of BERD among the EU countries. The 
contribution from private sector to the financing of R&D, in 2005, has been 54.5% of total R&D 
expenditures in the EU-27, whereas public funds accounted for about one-third of the total R&D 
spending.27 However, in most of the NMS this relation is vice-versa, meaning public sector spending 
on R&D is significantly larger than private sector'. In 2005, even more than 60% of the R&D in Poland, 
Bulgaria, Lithuania and Cyprus was funded by the government sector.28 
                                                                                                                                                                       
publicly available information from analytical sector and/or company case studies, and – in some case – from 
company interviews too (e.g. Czech Republic).  
26  Concerning data availability and reliability, in general, significant improvements can be recognized in the recent 
years. Nevertheless, for some countries/years it is still difficult to find reliable and sufficiently detailed data on R&D 
performance and investments. The latter is particularly lacking in small countries at sectoral level, like e.g. Malta, 
since sometimes a certain sector consists out of a few companies only and, therefore, data are not made publicly 
available due to potential confidentially issues.  
27  8.5% of total R&D expenditure was funded from abroad (both from private and public sources). 
28  It should be borne in mind that the shares of domestic R&D expenditure financed from private and public sources 
contain a certain margin of error, due to the unavailability of a breakdown in the category 'funded from abroad' 
between private ('abroad-private') and public ('abroad-public') sources. At EU-27 level, funding from abroad 
represents 8.5% of  total R&D expenditure (in 2005). Since it can be assumed that an important part thereof comes 
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However, considering R&D in the business enterprise sector in the EU-27, empirical evidence 
suggests that BERD growth is driven by few key sectors only.29 Hence, a selection of such sectors 
was made and the corresponding sectors have been analysed more in detail. Table 2 provides an 
overview of the selected sectors per country (see EC (2006c): Synthesis Report, pp. 18-51 for an 
individual consideration of corporate R&D in each of the NMS and the corresponding reasoning of the 
particular selection of sectors to be analysed accordingly). 
Evidently, the sectors considered as key for the NMS economies differ to some extent from country to 
country, reflecting the particular characteristics of the industrial structure and the corresponding 
dynamics (emerging sectors) of each NMS. Differences in this regard are not surprising in the light of 
an increasing international division of labour and further specialisation in course of the globalisation. 
Though, this makes deriving stylised facts in terms of business R&D in the NMS a none-trivial task as 
each sector follows individual dynamics and is affected by its particular global business cycle. Hence, 
exemplary for all sectors investigated, hereinafter Automotive & Parts (NACE 34…) and the 
Pharmaceutical Industries (NACE 24.4) will be discussed in brief as they are economically important 
either for many NMS and/or appear to be particularly emerging with or without long country-specific 
tradition in the particular sector (relevant for capturing structural changes in the NMS).30   
 
Table 2: Country – Sector Study – Matrix  
Manufacture of… NACE 
Czech 
Republic Slovakia Slovenia Poland Hungary Latvia Estonia Lithuania Cyprus Malta 
Food & Beverages 15       x x  x 
Textiles 17      x     
Publishing & Printing… 22          x 
Chemicals & chem. 
Products (incl. Pharma) 
24… x x x x x x  x x  
Rubber & Plastics  25 x x         
Base Metals & Fabricated 
Metal Products  
28  27-28    x     
Machinery & Equipment 29   x x   27-29 x x x 
Electrical Machinery 31… x  x  x      
Medical Precision & optical 
Instruments  
33   x  x   x   
Motor Vehicles, Trailers,…  34… x x  x x      
Other Transport Equipment  35…    x       
Furniture & Recycling 36, 37       x    
# Construction 45         x  
# Financial Services 65-67       x  x x 
# Other Business Services 74      x     
 
Source:  EC (2006c), Private Sector R&D in the NMS; individual Country & Sector Studies and Synthesis Report. 
6.1 Sector Study I: Motor vehicles and related industries 
Although the automotive sector is considered as a key industry in many NMS there is quite a 
difference in terms of absolute importance, particular sector composition and individual specialisation 
(cluster appearance).31 In total, the automotive sector in 2004 contributed about 2 bn. EUR or 2.7% to 
                                                                                                                                                                       
from private sources (from abroad), it is very likely that the share of the private sector in the financing of domestic 
R&D is in reality significantly higher than 54.5% (EC: Key Figures, 2007b, p. 55ff.). 
29  EC (2007b), Key figures, p. 58 ff (cited according to p. 62). 
30  See the individual sector studies (Annex II) for further results. 
31  As a very wide range of products are used to assemble a motor vehicle and practically all industrial sectors supply the 
automotive industry, beside NACE 34 sector, manufacture of electrical equipment for engines and vehicles (NACE 
31.61) and manufacturing of rubber and plastic parts (NACE 25) are considered for this analysis too. 
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the Czech GDP (representing 13% of manufacturing industry GDP and employing 7% of the total 
workforce). In Slovakia, in 2004, the sector generated 2.2% of the GDP (expected to increase further 
in future)32, in Poland 1.5%, and 1.3% in Hungary. According to ILO [2005], the automotive cluster 
currently comprises of about 260 suppliers and subcontractors in Slovakia, employing > 25 thousand 
people, and even 345 producers in Poland with 92.5 thousand employees.33 In the Czech Republic, 
the cluster (employing more than 80 thousand people), however, is more concentrated and mainly 
dominated by Volkswagen / Skoda and its suppliers. In fact, most of the companies in the NMS are 
managed by strong foreign owners or depend on foreign (tier 1) suppliers.  
In general, the overall organisational pattern of the industry, a hierarchically three tier structure, has 
significant impacts on the corresponding sector characteristics in the NMS. Typically, a number of 
foreign-owned T1 suppliers have set up plants in the NMS, either via green-field investments or by 
taking over domestic firms. Most of the domestic companies are T2 and T3 suppliers (with some 
exceptions) and usually rely on numerous small and medium-sized enterprises, producing basically 
simple, labour-intensive products given their wage and flexibility advantages compared to 
larger/foreign firms. 
Generally, the automotive sector has (re-)emerged in the NMS quite rapidly. Car producers as well as 
suppliers – mainly from abroad – have invested significantly. Thus, the main arguments for investing 
in this sector have been the cost advantages vis-à-vis the EU-15 and the emerging opportunities of 
getting a foot into the enlarged European market. The first argument holds equally for all investors; 
the second is mainly relevant for manufacturers from Asia. However, Foreign Direct Investments [FDI] 
are the main driver of the sector expansion. Investments are either secured by take-over of existing 
firms or in some cases by joint ventures, being either brown-field or green-field types of 
investments.34 Evidence suggests that particularly Asian car companies, engaged in the NMS, can 
draw upon their domestic networks of suppliers only to a limited extent (given geographical distance 
or, as in the case of Slovakia, since they are hindered to do so by national interest groups). Hence, 
suppliers in the NMS emerged and/or are expanding accordingly.  
                                                
Doubtless, FDI investment played also an important role in terms of R&D as new technologies and 
processes were brought to the NMS, making the sector productivity rising in most countries which can 
be mainly explained by intra-firm knowledge transfer. Moreover, for example in Poland, new R&D 
centres have been installed financed from abroad (like the ones by Delphi and TRW) that led to an 
increase in sector R&D personnel of more than one third from 2002 to 2004. In contrast, the absolute 
level of R&D personnel in NACE 34 stayed more or less stable in the Czech Republic and in Hungary 
(for Slovakia no data are available due to confidentiality restrictions). Indeed, for instance in the 
Czech Republic – due to the investment by VW –  the number of R&D employees increased from 
approx. 600 in 1991 to 1420 in 2005. But, many other domestic companies either had to close down 
or to restrict considerably their R&D activities in course of the privatisation what, in total, has led to the 
stagnating figures in terms of the R&D personnel. If R&D activities are approximated by 
corresponding expenditures, as done above in aggregated terms, again a slightly distinguished 
picture emerges. In all considered NMS the investments in R&D have been significantly increasing. 
Table 3 illustrates the R&D intensities of automotive (and related) industries as well as the 
corresponding changes in terms of R&D investments per sector. 
 
 
32  In 2003 and early 2004 both PSA Peugeot Citroen and Hyundai-Kia announced their plans to build large final 
assembly plants in Slovakia. This investment will nearly triple automotive output by the end of the decade and 
remains the key driver of the Slovak economy. These developments may as well lead to an increase in R&D intensity 
in the future. 
33  Main producers of passenger cars/vans in Poland are Fiat Auto Poland S.A. in Bielsko-Biala, FSO S.A. in Warsaw, Opel 
Polska in Gliwice Sp. z o.o., Volkswagen Poznan Sp. z o.o. in Poznan and Intrall in Lublin. Trucks, buses and coaches 
are produced by MAN Star Truck Sp. z o.o. in Starachowice, Zak ady Samochodowe JELCZ S.A. in Jelcz-Laskowice, 
Autosan S.A. in Sanok, Solaris Bus & Coach Sp. z o.o. w Bolechowie, Solbus Sp. z o.o. w Solcu Kujawskim, MAN 
Pojazdy U ytkowe Polska Sp. z o.o. in Poznan, Volvo Poland Sp. z o.o. in Wroclaw and Scania-Kapena Sp. z o.o. in S 
upsk. Delphi and TRW are the two first enterprises in the sector setting up their own R&D units in Poland. 
34  Important FDI projects have been for instance in the Czech Republic the acquisition of Skoda by VW, while in 
Hungary Suzuki, General Motors and Audi established their operations by green-field investments. Fiat and Daewoo 
took over Polish firms and General Motors set up a green-field investment in Poland. PSA Peugeot Citroen and 
Hyundai Kia are setting up Greenfield investments in Slovakia. 
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Table 3: Sectoral R&D intensity, GDP share and investment dynamics 
 NACE Sector (manufacture of…) 
Sectoral R&D 
intensity  
sectoral R&D as 
% of sector GDP 
2003 or 2004 
Change of R&D 
intensity 
 
Ø annual change 
 
Sector as % of 
national GDP 
 
 
2003 or 2004 
Czech 
Republic 
34 Motor vehicles, trailers, … 8.8% 
5% (2001-2004) 
about stagnating? 
2.7% 
 31 Electric machinery & apparatus  1.8% 104% (2001-2004) 1.8% 
 25 Rubber & plastic products 0.9% 91% (2001-2004) 1.6% 
Hungary 34.4 
Parts & accessories for motor 
vehicles & their engines 
2.8% 114% (2001-2003) 0.8% 
 31 Electrical machinery & apparatus 3.5% 54% (2001-2004) 0.3% 
Poland 34 Motor vehicles, trailers, … 1.3% 55% (2003-2004) 1.3% 
Slovakia 34 Motor vehicles, trailers, … 1.7% … 2.2% 
 25 Rubber & plastic products 1.1% 10% (1998-2004) 1.0% 
 
Source:  EC (2006c), Private Sector R&D in the NMS; individual Country & Sector Studies and Synthesis Report. 
 
Apparently, the sectoral R&D intensities differ significantly from country to country, being the highest 
in the Czech Republic where the sector also has the highest GDP share. In all other NMS the R&D 
intensity is lower, but significantly rising, which is supposed to affect likewise the sector share in GDP.  
In general, although there are obviously some country-specific paths due to individual historical 
determinants, different privatisation strategies, etc., which, to some extent, are still perceivable in the 
structures of the sector,35 the following can be summarized as common for all: The trend figures of 
the automotive sector in the NMS over the last years have shown an upswing, constant or rising 
sector contributions to the national GDPs and increasing R&D intensities, exceeding the country-
average levels in manufacturing industries in some cases even by far. These very positive sector 
trend patterns provide a contrast to the aggregated figures on R&D in NMS as discussed above. 
Indeed, looking at the R&D expenditure in the automotive sector country wise, it appears to be above 
the corresponding industrial average, meaning the sector is comparably R&D intensive36 (note: all 
NMS have been found to be low-R&D intensive in aggregated terms, see above). However, taking 
again the example Poland, the relation between sectoral R&D expenditures and total sales has 
reached only 0.2% in 2003 and 2004 (despite a 55% increase of R&D expenditures), what is still far 
away from the EU-15 average. 
                                                
In fact, all the promising figures at sector level cannot hide that there are also some drawbacks. For 
instance, according to some recently published labour market analyses a lack of suitably qualified 
personnel for R&D appears. Actually, the lack of qualified employees and university graduates with 
technical background was one of the reasons which led Skoda Auto towards the decision to build the 
university campus Na Karmeli. Obviously, the availability of highly qualified R&D personnel seems to 
be an ever increasingly important impeding factor for the expansion of R&D units in the NMS. 
Empirical evidence suggests within the NACE 34 a sector productivity growth higher than the labour 
costs growth, which is important for attracting FDI and keeping the sector internationally competitive. 
However, since more and more automotive companies are setting up their factories in the NMS it 
becomes increasingly difficult to get the adequately qualified people. It seems that the sector is 
suffering from its own success (and from the immigration of highly qualified people due to 
international salary disparities).  
 
35  As an example, the Soviet-Hungarian specialisation agreement from 1964 stipulated that Hungary would specialise in 
producing buses for the entire Council of Mutual Economic Assistance [CMEA]. Skoda was practically the only 
producer of cars in the NMSs with its own R&D unit. All other car manufacturers produced cars with licences from 
western companies. For more details on the history of the automotive industry in Central European countries, 
including recent developments, see e.g. Havas [2000a], [2000b], Pavlinek, [2002a], [2002b], [2003], [2005] 
36  It needs to be mentioned that the automotive sector in the literature commonly is classified as medium-low or 
medium-high R&D intensive sector.   
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Accordingly, extending and adjusting the national research infrastructures and the education systems, 
both a private as well as a public agenda point, returned to be in the focus. Admittedly, so far, there 
seems to be a communication gap among universities and their engagement in specific research 
tasks on the one hand side and the business sector on the other. There are many obstacles for co-
operations between companies and (still mostly public) R&D institutions, such as the emphasis of 
universities on basic science instead of focussing also sufficiently on applied research and 
development of marketable product solutions, administrative barriers, etc. Although this problem is 
known from almost all EU countries it applies particularly to the CEE NMS where the NIS and the 
public research infrastructures had to undergo the transition process and a difficult adjustment period 
too, while suffering from significant budget cuts. Therefore, nowadays the public infrastructure in the 
NMS is simply lacking behind the business sector requirements. Given that, indigenous automotive 
suppliers (T2 & T3) are likely to be forced to step up their R&D efforts by setting up own R&D facilities 
and/or intend to achieve a closer intra-sectoral co-operation (accelerated cluster building). Along this 
way, most likely, R&D will play a role in the efforts made to extend the value chain in the car 
manufacturing within the NMS. But, although the sector is economically important, the potential of 
R&D-induced growth in low- or mid-tech suppliers industries (as this sector is commonly classified) 
should not be overestimated. Considering the quite promising sector trajectories in the light of the 
overall NMS trends concerning technological development, R&D and innovation, evidently, it remains 
a long way to go for the NMS in order to close the existing gap to the EU-15. In fact, automotive and 
parts as an emerging sector can certainly pull the technological development of the NMS economies 
by spill over and spin over effects. However, more such examples are needed. Accordingly, in the 
following a look at the Pharmaceutical industries of the NMS will be made. 
6.2 Sector Study II: Pharmaceutical industries 
The pharmaceutical sector (NACE 24.4) is, in general, one of the most R&D intensive and dynamic 
sectors and thus an interesting comparative case study also in terms of the NMS. The sector has 
been analysed individually by national research teams in Poland, Hungary and Slovenia. 
Complementary, in Latvia, Lithuania, Slovakia, Cyprus and the Czech Republic the chemical sector 
(NACE 24) has been considered assuming that this reflects the main tendencies of the incorporated 
pharmaceutical sector too and, therefore, can be taken here as an approximation. Table 4 provides 
the R&D intensities as well as their corresponding recent growth rates referring to the analysed 
sectors. This may illustrate the relative importance of the particular sector for each country and the 
role of R&D accordingly.  
 
Table 4: Sectoral R&D intensity, GDP share and investment dynamics 
 NACE Sector (manufacture of…) 
Sectoral R&D 
intensity  
sectoral R&D as 
% of sector GDP 
2003 or 2004 
Change of R&D 
intensity 
 
Ø annual change 
 
Sector as % of 
national GDP 
 
 
2003 or 2004 
Cyprus 24 Chemicals & Chemical Products 3.8% 113% (2001-2003) 0.5% 
Czech Rep  24 Chemicals & Chemical Products 4.6% 65% (2001-2004) 1.4% 
Hungary 24.4 
Pharmaceutics, med. chemicals & 
chemical products 
19.3% -5% (2001-2003) 0.5% 
Latvia 24 Chemicals & Chemical Products 1.9% 50% (2001-2003) 0.6% 
Lithuania 24 Chemicals & Chemical Products 5.3% 974% (2002-2003) 1.0% 
Poland 24.4 
Pharmaceutics, med. chemicals & 
chemical products 
n.a. 39% (2003-2004) n.a. 
Slovakia 24 Chemicals & Chemical Products 1.1% 
unknown due to 
data protection 
0.8% 
Slovenia 24.4 
Pharmaceutics, med. chemicals & 
chemical products 
8.8% 19% (2001-2003) 3.3% 
Source:  EC (2006c), Private Sector R&D in the NMS; individual Country & Sector Studies and Synthesis Report. 
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According to Table 4, the pharmaceutical sector has indeed a quite significant GDP share in Slovenia. 
In all other NMS, both considered as sector aggregate NACE 24 or stand alone as NACE 24.4, it is 
rather unimportant for the National Accounts. However, the sectoral R&D intensity in general is 
comparably high in most of the NMS and it is particularly in those countries over-proportionally rising 
that are still lacking behind in this regard. Hence, there is a catching up in terms of sectoral R&D 
intensity, at least among the NMS laggards.  
Moreover, the R&D growth rates appear to be the highest in those countries that have the lowest 
sector share in GDP. The latter indicates that the NACE 24 / 24.4 sector is indeed an emerging sector 
in a number of NMS economies and therefore of particular interest. In fact, over the last 10 years the 
pharmaceutical sector has been growing with respect to total size (in terms of sales and value added) 
as well as concerning R&D expenditures and R&D employees in most NMS. Some countries had 
drawbacks (e.g. Latvia in 1999), but have recovered recently. Only in case of Slovakia a more 
persistent decline of the sector (NACE 24) had to be observed.  
Alike the case of the automotive sector, as described above, also the transition of the pharmaceutical 
sector has been dominated by the privatisation of large formerly state owned enterprises and by FDI. 
This led to a restructuring of R&D labs within larger organisations and, in some countries, also to a 
concentration of R&D in fewer R&D sites as happened for example in Hungary over the recent years. 
However, in general, the number of firms active in the sector appeared to be rather constant (which is 
in contrast to the automotive sector were it was found to be rising, see discussion above).  
According to the absolute figures of R&D expenditures, Hungary37 and Slovenia38 are the most 
important R&D performers in the NMSs competing on global markets. In contrast, in Poland and the 
Czech Republic39 enterprises in total invest much less; approximately only half of what is spent in 
Hungary. The later means that, although the contribution of pharmaceuticals to the total GDP as well 
as the spending on R&D in Poland and the Czech Republic is rising, in both countries the R&D 
capability is supposed to be still quite low. In fact, with the exception of Slovenia and Hungary, the 
National Innovation Systems in NMS are (still) little oriented towards the pharmaceutical sector.40  
In general, FDI appears to be the decisive factor of the sectoral development and the structural 
patterns of corporate R&D in the NMS pharmaceuticals. Nowadays, most large scale pharmaceutical 
companies in the NMS are subsidiaries of foreign MNCs, in Hungary for instance about 80%. 
However, in the pharmaceutical industry the sector concentration seems to be even higher compared 
to the automotive sector. In fact, T2 and T3 suppliers appear to be much less important, few in 
numbers and/or generally little dispersed. This is supposed to be mainly reasoned by the privatisation 
process. In course of the privatisation, the new - mostly foreign - owners have restructured the 
existing R&D systems, often reduced the number of R&D projects and narrowed the company's 
product range what has led to further specialisation, for instance in certain fields of product 
development and manufacturing. Particular emphasis was given to the production of generics, a field 
where the NMS companies traditionally had competencies. But, following this business and innovation 
strategy, most pharmaceutical companies in the NMS are currently carrying out applied R&D solely 
even though the development of fundamentally new drugs appears to be essential for their 
competitiveness in the mid/long run and, therefore, also for their survival. As a critical side effect of 
this specialisation strategy possible co-operations with domestic research infrastructures (universities 
and research organisations) have been limited. This environment may appear particularly struggling 
                                                 
37  Hungary's pharmaceutical sector has grown faster than the entire chemical sector and appears to be the most R&D 
intensive sector in Hungary (R&D expenditure growth of about 20% annually 2001-2003). Total sales and value 
added also grew remarkably between 1997 and 2004, mostly triggered by rising productivity. Thus, evidence suggest 
that the sector in Hungary is more capital intensive than in Slovenia. In 2002, 25% of the R&D personnel in Hungary 
were spending 35% of national BERD, whereas 15% of Slovenia's R&D personnel were spending 30% of national 
BERD. This might be explained by differences in the overall labour productivity (higher in Slovenia) and/or by the 
country specific enterprises structures. 
38  R&D expenditures in Slovenia almost sevenfold between 1992-2004, even though only two firms are doing R&D. 
39  In 2004, the R&D expenditures in the Czech chemical industry reached 50 mio. EUR. In fact, expenditures were 
decreasing in the first half of the 1990s affected by the privatisation. However, during the period 1995-2004 it 
doubled. The intramural private R&D expenditures in the pharmaceutical industry (NACE 24.4) reached almost 62% 
of R&D expenditures in NACE 24 and the share of NACE 24.4 increased significantly in recent years (49% in 2003). 
40  See European Commission (2006): Private Sector R&D in the NMS, Synthesis Report, pp. 59 – 65. 
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for innovative newcomers since both domestic push as well as pull factors seem to be un-incisive and 
spin-offs in this environment are supposed to be quite difficult too.41  
In fact, start-ups have generally been found very weak (and few) across the NMS studied and, 
however, no significant (domestic) demand pull factors42 in terms of the pharmaceutical sector could 
be identified. Moreover, in some NMS the companies seem to have problems to cope with the EU 
quality (safety) standards for pharmaceutical products (particularly in Poland) and also with applying 
some recently introduced common environmental protection regulations. The implementation of 
REACH [Registration, Evaluation and Authorisation of Chemicals] also appears to be a major 
challenge for any company in the sector (not only in NMS). Finally, company interviews revealed that 
currently the availability of adequately qualified human resources, previously a plus factor of the NMS, 
more and more becomes an impeding factor of their development. 
In the light of the significant R&D intensity growth rates (see Table 4 above) these drawbacks need to 
be pointed out, although, on the other side, the increased R&D spending – triggered by FDI – 
certainly has provided a substantial knowledge and technology inflow and also opened the doors for 
international co-operations via the networks of the multi-national parent companies. Accordingly, the 
situation in the pharmaceutical sector of the NMS can be summarized as promising in the sense of 
converging R&D intensities (and getting closer to the EU-15 in this regard), but, however, struggling 
with pitfalls of some unfavourable recent developments. There is evidently still a long way to go in 
order to fully catch up with the frontier setters of the pharmaceutical sector elsewhere.  
6.3 Conclusion of the sectoral considerations  
Based on the two sector studies discussed above it can be summarized that disaggregated 
considerations of R&D intensity and the corresponding trend patterns may indeed provide a 
differentiated picture compared to the aggregated figures. In fact, there is catching up in terms of R&D 
in the NMS, but the evidence is restricted to a few sectors only; particularly to such sectors as 
discussed above, which are emerging but have not (yet) achieved to be substantial pillars of the NMS 
economies. Accordingly, the mentioned positive developments appear to be (still) superimposed by 
other less dynamic or even reverse trajectories in other parts of the national economies.  
Thus, given the heterogeneous and even diverging R&D figures among the NMS as discussed above 
in aggregated terms, the emerging sectors with the outlined dynamic R&D trajectories might be seen 
more as 'bright spots' rather than being the heralds of a common catching up. Moreover, the fact that 
country-level aggregated and sector-level considerations may provide differentiated pictures calls for 
a complementary analytical focus on firm-level trajectories. In fact, the individual sector studies 
indicated a number of companies in each sector performing R&D quite successfully, making the pace 
and, however, setting the frontiers even if these frontiers may refer to the production possibility set 
given the particular environment of a certain country only. This finding implies that there might be also 
a number of companies that are laggards in this respect.43 Accordingly, the sectoral picture that has 
emerged may once again superimpose several differentiated trajectories at individual firm level.  
In general, empirical analyses at the firm-level may bring us closer to an answer concerning the 
question whether the NMS are already catching up or not. However, this cannot be done here,44 but it 
                                                 
41  In general, only little evidence of such effects could be found across NMS. However, in Lithuania some spin-off 
activities were observed (biochemistry). 
42  Specific national market demand conditions, e.g. by close co-operations with hospitals, universities, key scientists, 
etc. could create some niche markets and thus help to explore national competitive advantages. 
43  In course of the sector studies four basic types of companies have been identified: (A) type companies: autonomous 
domestic players that manage to initiate and implement their own R&D strategies and operate on domestic and/or 
international markets (e.g. financial intermediaries in Estonia, biotech niche players in Lithuania); (B) companies: 
firms that are embedded in global R&D networks and are mostly subsidiaries of foreign companies (e.g. automotive, 
pharma); (C) companies: firms that perform adaptation-oriented R&D in order to adapt existing products and services 
to local market needs and regulations (e.g. telecom equipment providers, IT services); (D) companies: firms with 
invisible R&D which is embodied in services or a cross-cutting activity in the companies' organisational units (e.g. 
service providers, SMEs).  
44  Apart from the fact that this could be done in a number of representative case studies only, the access to 
comprehensive micro-level data for analysing relationships between R&D, innovation, relevant firm characteristics and 
the company's ultimate performance is quite difficult, not at last due to the sensitiveness and confidentiality of 
individual firm data.  
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is currently a matter of interest in a number of projects as e.g. analysing corporate R&D at firm level in 
different sectors comprising distinctive R&D intensities,45 taking into account firm size patterns (e.g. 
SMEs), R&D environmental issues at certain regional levels,46 etc. Thereby, it should be particularly 
analysed what implications may have the above mentioned pitfalls and drawbacks in relation with the 
outlined favourable framework conditions for R&D in the NMS in a mid to a long term perspective. 
This certainly may help getting a clearer picture of the convergence trend patterns. 
Aside, in the literature47 some methodological approaches can be found allowing for a differentiated 
consideration of convergence, usually called "Conditional Convergence", Beta-, Sigma- Convergence, 
etc., often applied in productivity analyses and convergence considerations of GDP growth patterns. 
Although this is supposed to be very interesting for complementing the present analysis too, the 
heterogeneity of those circumstances identified to impede or foster the economic transition of a 
particular NMS as well as the corresponding R&D patterns prevent here the application of such an 
approach.48 In fact, filtering all these effects out of the data would – most likely – again lead to the 
situation that any relevant patterns are superimposed by others (and/or get removed in course of the 
data set adjustments), which finally would allow only a biased picture anyway and may appear to be 
an eyewash, neglecting the obvious trends and looking for any possible hidden patterns behind. 
Therefore, for the current consideration the application of this methodology is skipped. However, for 
any future analysis of the subject, particularly if going more in detail (e.g. at firm-level) or relying on 
longer time series, such an approach might be applicable and could disclose interesting insights.  
 
7 Determinants of current R&D trajectories in NMS: What really matters? 
According to the examination of R&D dynamics at country, sector, and partly company levels there is, 
at least currently, no common trend pattern uniformly evident in al NMS rather than a wide 
heterogeneity; and this picture seems to become even more diversified as more disaggregated the 
analysis is performed. However, for anticipating future developments and also for policy making 
perhaps even more relevant as searching for convergence in terms of R&D are the determinants and 
main drivers of the corresponding trajectories.  
 
In fact, what actually prevents NMS to catch up faster? 
 
The answer is complex and, once again, country/sector specific. For instance, above in aggregate 
figures, some countries have been identified as catching up to the EU-15 in terms of R&D intensity, 
some are keeping a constant level and some apparently are diverging. By looking at R&D expenditure 
patterns this has been attributed rather ad hoc to the government and/or to the business sector. 
Looking at it more in detail, indeed, a more differentiated picture emerges. Regrettably, identifying the 
individual drivers of the trajectories for each NMS/sector – namely the impeding and fostering factors 
while taking into account all the mentioned superimposing effects – would go beyond this analysis by 
far. Nevertheless, based on the individual country and sector studies some main R&D determinants 
can be identified as cross-cutting issues being analogously relevant for the NMS in general:49   
First of all, FDI appears to play a very significant role in many sectors in the NMS (see e.g. 
automotive and pharmaceutical sector), implying a more or less tight embedding of the R&D 
investment in the overall R&D strategy of a multi-national firm. This development – while being 
generally perceived as very positive – has a number of double-edged impacts on the evolution of the 
R&D base in the NMS. On the one hand, foreign investments tend to contribute to the upgrading of 
                                                 
45  See Sector Study: Framework Service Contratc 150083-2005-02-BE; EC (2006c) 
46  See ERA-Analysis: http://ipts.jrc.ec.europa.eu/activities/research-and-innovation/era_analysis.cfm  
47  See for example Gutierrez, L. (1999) exemplary for a study on EU accession and growth patterns or Ragnitz et al. 
(2001) for an overview of convergence measures (Beta-, Sigma-, ...) and an application on spatial/sectoral 
convergence.  
48  Moreover, the low number of relevant observation points (short time horizon in case of NMS) would also weaken the 
analytical value of the corresponding estimates. 
49  Annex II (project Synthesis Report, see below) provides more details and summarizes the mentioned individual 
country studies.    
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the managerial knowledge and organisational competencies as well as diffusion of new technologies. 
On the other hand, the embedding in a global company's R&D strategy often entails a narrowing of 
the scope of the R&D performed in the country concerned. This, in turn, has consequences for the 
spectrum of R&D collaboration with domestic universities and research centres. In this context it is 
also worth noting that the type of R&D that is being performed by enterprises in the NMS appears to 
be less basic research oriented than in countries hosting the headquarters of MNC. Indeed, it is much 
more focused towards specific niches (e.g. pharmaceuticals in Hungary), as well as adaptation-
oriented in the sense that restructuring and modernisation of the economy is still taking place to a 
noticeable extent (e.g. R&D in financial intermediaries in Estonia). Moreover, due to the internal 
competition between R&D locations of a MNC, there is a non-negligible risk that these activities may 
move elsewhere if the conditions for R&D or the overall R&D strategy of the company change. The 
maintenance of private sector R&D activities by means of FDI thus comes at the price of uncertainty 
about the sustainability of this investment. However, in the end, the extent to which R&D might 
become footloose depends on the quality and continuous improvement of the factors and conditions 
due to which R&D-investment were initially set up (and maintained!) in a specific location.50 
The sector case studies have shown that the reasons for foreign investment in R&D can be manifold. 
Of outstanding importance for any investments in R&D in the NMS seems to be a combination of 
three factors: (1) the quality of the available human resources, (2) the labour costs, and (3) the access 
to local markets. However, each factor might be also seen stand alone as a main determinant of the 
R&D trajectories in the NMS impeding or fostering the corresponding trends (as discussed below).  
In fact, the availability of highly qualified R&D personnel is widely acknowledged as strength of 
many NMS, often building on a long-standing industrial tradition in the respective sector (e.g. Czech 
automotive industry, pharmaceutical industry in Hungary and Slovenia). However, growing R&D 
investments, be it in the business or in the public sector, are likely to exhaust the capacities of the 
local labour markets in terms of qualified staff. In some cases a lack of staff for performing R&D is 
already reported. This is attributed to the brain drain and over-ageing process (e.g. Estonia, Latvia, 
and Lithuania). Moreover, the intention of most NMS to invest EU structural funds into R&D 
infrastructure and innovation projects may also raise pressure on the HES in the NMS to provide the 
research staff needed. While this problem may disappear in the mid/long run by reinforcing efforts to 
educate a new generation of engineers and scientists, it may lead to a scarcity of qualified personnel 
in those locations where already now substantial further investment in manufacturing and/or R&D is 
planned (e.g. in the automotive industry in the Slovak Republic). The least that can be concluded from 
this observation is that it is not very likely that the NMS will be able to provide a labour force reserve 
of high skilled employees compensating the foreseeable shortages in the EU-15 countries. 
Labour costs have been a major advantage of the NMS, particularly in production but also in terms 
of R&D. Empirical evidence suggests that some NMS are already facing diminishing competitive 
advantages due to growing wages (e.g. in Estonia). Although this factor was not reported to be "highly 
important" in course of the sector studies it may appear to be increasingly important in the future. 
Finally, domestic markets also tend to play a particularly important role regarding the local 
embedding of R&D. While some foreign R&D investments were motivated by the ease of access to 
the enlarged internal European market, in some NMS also the domestic markets are economically 
quite interesting. This holds, for instance, for the pharmaceutical industry where specific conditions 
and relationships prevail with hospitals and R&D infrastructures, thus offering opportunities that are 
favourable for the creation of niche markets. Moreover, for instance observed in terms of the IT 
services in Estonia, the combination of qualified personnel and demand for an upgrading of service 
quality was conducive to the establishment of a strong national R&D market.  
 
In contrast to these evident key factors, it is difficult to assess the impact of a number of framework 
conditions supposed to be beneficial for performing R&D, like for example tax incentives. While they 
certainly matter for specific decisions, a corresponding survey conducted in course of the individual 
                                                 
50  In fact, a sustainable embedding of R&D might not always be guaranteed in the case of FDI. Localised R&D could on 
the one hand lead to local value added. On the other hand, FDI might skim the cream of high-potential researchers in 
labs that produce footloose R&D for value added elsewhere in the world. In the NMS there is evidence for both.  
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NMS analyses tends to suggest that their importance seems to be over-estimated. If available, 
specific incentives are welcome, but the main determinants of investments in R&D apparently lie 
elsewhere (see key factors above). In fact, although R&D support measures as well as international 
technology and know-how transfers may bring important knowledge to an economy, that alone 
certainly is not enough. Using new technologies efficiently requires creating additional absorptive 
capacity, while a continuous effort has to be made to keep up with technical change. This is 
particularly true given the fact that wages tend to rise as a country develops, facilitating the entry of 
lower cost competitors in the market, both currently observable in the NMS.  
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Executive summary    
Increasing private sector R&D is of vital importance for the medium- to long-term economic 
development perspectives of the New Member States. In this context, the 3% Barcelona tar-
get for R&D expenditures represents an important objective and challenge. It requires more 
than a doubling of current levels of R&D spending, to which the private sector is expected to 
contribute two thirds. In order to get an as accurate and up-to-date picture as possible of pri-
vate sector R&D at sectoral level, this study provides policy makers with up-to-date informa-
tion and details on private sector R&D in the New Member States (NMSs). It focuses on sec-
tors which are contributing or have the potential to contribute significantly to economic activity. 
Four sectors have been studied in each country whereas ICT related sectors have not been 
addressed which are covered within a separate project by the IPTS.     
The study covers sectors of economic activity in each of the ten new Member States: Cyprus 
(CY), the Czech Republic (CZ), Estonia (EE), Hungary (HU), Latvia (LV), Lithuania (LT), 
Malta (MT), Poland (PL), the Slovak Republic (SK) and Slovenia (SI).  
The objectives of this project are:  
to give an as accurate and structured overview of patterns, determinants and im-
pacts of R&D investment in the NMSs as possible, 
to help assess the availability, reliability and quality of data on R&D investment in 
the NMSs.  
The availability of data is documented in a matrix covering 24 indicators. The matrices for 
each country can be found as an annex to this report. The matrices cover information on all 
available sectoral data of the national economies and indicate for which years data are avail-
able.  
The following overall observations can be made regarding data availability:  
There is a gap in availability of data between EUROSTAT and the national statistical 
offices. Generally speaking, data are available at more detailed sectoral level in the 
national offices than published by EUROSTAT.  
Availability of data differs between larger and smaller NMSs. In some sectors on 
NACE 3 level data are not published due to individual data protection in the case of 
limited number of enterprises involved (e.g. automotive industry in Slovakia). 
No general pattern of gaps can be found, however, the weakest category of indicators 
in terms of availability are indicators related to sources of funding of R&D activities   
The reliability of sectoral data is considered to be high. All data sources are based on Frascati 
Manual or Oslo Manual (for CIS). Caveats are mainly due to changes in the method of R&D 
survey, but date back to the 1990s.   
Country Case Studies 
The report provides brief summaries of the country studies including statistical material on 
the R&D expenditures and R&D personnel employed for each of the selected sectors. Details 
on the sectors based on statistical material, secondary data analysis and company case stud-
ies can be found in the individual country reports.  
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As shown by the sectoral case-studies in this project, the patterns, determinants and frame-
work conditions of private R&D investment in New Member States are very heterogeneous. 
This heterogeneity is to a significant extent a reflection of the respective national and sectoral 
R&D histories , i.e. a result of path-dependencies. Specifically in the former communist coun-
tries, it becomes obvious that the division of specialized industries and related research ef-
forts between the countries of the eastern block economic alliance still influences the impor-
tance of the different sectors and their R&D intensity. In the Czech Republic, for instance, 
R&D activities in car manufacturing were high. This is still reflected in today s economic struc-
ture of the country and the private R&D expenditure in the sector. Other countries like Slove-
nia, have never had a significant share in the automotive sector or were specialised in niches 
as Hungary illustrates. The heterogeneity of the sectoral case studies is also partly deter-
mined by the size of the countries. Countries like Malta or Cyprus hardly show any R&D ac-
tivities. Larger countries like Poland, Czech Republic have a longer tradition in R&D activities.   
Moreover, the current situation is still very much in flux; the processes of industrial transfor-
mation and integration in the global economy have not yet settled. These general observa-
tions imply that any recommendations to policy should be based on a sectorally and nation-
ally differentiated interpretation of patterns of private R&D investment. This is consistent 
with the recent trend in research and innovation policy research to stress the integration of 
RTDI-policies into stronger industrial or sectoral policies (Malerba 2004). Although a differen-
tiated perspective seems to be appropriate from a conceptual point of view, it turned out to be 
very difficult at least in some countries to underpin the transformation with statistical data. 
In some countries (Malta, Cyprus, Lithuania and others) this is simply a matter of data avail-
ability, in others the interpretation of data is not unequivocal due to problems of confidentiality 
(e.g. Slovakia), inappropriate international statistical standards (e.g. in services). In  the 
smaller NMSs it is a matter of scale of the sector (Malta, Cyprus, Lithuania, Latvia, Estonia).  
In spite of a call for a differentiated and cautious interpretation of private R&D investment 
data, some cross-cutting observations can nevertheless be made.   
First of all, foreign direct investment (FDI) tends to play a very significant role in many sec-
tors (automotive, pharmaceuticals), implying a more or less tight embedding of the R&D in-
vestment in the overall R&D strategy of a multi-national firm. This development while being 
generally perceived as very positive has a number of double-edged impacts on the evolu-
tion of the R&D base in a country. On the one hand, foreign investment tends to contribute to 
the upgrading of the managerial knowledge and organisational competencies as well as diffu-
sion of new technologies by way of FDI (overall and/or R&D). On the other hand, the embed-
ding in a global company s R&D strategy often entails a narrowing of the scope of the R&D 
work performed in the country concerned.   
The availability of highly qualified R&D personnel is widely acknowledged as strength of 
many New Member States, in many cases building on a long-standing industrial tradition in 
the respective sector (e.g. Czech s automotive industry, pharmaceutical industry in Slovenia). 
However, growing R&D investment be it in the private sector or in the public sector is likely to 
exhaust the capacities of the local labour markets in terms of qualified staff in the foreseeable 
future. In some cases a lack of scientific staff for R&D is already reported. This is caused by 
brain drain and over-aging (e.g. Estonia, Latvia, Lithuania). The intention of most NMSs to 
invest the foreseen EU structural funds into R&D infrastructure and innovation projects, will 
also create a pressure on the countries educational system to provide the research staff that 
contribute in a sustainable way to the creation of knowledge.   
Labour costs have been a major advantage of the NMSs, particular in production but also in 
R&D. Some sectoral studies show that national politics is already faced with the diminishing 
competitive advantage by means of growing wages (e.g. in Estonia). Although this factor was 
not reported to be that important in the sectoral studies, this factor is frequently named as im-
portant (e.g. in the ICT sector)  
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As a third key factor, home markets, tend to play a particularly important role with respect to 
the local embedding of R&D. While some foreign R&D investment was motivated by the ease 
of access to the large internal European market, in some sectors the national markets are 
also an important argument for investment. This holds, for instance, in the pharmaceutical 
industry where specific conditions and relationships prevail with hospitals, universities and 
key scientists, thus offering opportunities that are favourable for the creation of niche markets.   
A sustainable embedding of R&D might not always be guaranteed in the case of FDI. Local-
ised R&D could on the one hand lead to local value added. On the other hand FDI might skim 
the cream of high-potential researchers in labs that produce footloose R&D for value added 
elsewhere in the world.   
As compared to these three key factors, it is difficult to assess the role of favourable frame-
work conditions (e.g. tax incentives). While they certainly matter for specific decisions, the 
interviews conducted in the course of the project tend to suggest that their importance seems 
to be over-estimated. If available, specific incentives are welcome, but the main determinants 
of foreign investment lie elsewhere, e.g. in the lower labour costs and emerging markets.  
From this analysis, a number of issues arise that cut across as critical for the future and thus 
are requiring particular policy attention:  
The consideration of national and sectoral innovation systems to ensure the embed-
ding of R&D; 
The future development of the human resources base as a pre-condition for perform-
ing R&D and thus for attracting R&D investment; 
The continuous improvement of the innovation infrastructure (universities, research 
centres, etc.), not only as sources of qualified R&D personnel, but also as potential 
partners for industrial R&D; 
A growing attention to the role of services, either as stand-alone research-intensive 
activities (e.g. KIBS) or as support services to R&D performed in other sectors (e.g. 
standardisation, IT services); 
Improving the innovation climate by structural measures rather than by financial in-
centives. This concerns, for instance, also the strengthening of the relationships be-
tween different innovation actors, private and public ones. There are already some 
examples of private firms getting engaged in funding of R&D centres or university in-
stitutes; 
Bundling of national R&D capacities (e.g. through national technology platforms) and 
seeking a better coordination with European initiatives.  
Motor vehicles and related Industries 
The sector of car manufacturing (NACE 34) was in focus of the national research teams in 
Czech Republic, Poland, Hungary and Slovakia, due to its present or foreseeable importance 
for the national economy. Other sectors, extending the value chain were included in the 
analysis: the production of tyres in the Czech Republic and Slovakia (NACE 25), and electri-
cal equipment for engines and vehicles in Hungary (NACE 31.61).    
Pattern of R&D 
There is a big difference in the importance of the automotive sector in the national economies 
in terms of value added. The share of private R&D expenditure also varies significantly be-
tween countries. The automotive sector is most important in the Czech Republic. The sector 
contributed 2 bn. EUR or 2.7% to the GDP with 7% of Czech employees working in the sector 
in 2004. The relative importance of the sector is 2.5% of GDP in Hungary and Slovakia and 
1.5% in Poland. In the Czech Republic, the sector s R&D expenditure was around 
180 mio. EUR in 2004. R&D expenditure as a percentage of GDP is above EU average in 
NACE 34 in the Czech Republic. In Hungary, Poland and Slovakia it is below average. But, 
unlike in the Czech Republic, with stagnating R&D expenditure, growth rates in these coun-
tries were between 54% and 114% over a two to four year period.  
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Determinants of R&D investment 
The automotive sector is a dynamic sector in many NMSs with differing levels of R&D inten-
sity. The development of the automotive sector over the last years took various paths and 
cannot be described as a single phenomenon due to individual historical determinants. The 
Czech Republic, for instance, has a long tradition in car manufacturing while other countries 
are specialised more on trucks or motors.  
The two main arguments for investors in this sector are lower costs vis a vis the old member 
states of the EU and the emerging opportunities to get a foot into the enlarged European 
market. Foreign direct investment (FDI) is the main determinant of the expansion of the 
sector. Investments are either secured by take-over of existing firms or in some cases by joint 
ventures. Investments are either brown-field or green-field types of investments. Slovakia cur-
rently manufactures over 250 thousand cars per year. This investment by PSA Peugeot Cit-
roen and Hyundai Kia for final assembly plants will nearly triple automotive investment output 
by the end of the decade. These developments may as well lead to an increase in R&D inten-
sity in the future.  
Framework conditions 
Apart from legal regulations (e.g. REACH), the sectoral production system is characterised by 
standardisation efforts which are caused by the three tier-system. The impact of tax incen-
tives has not yet been evaluated. The availability of highly qualified R&D personnel seems to 
be an ever increasingly important factor for the expansion of R&D units in the NMSs. Some 
recently published labour market analyses point out the lack of suitably qualified personnel for 
R&D. Lack of qualified employees and university graduates with technical background was 
one of the reasons which led Skoda Auto towards the decision to build the university campus 
Na Karmeli . The public support in setting up technology parks which will be subsidised by 
EU structural funds in the future might be an additional incentive to attract R&D units.  
Impact of R&D 
The direct impact of R&D activities is reported in only very rare cases. Doubtless, there is a 
large impact of technologies and processes that were brought to the NMSs by FDI. Productiv-
ity rates are rising in the sector in most countries which can be explained by intra-firm knowl-
edge transfer.   
Pharmaceuticals (argument-because of traditionally high R&D) 
As the pharmaceutical sector allows to study R&D dynamics at the front end of technological 
development and since some pharmaceutical companies have played a significant role in 
nearly all NMSs, the pharmaceutical sector has been chosen to be studied and compared 
across the NMSs. The pharmaceutical sector has been studied in Poland, Hungary, Slovenia, 
Latvia and Slovakia. However, so far, only for the first three countries figures are available 
describing the R&D development of the pharmaceutical sector (NACE 24.4.), which is a sub-
sector of the chemical sector, while for the others, R&D data are only available for the chemi-
cal sector.  
Pattern of R&D 
With respect to the value added of the sector, the pharmaceutical sector has the highest 
share in Slovenia s economy (3.3%) and a share below 1% in the other countries. The sector 
has thus a minor relative importance in most NMSs compared to other westerly countries. 
The absolute figures of R&D expenditure show that Hungary and Slovenia are the most im-
portant R&D performers in the NMSs competing on the global market. Apart from Slovenia 
and Hungary, the National Innovation Systems are thus obviously not very much oriented to-
wards the pharmaceutical sector. However, in general, the pharmaceutical sector has been 
growing with respect to value added, R&D expenditures and R&D employees in all countries.   
Determinants of R&D investment 
The successful privatisation of former state-owned large enterprises and FDI are the most 
significant driving factors for the development of the pharmaceutical sector. In most coun-
 Framework Service Contract 150083-2005-02-BE 
Private sector R&D in the New Member States 
Final Report D2 and 3  
V.2.0  
Page 9 of 76  
tries, the largest firms are now subsidiaries of foreign MNCs which also led to a restructuring 
of R&D labs within larger organisations. This restructuring process has led to a concentration 
of R&D activities in fewer R&D sites and to a reduction of the product range. However, all in 
all, the number of firms has not changed significantly. Slovenia is an exception in so far as the 
largest pharmaceutical firm is still partly nationally owned since it span off from a merger of a 
Czech and Slovakian firm. FDI have also opened up new opportunities for international co-
operations via the networks of the multi-national parent companies. However, this can also 
have a side effect as the Hungarian case demonstrates: The aforementioned development 
limited the co-operation with domestic universities due to the high specialisation of R&D. In 
this context, the case studies reveal that the research infrastructure plays a minor role in the 
different countries concerning the development of the pharmaceutical sector as scientific 
source for drug development and co-operation partner. The links to the national research in-
frastructure seem to be rather weak in most countries. Nevertheless, there are also some ex-
amples of firms which have successfully exploited the national research capacity as Latvia 
and Lithuania demonstrate. In these two countries, pharmaceutical companies have success-
fully specialised in niche markets internationally.   
In the last century, the R&D strategy of the majority of pharmaceutical firms in the NMSs was 
mainly based on the production of generic products. Following this business and innova-
tion strategy, most pharmaceutical companies are now carrying out applied R&D, even 
though the development of new drugs and the ability to develop or discover new molecules is 
becoming increasingly important to remain competitive in the long run. Cases in Hungary, 
Slovakia and the Czech Republic show that firms were not only successful in improving pro-
duction processes but also in mastering the product innovation challenge.   
Framework conditions 
At the moment, human resources seem to be the most critical hampering factor for the fur-
ther development of the sector. The lack of qualified scientists due to lower attractiveness of 
natural sciences among students, brain drain and ageing of researchers is a serious problem 
in most NMSs. In contrast, rising demands related to regulation and quality management 
seem not to be a serious hampering factor. Except for Poland, most countries have already 
mastered the challenge of coping with new regulations for the approval of new drugs and the 
necessary quality and safety standards. Poland has sill a particular problem with quality man-
agement and safety regulations which has delayed the development of the sector in the last 
few years and requires further foreign capital in the future.   
Impact of R&D 
In general, investments in R&D have helped to increase productivity, in particular with respect 
to the production of generic products, in some cases even the development of new pharma-
ceuticals. Thus, increasing R&D investments has most likely fostered growth and kept com-
panies competitive in the NMSs. However, newly established firms, spin-offs and start-ups 
hardly play a role in the R&D performance of the NMSs. Even though the pharmaceutical sec-
tor increased its competitiveness in the past, in general, perspectives appear to be rather un-
favourable. It remains unclear if the sectors in all NMSs will be able to grow in the future un-
der the given framework conditions. The main challenges will be to build capacities for devel-
oping new molecules, to closer co-operate with domestic research institutes, and to develop 
the necessary qualification of human resources to match the needs of the sector.   
Further research 
This study has been of an exploratory nature and was not meant to deeply investigate all as-
pects that would have been worth investigating. However, it was going into sufficient depth to 
identify a number of research needs for the future. These can be subsumed under five main 
headlines: 
Data availability (to be based on analysis of availability matrix), 
Broadening and deepening the empirical base,, 
Impacts of private sector R&D, 
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I. Introduction 
Business enterprise expenditure on R&D (BERD) in all new Member States (NMSs) in 2003 
was below the EU average of 1.23% of GDP, which makes the overall Barcelona target of 3% 
of GDP for gross domestic expenditure on R&D, of which two thirds are financed by the pri-
vate sector, an even greater challenge for them than for other member states. A continuation 
of low levels of private R&D in the new Member States may also hinder the catching-up and 
integration of their economies into the EU.  
To reach the Barcelona target of approaching 3% of GDP for gross domestic expenditure on 
R&D, considerable efforts will have to be made by the NMSs. Policy makers within these 
countries need to have up-to-date information on the status, the determinants and the impacts 
of private R&D investment.  
This study provides policy makers in the EU and the Member States with up-to-date informa-
tion and details on private sector R&D in the new Member States. It focuses on sectors which 
are contributing or have the potential to contribute significantly to economic activity (4 sector 
studies in each country). In specific cases, the sectoral analysis is also illustrated by case 
studies of individual firms.   
The study covers sectors of economic activity in each of the ten new Member States: Cyprus 
(CY), the Czech Republic (CZ), Estonia (EE), Hungary (HU), Latvia (LV), Lithuania (LT), 
Malta (MT), Poland (PL), the Slovak Republic (SK) and Slovenia (SI).  
The overarching objectives of this project are:  
to give an as accurate and structured overview of patterns, determinants and im-
pacts of R&D investment in the NMSs as possible, 
to help assess the availability, reliability and quality of data on R&D investment in 
the NMSs.  
More specifically, the following operational objectives are pursued:  
1. collect statistical (and other) data on key patterns, the nature and the sources of 
R&D investment at sectoral level in the NMSs, 
2. assess the impact of framework conditions on R&D investment at sectoral level  
The report begins with describing the selection of industries, the data sources used and the 
availability and reliability of data in a section on methodology. In a second section for each of 
the NMSs an overview is given on private R&D in four selected sectors. To be able to give a 
more detailed overview on specific sectors two sector were chosen: automotive and related 
industries and pharmaceutical industries. For these two synthesis-chapters patterns, 
determinants, framework conditions and impacts of private R&D are described using 
information from those countries who investigated these sectors. In a concluding chapter 
cross cutting issues are discussed to learn from the sectoral studies performed. Furthermore, 
future research needs are discussed. In the Annex the availability of data on 24 private R&D 
indicators is documented for each country.  
As the information collected in the individual country reports is too voluminous, it is not in-
cluded in the final report. Details on the sectors based on statistical material, secondary data 
analysis and company case studies can be found in the individual country reports, which will 
be available at the ETEPS website.  
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II. Private R&D in New Member States 
1. Method  
In order to achieve the specific project objectives as described above, quantitative and quali-
tative analyses at sectoral level were combined with company-level case studies.   
In conceptual terms, the project builds on the framework of Sectoral Systems of Innovation 
(SSI).1 According to this approach, sectoral factors such as the nature of the knowledge base, 
the interaction and role of different actors such as suppliers, universities and users as well as 
institutions are considered explicitly to study the nature of the innovation process and out-
comes in various sectors. The IPR regime, concentration of industry, knowledge characteris-
tics (stickiness, appropriability, tradability), etc. are important factors for the scope of R&D 
activities, and thus of R&D investment.    
The overall architecture of the project approach was as follows:  
Specification of the methodology: Agreement on a common understanding of the ap-
proach and the methodology of data collection among project partners.  
Pre-screening: A pre-screening of international data sources was conducted.  
Sectoral analysis: The analysis of R&D investment concentrated on the level of sec-
tors, but required complementary information on national framework conditions. 
o Country level analysis: The analysis at the country level focused on those as-
pects that are essential for the implementation of the sectoral and company-
level case studies, for instance, in relation to framework conditions to be 
taken into account.  
o Sectoral level analysis: At sectoral level, statistical data sources were ex-
ploited as far as possible in order to deal with the patterns, sources and na-
ture of R&D expenditures, to be complemented by other secondary sources. 
The role of framework conditions and the impact on company performance 
are based on some selected statistical sources (e.g. CIS data where avail-
able) and existing studies, but mainly relied on anecdotal information by 
means of company case studies. 
o Availability and reliability check: The analysis at international, country and 
sectoral level feed into an assessment of availability and reliability of statisti-
cal and secondary data sources. 
Company level: Between 2 and 4 company case-studies were conducted per country 
by means of analysing company reports and conducting interviews in order to deepen 
the understating of R&D activities and their determinants at the firm level.   
1.1. Selection of industries  
For each country four sectors are covered, selected from a list of manufacturing and service 
sectors on the basis of their R&D intensities (R&D/GDP), the recent rise in these figures and 
the contributions to GDP of these sectors. The two sectors with the highest R&D intensities 
were chosen, accompanied by the two sectors with the highest increase in R&D intensity in 
recent years. Initially, for the first two sectors the selection criteria included using a minimum 
threshold of 2% for their contributions to GDP and 1% for the first two sectors contributions to 
GDP. This second criterion was not used in all cases, mainly when the NACE two-digit level 
                                                     
1
 See Malerba, F. (ed.)(2004): Sectoral Systems of Innovation. Concepts, Issues and Analyses of Six 
Major Sectors in Europe, Cambridge University Press: Cambridge 
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was evaluated as too diverse to answer the research questions, and thus NACE three-digit 
data were used and analysed (e.g. in the case of pharmaceuticals) instead. Moreover, one 
sector had to be common to all or at least most countries to enable some comparative analy-
sis.  
The ICT sectors were not included in the selection for this study as information about ICT sec-
tors is covered by a separate IPTS activity within the JRC Enlargement and Integration Ac-
tion.   
All sectors considered correspond to the NACE standard classification.  
Based on the selection criteria and the discussion on the selection of sectors at the kick-off 
meeting, the following sectors were chosen for sectoral studies (see Table 1)2.  
Table 1: Selection of Sectors for the Sectoral Studies 
Country NACE code Sector  
R&D intensity 
private R&D  
investment as 
% of sectoral 
GDP (2003 or 
2004) 
Increase in 
R&D inten-
sity (%)   
Sectoral 
GDP as  
% of na-
tional GDP 
(2003 or 
2004) 
45 Construction 0.01% 10% (2001-2003) 7.3% 
24 
Manufacture of  
Chemicals and Chemical 
Products 
3.8% 113% (2001-2003) 0.5% 
29 Manufacture of Machinery 
and Equipment 0.8% 
0% 
(2001-2003) 0.2% 
Cyprus 
65 
Financial intermediation 
except insurance and pen-
sion funding 
0.03% 1286% (2001-2003) 5.6% 
34 
Manufacture of motor vehi-
cles, trailers and semi-
trailers 
8.8% 5% (stable)(2001-2004) 2.7% 
24 Manufacture of chemicals 
and chemical products 4.6% 
65% 
(2001-2004) 1.4% 
25 Manufacture of rubber and plastic products 0.9% 
91% 
(2001-2004) 1.6% 
Czech 
Republic
31 
Manufacture of electrical 
machinery and apparatus 
n.e.c. 
1.8% 104% (2001-2004) 1.8% 
                                                     
2  In Estonia, the non-ICT sectors of 'Manufacture of electrical and optical equipment' could have not been 
studied in detail, although data at aggregated level would have suggested to include the sector, as only aggregate 
data was available. Other studies have shown, though, that R&D expenditures in this aggregated sector are attribut-
able to ICT sub-sectors. 
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65-67 Financial  intermediation 1.6% n.a. 3.4% 
15 Food and beverages 0.7% 217% (2000-2003) 2.8% 
27-29 Metal products,  
machinery 0.2% 
161% 
(2000-2003) 2.5% 
Estonia 
36-37 Furniture, recycling 0.6% 196% (2000-2003) 1.5% 
24.4 
Manufacture of pharmaceu-
tics, medicinal chemicals 
and botanic products 
19.3% -5% (2001-2003) 0.5% 
34.3 
Manufacture of parts and 
accessories for motor vehi-
cles and their engines 
2.9% 114%  (2001-2003) 0.8% 
33.1 Manufacture of medical instruments 2.7% 
34% 
(2001-2003) 0.1% 
Hungary
31.6 Manufacture of other elec-tric equipment 3.5% 
54% 
(2001-2003) 0.3% 
24 Manufacture of chemicals 
and chemical products 1.9% 
50% 
(2001-2003) 0.6% 
74 Other business services 1.0% 68% (2001-2003) 3.0% 
17 Manufacture of textiles 0.03% 58% (2001-2003) 2.2% 
Latvia 
28 Manufacture of fabricated 
metal products 0.1% 
1153% 
(2002-2003) 2.4% 
24 Manufacture of chemicals 
and chemical products 5.3% 
974% 
(2002-2003) 1.0% 
33 
Manufacture of medical, 
precision and optical in-
struments, watches and 
clocks 
0.8% -3 1.3% 
29 Manufacture of machinery 
and equipment 0.9% 
15% 
(2002-2003) 0.6% 
Lithuania
15 Manufacture of food prod-
ucts and beverages 0.3% -
4 3.5% 
67.2, 
66.1 Financial intermediation 0.4% n.a. 1.4% 
29 Manufacture of machinery 
and equipment 0.9% 
36% 
(2001-2003) 0.4% 
15 Food & Beverages 0.2% n.a. 3.0% 
Malta 
22 Printing 0.4% n.a. 1.4% 
                                                     
3
 strong fluctuations, no trend 
4
 strong fluctuations, no trend 
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29 Manufacture of machinery 
and equipment 1.3% 
11% 
(2003-2004) 1.3% 
24.4 
Manufacture of pharma-
ceutics, medicinal chemi-
cals and botanic products 
n.a. 39% (2003-2004) n.a. 
35.3 Manufacture of aircraft 
and spacecraft 2.0% 
77% 
(2003-2004) 0.4% 
Poland 
34 
Manufacture of transport 
equipment (motor vehi-
cles, trailers and semi-
trailers) 
1.3% 55% (2003-2004) 1.3% 
27+ 
28 
Manufacture of base met-
als, fabricated metal prod-
ucts 
0.1% -5 3.5% 
34 
Manufacture of motor ve-
hicles and transport  
equipment 
1.7% - 2.2% 
25 Manufacture of rubber and plastic products 1.1% 
10% 
(1998-2004) 1% 
Slovakia
24 
Manufacture of chemicals, 
chemical products and 
man-made fibres 
1.1% -6 0.8% 
31 
Manufacture of Electrical 
Machinery and  
Apparatus 
4.6% 18% (2001-2003) 1.3% 
24.4 Manufacture of  Pharmaceuticals 8.8% 
19% 
(2001-2003) 3.3% 
29 Manufacture of Machinery 
and Equipment 4.4% 
22% 
(2001-2003) 2.2% 
Slovenia
33 
Manufacture of medicine, 
precision and optical in-
struments 
9.1% 27% (2001-2003) 0.7% 
 
1.2. Data sources  
For a general overview of comparable data on R&D investments at country and sectoral level, 
a screening of international databases was performed first. Thereby international statistical 
sources provided by OECD and EUROSTAT were taken into account.  
The pre-screening showed that from the international sources only EUROSTAT provides a 
range of comparable data for the NMSs on aggregated level and some data on specific sec-
tors.  
The OECD provides another source, the Online Database OECD STAN Structural Analysis 
Database.7 However, only Czech Republic and Poland from the NMSs are covered. Due to 
the lack of comparability and due to reliability restrictions in the OECD Database given inter-
polations and estimations of data, the OECD data are not included in this report.  
                                                     
5
 Unknown, because of the individual data protection. The company data suggest increase by about 20 % by 2004 
6
 Unknown, because of the individual data protection 
7
 This table presents comprehensive and internationally comparable time-series on industrial R&D expenditures in 
ISIC Revision 3 for 19 OECD countries, as well as total EU. Compatible with those used in other OECD databases, 
the industry list covers a number of service and technological sectors. Data covered are from 1987 onwards. 
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In parallel, national statistical sources were analysed that can provide additional comparable 
data to those available from international statistics. These national sources are based on R&D 
surveys and CIS surveys. A list of sources used can be found in the annex to the report.   
1.3. Availability and reliability of data  
The availability of data is documented in a matrix covering 24 indicators. The matrices for 
each country can be found as an annex to this report. The matrices cover information on all 
available sectoral data of the national economies and indicate for which years data are avail-
able. The sectors selected for the country studies are covered in addition to the general over-
view, to document some differences in availability per year and to reveal confidentiality of 
data.  
Information given includes the level of availability of 24 indicators:  
Two overall indicators: 
1. Staff employed in R&D   
2. R&D expenditure in NACE categories  
Pattern of R&D expenditure according to different categorisations  
In-house / outsourced:  
3. in-house R&D expenditure  
4. outsourced R&D expenditure  
Tangible / intangible / human resources:  
5. expenditure on acquisition of machinery/equipment 
6. expenditure on acquisition of know-how 
7. investment in human resources 
Nature of private sector R&D activities  
8. volume and share of basic research 
9. volume and share of applied research 
10. volume and share of experimental development 
11. volume and share of new product development 
12. volume and share of product improvement 
13. volume and share of process improvement 
14. volume and share of new service development 
Source of funding of R&D activities  
15. from within business enterprise sector  
16. from abroad - total 
17. from abroad - private sector 
18. cash flow 
19. company funds 
20. loans 
21. venture capital 
22. grants 
23. intellectual property licensing 
24. public support   
For these indicators the following information is given in an availability matrix for each coun-
try: 
1. Data source  
The name of the source and of the publishing organisation is provided. 
2. Level of availability of sectoral data  
The availability is given for aggregated data for whole economy for aggregated NACE 
categories (A-Q), for NACE 2 and 3 digit levels.  
3. Years available   
To provide information on the years for which data are available, one column, which is called 
general availability , provides the range of available years that is covered in most cases. Fur-
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thermore, for the sectors of the sectoral studies the years with available data are indicated to 
provide more specific information.   
The following overall observations can be made regarding data availability:  
There is a gap in availability of data between EUROSTAT and the national statistical 
offices. As a general experience, data are available at more detailed sectoral level in 
the national offices than published at the EUROSTAT. As an exception to the rule, in 
the Hungarian case, some data are available from EUROSTAT which are not freely 
made available from the national statistic office. 
Availability of data differs between larger and smaller NMSs. In some sectors on 
NACE 3 level data are not published due to individual data protection in the case of 
limited number of enterprises involved (e.g. automotive industry in Slovakia). 
No general pattern of gaps can be found, however, the weakest category of indicators 
in terms of availability are indicators related to sources of funding of R&D activities 
(see indicators 15 to 24 above).  
The reliability of sectoral data is considered to be high. All data sources are based on Frascati 
Manual or Oslo Manual (for CIS). Caveats are mainly due to changes in the method of R&D 
survey, but date back to the 1990s.   
For some countries R&D data show dramatic changes in expenditure or employment figures 
from one year to another. This might be due to the fast structural changes that are taking 
place and the influence of FDI. Especially in smaller countries, FDI of multinational firms 
might be able to influence the characteristic of a sector within one year. Nevertheless, it is not 
clear if enterprises were always fully aware of standard definitions (of R&D, capital investment 
in R&D, etc) when filling in the surveys. In some cases, for instance, the investment in capital 
goods for R&D is not reflected in increasing R&D activities carried out by researchers. Thus, it 
must be doubted that R&D related capital investment without increases in R&D employment 
is a feasible way for sustainable capacity building.     
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2. Private R&D in selected sectors of NMSs  
2.1. Cyprus  
National Framework conditions  
In May 2004 Cyprus joined the European Union and, therefore, has accelerated a number of 
developments in order to modernise its economic structure and adopt the acquis communau-
taire. Despite the small size of the country its income is higher than one would expect. This is 
due to the composition of its economy. Cyprus is taking advantage of its significant strategic 
location as the crossroads of three continents.   
Research activities in Cyprus were limited up until the beginning of the 1990s. For the years 
1991 and 1992 expenditure on R&D amounted to just 0.18% of Gross Domestic Product 
(GDP). Nevertheless, the R&D expenditure as a percentage of GDP remained low in 1999 
reaching 0.3% of total GDP while an increase was recorded in 2004 reaching 0.4% of total 
GDP.   
Total R&D expenditure in Cyprus in 2003 is estimated at 23.9 mio. C (41.4 mio EUR) (1 
EUR = 0.577 Cyprus Pounds) which corresponds to 0.35% of the, GDP compared to 19,4 
mio. C (33.6 mio EUR) or 0.32% of the GDP in 2002. Despite the increase of 23.1% ob-
served in R&D expenditure in 2003, the share of GDP of Cyprus devoted to R&D activities 
continues to be low compared to other countries. During 2000, the rate of growth of the econ-
omy in real terms was 4.8% as compared to a 4.5% rate of economic growth in 1999. The 
main factors influencing this were a favourable external environment. The next table demon-
strates the levels of development within the different and most important economic indicators 
in Cyprus.  
EU Membership is now creating new opportunities for public initiatives in the area of innova-
tion and development, using the resources of the structural funds. Cyprus is at a stage where 
there is a wish to diversify its policies and turn its major activities towards different sectors of 
the economy, other than tourism, financial services and shipping. The expansion of basic in-
frastructures, the development of human capital and the promotion of equal opportunities to 
both female and male researchers as well as the protection of the environment and the ad-
vancement of quality of life for citizens are considered to be the leading priorities towards 
promoting competitiveness from the Cypriot government.  
Construction Sector (NACE F)  
The construction sector is a significant contributor to the country s economy, especially in the 
last few years. In the southern part of the island the construction industry was in decline in 
real terms for several years during the second half of the 1990s. In 2000, construction ac-
counted for 7.1% of gross value added and 8.2% of total employment.   
There was further decline in the sector by 2% in 2000, although leading indicators of future 
performance point out that the sector has entered a recovery phase and that this downward 
trend will be reversed.   
In 2004, the sector continued to register an upwards trend, recording a positive rate of growth 
in its value added in real terms. In 2004, the real growth was 5.8% compared to 7.1% in 2003 
and 5.5% in 2002. This is attributed mostly to the significant increase in the construction of 
residential buildings, an industry branch which is not considered to be R&D intensive. The 
value of new construction at current market prices comprised 89.8% of the total gross output 
in the construction industry in 2004.  
As far as R&D activities are concerned, this sector does not contribute significantly to the de-
velopment of the economy in this field. According to statistics, the main type of research un-
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dertaken in this sector is basic research which records approximately 50% of this sector R&D 
activity in 2003.   
As far as employment is concerned, in the construction sector the number of persons em-
ployed increased from 29,518 persons in 2003 to 29,970 in 2004 and accounted for 9.3% of 
the gainfully employed population for the production of GDP. The number of persons regis-
tered as unemployed is increased from 685 persons in 2003 to 780 in 2004. At the same time, 
the construction sector s labour costs during 2004, continued to rise registering an increase of 
4% compared to 5.8% in 2003 and 5% in 2002. The overall price index of construction mate-
rials increased by 8.2% compared to 4.6% in 20038.  
According to statistics, the researchers in the construction sector were 3 (in head count), 
which represents approximately 1.17% of the total number of researchers in the private sector 
in 2003. Additionally, the total number of researchers in FTE was 0.5, which represents about 
0.5% of the total number of researchers in this sector in Cyprus.   
For the first quarter of 2005, the volume of production in the construction sector increased by 
1.9% while the increase in the first quarter of 2004 was about 3.2% and 4.5% in total in 2004. 
This positive development continued up until recently according to a list of specific indicators 
that have been analysed in relation to investment actions in construction projects.   
According to the case study in the construction sector, R&D activities were not undertaken by 
a single R&D department. In more detail, R&D activities are not considered to be part of every 
day work routine in such companies. Based on the case study performed within this project, 
the goals set are not long-term and they don t affect much the production and innovation 
processes. The main focus of their R&D activities is not in the innovative products develop-
ment but mainly in the processes and methods used in their work.     
Manufacture of chemicals and chemical products (NACE 24)  
The manufacturing sector of chemicals and chemical products is being faced with difficulties, 
having to cope with a fall in the growth of production, exports and employment. This has been 
due to increased and intensive competitiveness, both abroad and in the local market. By 2002 
the sector accounted for about 10% of GDP and almost 12% of the total employment in the 
country. However, it continues to be an important sector for the economy, accounting for ap-
proximately 12% of GDP and 16% of employment. Exports of manufactured products in 2003, 
compared to 1973 figures (15 mio. C ), recorded a large increase and reached about 191.6 
mio. C (331.8 mio. EUR).
 
In the first semester of 2005 there was a decrease in the production volume by 1.6%, while in 
the same period in 2004 the production volume was increased by 2.4%. This decline was due 
to the low internal demand (owed to the increased imports). Exports of manufactured prod-
ucts constitute the bulk of Cyprus domestic exports and represented 63.8% of total exports in 
2002. 9  
The chemical industry production in Cyprus is characterised by very heterogeneous products. 
They range from basic chemicals to fine chemicals and from paints through detergents to 
polymers. The sector has both strong and weak points.   
Researchers in this sector are mainly stemming from natural sciences. On the one hand, the 
total number of researchers was 61 (in head count) in 2003, which represents approximately 
24% of the total number of researchers in the private sector in 2003 and about 50% of re-
searchers in the manufacturing industry. On the other hand, the total number of researchers 
in FTE was 35.7 in 2003, figure which represents 34.7% of the total number of researchers in 
the private sector in Cyprus and about 67% of researchers in the manufacturing industry.  
                                                     
8 Cyprus Statistics, Construction and Housing Statistics, 2004, Republic of Cyprus 
9
 Source: http://countrystudies.us/cyprus 
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According to the Cypriot Statistical office data, there are 55 enterprises producing chemicals 
and chemical products and the average number of all employees per enterprise for this sector 
has been recorded to 17.7%. The R&D expenditure related to personnel reached the 1.3 mio. 
EUR in 2003 while the capital expenditure has reached the amount of 573 thousand EUR. 
According to statistics, the main type of research activity that has been observed is mainly 
experimental research, while applied and basic research comes next.  
The manufacturing sector exhibited a 4% increase in real terms, although its contribution to 
GDP fell to 20% from 20.7% in 1999. The volume of exports of manufactured goods in-
creased significantly by 11.9% as a result of increased external demand.   
According to the case study, the company interviewed has experimented and succeeded with 
new products. Benefiting from advancements in technology, it has also managed to specialise 
in a variety of products. A distinctive feature of the company and of the sector in general is the 
efforts made in introducing novel ideas and products.  
Manufacture of machinery and equipment (NACE 29)  
In 2001, manufacturing of machinery and equipment was the second largest manufacturing 
NACE division in value added terms, following the manufacturing of food products and bever-
ages. In 2002 the machinery and equipment manufacturing sector was the third largest follow-
ing the manufacture of food and beverages and that of chemicals and chemical products. 
With 164.7 bn. EUR of value added generated in the EU-25, the sector accounted for 9.4% of 
total industrial value added.   
In 2002, there were 3.5 mio people employed in this sector in the EU-25. This was equivalent 
to 9.8% of the overall industrial workforce. In terms of headcount, the people employed in this 
sector were 1314 in Cyprus. The sector is male dominated, as the male employees registered 
in 2004 were 77.8% of the total. In 2003, there were 248 enterprises registered in the sector. 
The capital expenditure in R&D was about 72 thousand EUR in 2003 while the labour costs in 
R&D in this sector have been 103 thousand EUR.   
Given the importance of the manufacturing sector as a whole in increasing the overall R&D 
expenditure,  experimental research was the basic type of research activity undertaken (with 
a total expenditure of 103 thousand EUR), while applied research followed registering an 
amount of 54 thousand EUR.   
In 2003, the total number of researchers was 13 (in head count). This represents approxi-
mately 5% of the total number of researchers in the private sector in 2003 and about 10% of 
researchers in the manufacturing industry. On the other hand, the total number of researchers 
in terms of FTE was 2.9 in 2003, representing 2.8% of the total number of researchers in the 
private sector in Cyprus and about 5.5% of researchers in the manufacturing industry.   
Financial Intermediation (NACE J65)  
The newness of the financial service sector, the recurring crises and the low level of confi-
dence of depositors largely account for the relatively small size of the financial sector in the 
transition economies.  Although it was expected to find some interesting evidence on R&D in 
the financial sector, the sectoral study showed that hardly any significant activity can be de-
tected.   
The company that was contacted for the case study mentioned that there is no R&D unit, but 
all staff members are involved in research concerning new products and services. Official sta-
tistics report 5 employees in R&D (full time equivalent) in 2003. Expenditure of the private 
sector was reported to be 238 thousand EUR which were mainly spent for labour costs. An-
other 121 thousand EUR were contributed by the EU by means of the 5th Framework Pro-
gramme. 
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The financial services sector contributes around 20% of GDP. This figure has increased by 
95.9% since 1995. However, there has been little or no growth since 2000. In 2001, the finan-
cial intermediation sector comprised 7.3% of total gross value added.   
The financial intermediation sector in Cyprus uses applied research as its main type of re-
search activity with 121,500 EUR while experimental research comes second and no basic 
research is undertaken.  
The corporate bond market is rather small, while the government bond market is of limited 
importance, due to the low level of government debt. For example, in 2003 the general gov-
ernment debt of the ten acceding countries amounted to 42.4% of GDP on average, as com-
pared with 64% in EU-15. Cyprus at 60.3% of GDP and Malta at 66.4% of GDP, displayed 
relatively high levels, approaching the EU average.   
Financial markets of New Member States are small in both absolute and relative terms. While 
total financial intermediation relative to GDP is about 300% in the Euro zone and in the EU, it 
is a mere 85% of GDP in the New Member States and especially low in the Baltics with 36% 
of GDP. Only the small financial markets of Cyprus and Malta come somewhat closer to the 
EU average of financial intermediation, partly due to their function as offshore financial cen-
tres. In Cyprus total bank assets including domestic and foreign assets with 388% of GDP are 
larger than total domestic financial intermediation with 267% of GDP10. The development of 
the financial intermediation sector is significant due to its remarkable increased demand. Re-
searchers are more focused in natural sciences which makes this sector more likeable.  
Financial intermediation regarded by entrepreneurs as more male dominated than employees 
regard it. On the one hand, the total number of researchers was 11 (in head count) in 2003, 
which represents approximately 4.2% of the total number of researchers in the private finan-
cial intermediation sector in 2003. On the other hand, the total number of researchers in FTE 
was 5.1 in 2003, figure which represents 5% of the total number of researchers in this sector 
in Cyprus.     
2.2. Czech Republic  
National Framework conditions 
Total R&D expenditures (GERD) have been increasing in the Czech Republic since 1995 and 
in 2004 the total amount exceeded 35 000 mio. CZK (1.1 bn. EUR). The share of total R&D 
expenditures in GDP was 1.3 % in 2004. 
Private sector represents the most important source of R&D financing in the Czech Republic. 
The share of private funds has been slightly increasing since 2000 and it reached 0.7 % of 
GDP in 2004 (more than 700 mio. EUR). More than 90% of total BERD is spent in the busi-
ness enterprise sector. Low share of private resources in R&D expenditures of the govern-
ment and the higher-education sectors indicates that private companies insufficiently utilise 
public research institutions and universities. The number of researchers in the private sector 
has been growing since 2000 and reached 7,297 researchers (FTE) in 2004. About 50 % of 
researchers are in the manufacturing industry (3,654 researchers) and their number has been 
slightly increasing since 2000. 
Public funds are stagnating and their share amounted to 0.53 % of GDP in 2004. Funding of 
industrial research and development is administered by the Ministry of Industry and Trade. 
Some of the programmes (e.g. Research Centres and Tandem) are focused on collaborative 
(joint) research, where only common projects of the industry and academia are eligible.  
                                                     
10 Breuss, F., Fink, G. and Haiss, P., How well prepared are the New Member States for the European Monetary 
Union?, paper for the special issue on Enlargement of the European Monetary Union by Dominick Salvatore(ed.) of 
the Journal of Policy Modeling, Summer 2004. 
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The Ministry of Industry and Trade has also launched several programmes supporting indus-
trial development, innovation and growth of competitiveness of SMEs within the Operational 
Programme Industry and Enterprise (e.g. INOVACE - Innovation, PROSPERITA Prosperity 
and ROZVOJ  Development). 
The Czech government introduced a system of investment incentives for foreign and domes-
tic investors in 1998, which is fully compatible with relevant regulation of the EU. The system 
of investment incentives has a significantly positive influence on the Czech economy, encour-
ages economic recovery (including enhancement of research infrastructure) and helps the 
national active employment policy. 
The Czech government has also introduced an indirect support of R&D through a new tax 
regulation which has been in force since 2005. This modification of the revenue act enables 
business entities to deduct expenses spent on R&D from their tax base. R&D related costs 
may be applied twice in the accounting  first as expenses as such and then separately as an 
amount to be deducted from the tax base before taxation. 
The infrastructure of the industrial R&D was seriously affected by the privatisation process in 
the 1990s. Its size decreased by more than a half - in some branches even more - and the 
profile of individual R&D units has been changed in favour of non-research activities. The 
situation in private R&D has been becoming stable recently and research infrastructure was 
effectively profiled according to capacities of the Czech science system.  
Manufacture of motor vehicles, trailers and semi-trailers (NACE 34) 
The business enterprise R&D expenditures in NACE 34 - Manufacture of motor vehicles, 
trailers and semi-trailers - amounted to about 180 mio. EUR in 2004, considerably exceeding 
R&D expenditures in other sectors of the manufacturing industry in the Czech Republic. R&D 
expenditures in this sector increased more than three times from 1996 to 2004 and have been 
relatively stable since 2000. The share of R&D expenditures of the automotive industry in the 
total BERD exceeds 26%, which is more than 42% of the R&D expenditures in the manufac-
turing industry. 
Number of researchers has been gradually increasing since 1991. The total number of re-
searchers was 982 (FTE) in 2004, which represents more than 13% of the total number of 
researchers in the private sector in the Czech Republic and about 27% of researchers in the 
manufacturing industry. 
The automotive industry is also a sector with the largest share of the gross value added in the 
manufacturing industry and its share in the national gross value added has grown to 2.7 % 
(more than 2 bn. EUR) in 2004. Moreover, main production indicators like receipts from sales 
of own products and services, number of employees, value added and labour productivity 
have been permanently increasing since 2000 (for instance, receipts in automotive industry 
have increased by 50% in the last five years). 
The automotive industry is one step ahead in comparison with other branches of the Czech 
industry. The sector benefits from massive FDIs, which have supranational character. FDIs 
have helped to increase the labour productivity and quality while it maintains favourable la-
bour costs and output price. The recent growth of R&D expenditures in this sector can be also 
attributed to these FDIs. 
Economically strong companies tend to have their own R&D capacities (e.g. Skoda Auto, 
Karosa or Autopal). There are also several private R&D institutes specialised in automotive 
engineering in the Czech Republic. Public sector R&D capacities for the NACE 34 sector are 
mostly at technical universities, which are located in Prague, Brno, Pilsen and Ostrava. These 
universities cooperate with enterprises in particular research projects and their graduates are 
often employed by industrial companies in the region. 
Generally, the automotive industry sector as a whole is under increasing price competition. 
Vehicle manufacturers are permanently trying to decrease their costs due to the significant 
influence of globalisation. The Czech automotive industry is exposed to a pressure on quality, 
product range and price and must be more flexible in terms of the fast changing market situa-
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tion. Any change in production is related to investment and therefore it is very important to 
consider every step towards innovation. A very competitive domestic market also forces local 
automotive suppliers to be flexible and customer friendly .  
The Czech Republic has become an important manufacturer of cars in Central Europe. The 
annual manufacture is assumed to be 800 thousand cars in 2006, from which 700 thousand 
cars will be exported. Skoda Auto Inc. as the most important exporter participates in the total 
export of the Czech Republic by more than 9%. One may add Toyota-Peugeot-Citroën Auto-
mobile (TPCA) to these figures, and in the foreseen future the two automobile plants will rep-
resent 12-15% of the total export of the Czech Republic.  
Manufacture of chemicals and chemical products (NACE 24) 
Manufacture of chemicals and chemical products is a sector with the second highest business 
enterprise R&D expenditures in the manufacturing industry. The R&D expenditures reached 
50 mio. EUR in 2004, covering more than 10 % of R&D expenditures in the manufacturing 
industry and 7 % of the total BERD. R&D expenditures were decreasing in the first half of the 
1990s due to the privatisation, however, during the period 1995  2004 the R&D expenditures 
in this sector doubled and a considerable increase was evident particularly in 2004. The busi-
ness enterprise R&D expenditures in the pharmaceutical industry (NACE 24.4) amounted to 
almost 62% of R&D expenditures in NACE 24 and the share of NACE 24.4 in R&D expendi-
tures increased significantly in recent years (49% in 2003).  
Number of researchers decreased in the second half of the 1990s. However, the number of 
researchers started to grow again in 2000, reaching 549 researchers (FTE) in 2004, which 
represents more than 7% of the total number of researchers in the private sector and 15% of 
researchers in the manufacturing industry. This development can be explained by restructur-
ing of the Czech chemical industry and the overall improvement of the economic performance 
during the last years. 
The share of this sector in the national gross value added reached 1.4% in 2004 (more than 
1.1 bn. EUR). A significant part of this gross value added is produced in the sub-sector 24.1 
Manufacture of basic chemicals (almost 60%) and NACE 24.4 Manufacture of pharmaceuti-
cals (22.6%). 
Privatisation by a strategic partner has not been so frequent and successful in this sector 
compared to the automotive industry (e.g. Skoda Auto). Privatisation of the most important 
group Unipetrol (a shareholder of producers of hydrocarbons, petrochemicals and other 
chemicals) has been postponed and is not finished yet. A part of the traditional Czech 
chemical industry suffered from the unsuccessful privatisation of Chemapol and hence lost its 
innovation dynamics. Some companies have even been re-privatised (Chemicke zavody 
Sokolov Eastman, now Hexion Specialty Chemicals or Moravske chemicke zavody, now 
BorsodChem).  
In some cases established company research facilities have not been fully utilised. Some-
times companies placed their R&D facilities in daughter companies and now they outsource 
the necessary R&D (in a reduced volume). The (former) research institutions try to compen-
sate for the lacking demand for R&D by working for third parties including foreign companies. 
Many of them developed activities in related sectors (services, production of valuable chemi-
cal specialties etc.). Public R&D capacities for the NACE 24 sector are mostly at technical 
universities, which are located in Prague, Pardubice and Brno. These universities cooperate 
with enterprises in particular research projects, which are in some cases co-funded from the 
state budget. There are comparatively strong public R&D capacities in the Czech Academy of 
Sciences, which offer a big potential for further utilisation in more advanced production of 
chemical products and in chemical technologies. 
The whole picture should be completed by some very successful cases of privatisation, like 
Zentiva or IVAX. Those companies have built systematically their R&D capacities and now 
base their further growth on innovation. Besides these companies there are a few small com-
panies (Aroma, Interpharma, Synthon, NeraPharm) and spin offs (Katchem) which are 
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strongly innovative and in many cases collaborate with academic institutions in various col-
laborative (joint) R&D programmes.  
Manufacture of electrical machinery and apparatus n.e.c. (NACE 31) 
Manufacture of electrical machinery and apparatus is a sector with very high increase of busi-
ness enterprise R&D expenditures in the Czech Republic in recent years. R&D expenditures 
were rapidly decreasing in the first half of the 1990s due to the privatisation, however, in 1998 
R&D expenditures started to grow again and increased four times from 1997 to 2004 reaching 
25 mio. EUR in 2004 (5.7% of the total BERD, 3.5% of the R&D expenditures in the manufac-
turing industry). Considerable increase is evident in 2002 and during the last four years R&D 
expenditures doubled. R&D expenditures have been growing faster in the NACE 31 sector 
than in the whole manufacturing industry and their share in the manufacturing industry as well 
as in the total BERD has been increasing. 
The highest R&D expenditures are in the NACE 31.6 - Manufacture of electrical equipment, 
which includes production of electrical equipment for motors and cars (NACE 31.61), 
NACE 31.1 
 Manufacture of electric motors, generators, and transformers, and NACE 31.2 
Manufacture of electricity distribution and control apparatus. 
The number of researchers in the NACE 31 sector has been generally growing since 1994. A 
slight decrease in the number of researchers in 1998 and 1999 corresponds to a fall in the 
growth of R&D expenditures in this sector between 1999 and 2001. A significant increase in 
the number of researchers is evident in 2002 and from 2001 to 2004 the number of research-
ers in NACE 31 increased by 60% reaching 256 researchers in 2004, which is about 3.5% of 
the total number of researchers in the private sector and about 7% of researchers in the 
manufacturing industry. 
The share of the NACE 31 sector in the national gross value added has grown to 1.8% 
(1.6 bn. EUR) in 2004. The number of employees has been stable in this sector since 2000, 
however, receipts from sales of own products and services, value added, and labour produc-
tivity have been growing faster than those in the manufacturing industry. According to the 
sales, NACE 31.6 Manufacture of electrical equipment, NACE 31.2 Manufacture of elec-
tricity distribution and control apparatus, and NACE 31.1 - Manufacture of electric motors, 
generators and transformers are the most important sub-sectors. The most important sub-
sector, NACE 31.6, reported the highest growth of sales in 2004, which can be attributed to 
the expansion of the automotive industry (NACE 34). This subsector also creates the highest 
value added in the entire NACE 31. 
Privatisation in the early 1990s negatively influenced performance of this sector and resulted 
also in a reduction of private R&D activities. Nowadays this sector benefits from FDI, which 
have been positively affecting rapid restoration and further development of R&D activities in 
this sector. The sector also benefits from the development of the automotive industry (Skoda-
Auto and recently Toyota-Peugeot-Citroen Automobile).  
Economically strong companies have usually their own R&D capacities (e.g. Siemens, ABB, 
and SKODA) in the Czech Republic. There are also several private R&D institutes specialised 
in electrical engineering in the Czech Republic. Public sector R&D capacities for the NACE 31 
sector are mostly at technical universities, which are located in Prague, Brno, Pilsen and Os-
trava. These universities cooperate with enterprises in research projects and their graduates 
are often employed in industrial companies in the region. 
The NACE 31 sector has been attractive for foreign companies to invest in due to the quality 
and still a relatively cheap labour force. However, the lack of qualified technical workers (es-
pecially young technicians) in some regions of the Czech Republic can negatively influence 
future development of this industry and building uo new production and development capaci-
ties.  
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Manufacture of rubber and plastic products (NACE 25) 
Manufacture of rubber and plastics products belongs to the most dynamic industries in the 
Czech manufacturing sector since the second half of the 1990s. Its position in the manufac-
turing industries has significantly improved and this enormous increase has resulted from its 
close relation to the rapidly increasing automotive, electrical, food as well as building industry 
that create the core of the Czech industrial structure.  
R&D expenditures in the NACE 25 are still quite low (more than 10 mio. EUR in 2004, which 
is about 1.5% of the total BERD and 2.4% of the R&D expenditures in the manufacturing in-
dustry). However, for the next development of this sector it is positive that R&D expenditures 
increased almost twice from 2001 to 2004. The increase of R&D expenditures in this sector 
was higher than in the whole manufacturing industry and resulted in a strengthened position 
of this sector in the R&D structure. Significant amount of R&D expenditures in 1998 was 
caused by a privatisation of some key producers. Nevertheless, the share of R&D expendi-
tures in the sector is still lower in comparison with its shares in employment, sales and value 
added. 
The number of researchers stagnated in the last 5 years and is lower in comparison with the 
year 1995 (123 researchers in 1995, 83 researchers in 2004). The number of researchers in 
2004 represents 1.1% of the total number of researchers in the private sector and 2.3% of 
researchers in the manufacturing industry. 
The share of the NACE 25 sector in the national gross value added has grown to 1.6% (more 
than 1.2 bn. EUR) in 2004. The value added in this sector increased by more than 90% from 
2000 to 2004 and also the number of employees, receipts from sales of own products and 
services and labour productivity have been permanently increasing since 2000. 
Recent dynamic growth of the rubber and plastics industry and its integration in global suppli-
ers networks was followed by restructuring of enterprises and product modernisation. As a 
result of a successful privatisation and establishment of new production units the expendi-
tures on R&D activities have increased since 2001. 
R&D in manufacture of rubber and plastics products has a long tradition in the Czech Repub-
lic. R&D activities in the NACE 25 are mainly driven by foreign companies operating in the 
Czech market, enormous growth in production of automotive and electrical machinery and a 
growing foreign demand. The largest producers in the NACE 25 tend to have their own R&D 
capacities (e.g. MITAS, RUBENA, GUMOTEX or Kaucuk). Private R&D is also provided by 
many private R&D institutions, transformed R&D institutions (formerly in state ownership) and 
newly established organisations. Cooperation between universities and firms consists in a 
joint involvement in specific research projects, memberships in scientific and examining 
commissions, students expert practice, etc.    
2.3. Estonia  
According to the projections of the strategy document Knowledge-Based Estonia, Research 
and Development Strategy 2002-2006 total R&D investments were expected to reach 1.5% of 
GDP by the year 2006 with the government contributing a significant share of this as the pri-
vate sector slowly increases its investment levels. The actual investment into R&D in 2006 is 
about two-thirds of what was expected (in 2004 total investments into R&D amounted to 0.9% 
of GDP)11.   
                                                     
11 Two studies of the Statistical Office of Estonia are used as main data sources. Although detailed statistical infor-
mation is sometimes not released due to individual data protection, the regular survey on business sector on R&D 
and the Community Innovation Survey (CIS3 for 1998-2000 and CIS4 for 2002-2004) are used here. Also, some 
major fluctuations can be observed in time series that could be explained by the addition of just some R&D reporting 
companies, although the latter could be due to administrative changes in reporting and not to changes in company 
activities. Extensive secondary sources were also used in preparing the report. In addition, to get a better and deeper 
understanding of the patterns and dynamics of R&D activities in private firms, two case studies were prepared based 
on semi-structured interviews with representatives of the companies.  
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Personnel engaged in business sector R&D has grown more than twice in Estonia over 1998-
2004. Two sectors manufacture of electrical and optical equipment and computer and re-
lated activities employ more than half of the total R&D personnel and spend one third of the 
total R&D expenditures. These sectors were not in the focus of the current study, although, 
based on some other studies carried out on these sectors, one could hesitate if such rapid 
increasing indicators are in accordance with reality.   
In addition, almost no studies have been carried out which measure the impact of public R&D 
subsidies on economic performance. The first such wide-scale assessment is going on at the 
moment. Therefore no reference can be made in this respect in this report.   
National Framework Conditions  
All in all, the current situation is partially caused by the science, technology and innovation 
(STI) policies of the past and reinforced with the current policies. Namely, Estonian reforms in 
the field of STI have even been characterized as "shock without therapy" approaches leading 
to a loss of lot of R&D supply channels as well as absorptive capacities. There have been no 
selective FDI-policies implemented in Estonia and Estonia had no industrial policy, too.  State 
financing of the Estonian innovation system has been and is, to a great extent, targeted at the 
promotion of commercialisation and other economic uses of research and knowledge. It is 
concentrated in universities and other R&D institutions, i.e. it is intended to finance research-
ers and knowledge transfer into the enterprise sector.   
As a consequence, relatively high economic growth (both GDP and export growth) is taking 
place, but in the course of fast export- and consumption-based growth, the volume of tech-
nology and skills in the economy has decreased. Many important economic sectors are of 
subcontracting nature and local clustering (contacts with other companies, educational and 
R&D institutions) - positive feedback mechanisms - are essentially missing. As Estonia is 
loosing its attractive position as cheap production place, higher value added production and 
related R&D is seen, in rhetoric, as a possible alternative. However, due to path dependen-
cies it is by no means easy to achieve.   
Financial intermediation (NACE 65-67)  
Out of the four sectors studied the most successful one is financial intermediation. The share 
of the sector in the national GDP was 3.4% (273 mio. EUR) in 2003. The private R&D expen-
ditures amounted to 4.3 mio. EUR in 2004. The share of R&D expenditures of the financial 
intermediation in the total BERD exceeds 11%.   
The number of researchers has also been increasing in 2003-2004. The total number of re-
searchers was 81 (FTE) in 2004, which represents more than 7.8% of the total number of re-
searchers in the private sector in 2004.  
The share of innovative companies has been very high, most of the technological innovations 
are arguably ICT-related. R&D employees are mainly ICT experts. The financial intermedia-
tion market is rather consolidated and all of the main players are active in R&D and ICT-
innovations. Some R&D intensive collaborative efforts have been noted.   
The currently very high level of R&D and innovation in the Estonian financial intermediation 
sector (and especially in the banking sector) can be explained by the following factors: high 
level of ICT competence as Soviet legacy, the emergence of modern banking sector in Esto-
nia overlapped with emergence of Internet-based ICT-paradigm, and an explosive use of the 
Internet in Estonia. The consolidated structure enabled a few key players to invest remarkably 
and an on-going expansion of the financial intermediation sector due to favourable circum-
stances in the market boosted the development.   
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Food and beverages (NACE 15)  
The food industry is the biggest manufacturing industry in Estonia. The share of the sector in 
the national GDP was 2.8% (205 mio.. EUR) in 2003. The two most important fields in the 
Estonian food sector have traditionally been dairy products and fish industry.   
The private R&D expenditures amounted to 1.2 mio. EUR in 2004, private R&D expenditures 
in this sector increased 3 times from 2000 to 2004. The share of R&D expenditures of the 
food and beverages industry in the total BERD exceeds 3%, which is more than 7% of the 
private R&D expenditures in the manufacturing industry.  
The number of researchers has been decreasing in 2000-2004. The total number of re-
searchers was 16 (FTE) in 2004, which represents more than 1.5% of the total number of re-
searchers in the private sector in 2004 and about 3.6% of researchers in the manufacturing 
industry.  
The most relevant factors which have influenced the Estonian food industry s structure in the 
years 1990 to 2004 are mostly state enforced food trade policy and little agricultural assis-
tance policy in the beginning of the 1990s. In addition, Russian crisis hit very hardly on the 
Estonian food sector and additional pressure has been exerted on the Estonian food industry 
by the fulfilment of EU requirements.   
When looking at the ownership structure of the Estonian food sector, it becomes evident that 
besides dairy production and fishing industry, over half of the whole industry belongs to for-
eign investors operating in Estonia. Such ownership structure is the main reason why only the 
first two sectors lean on the co-operation with Estonian R&D establishments. Other industries, 
operating under FDI have indicated unwillingness to carry out R&D in Estonia.   
Although food enterprises are reported as being more innovative than the average of manu-
facturing industry, R&D expenditures as well as employment related to R&D are quite modest. 
Over a longer time series even decreases can be observed. There is very little research-
intensive product development carried out in Estonia. Most innovations are related to the ful-
filment of EU sanitation requirements. Product developments have been mainly related to 
widening the product mix, new packaging and marketing.   
Manufacture of metal products and machinery (NACE 27-29)  
The metal and machinery industry developed very fast during the re-independence period. 
Production of the metal industry grew tenfold in ten years, thanks to exports. But also domes-
tic demand (in machinery and equipment and construction sectors) increased significantly.   
The share of the sector in the national GDP was 2.5% (183 mio. EUR) in 2003. The private 
R&D expenditures amounted to 1.1 mio. EUR in 2004, private R&D expenditures in this sec-
tor increased 5 times from 1999 to 2004. The share of R&D expenditures of the metal prod-
ucts and machinery industry in the total BERD exceeds 3%, which is more than 7% of the 
private R&D expenditures in the manufacturing industry.  
The number of researchers has been increasing in 2000-2004. The total number of research-
ers was 65 (FTE) in 2004, which represents more than 5.2% of the total number of research-
ers in the private sector in 2004 and about 12.6% of researchers in the manufacturing indus-
try.  
The development of the machinery industry is mainly rooted in foreign markets, as most of the 
production is exported. In 2004, the machinery sector experienced the highest growth in R&D 
expenditures and R&D personnel of all sectors.   
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The shortage of skilled labour has been becoming a major obstacle for further development of 
the sector. Many engineers retired or are on the verge of retiring by now. Finding new special-
ists to replace these people have been a painful process for the companies.   
The share of new products in metal and metal products industry has been rather modest in 
terms of turnover and current competitive advantages are based on lower labour costs. A fur-
ther characteristic of the sector is the fact that only one company has received public funding 
for a R&D project. The companies in the machine building sector tend to be more innovative 
than other sub-sectors. These companies co-operate with R&D institutions and apply for pub-
lic funding. Most of these projects are set up to develop machines for forestry, agricultural and 
communes.   
Manufacture of furniture and recycling (NACE 36, 37)  
The share of the sector in the national GDP was 1.5% (109 mio. EUR) in 2003. The private 
R&D expenditures amounted to 0.4 mio. EUR in 2004, private R&D expenditures in this sec-
tor increased 2 times from 2000 to 2004. The share of R&D expenditures of the furniture and 
other manufacturing industry in the total BERD exceeds 0.9%, which is more than 2% of the 
private R&D expenditures in the manufacturing industry.  
The number of researchers has been decreasing in 2001-2004. The total number of re-
searchers was 15 (FTE) in 2004, which represents more than 1.4% of the total number of re-
searchers in the private sector in 2004 and about 3.4% of researchers in the manufacturing 
industry.  
The share of the furniture sector in R&D expenditures of the whole manufacturing industry 
(2%) is considerable smaller than its contribution to industrial production or value added (9%). 
Thus, production volumes have grown rapidly and the existing competitive advantages are 
based on low labour costs and other favourable cost structures. The availability of domestic 
resources (production of sawn wood and wood-based panels), the closeness of main target 
markets, and availability of good transport capabilities (e.g. ports) are the main strengths of 
the Estonian furniture industry.   
Most of the innovative activities of the companies are related to process innovations (e.g. 
computer-aided manufacturing systems), marketing innovations (advertisements, large com-
panies investing into distribution channels), but the share of product innovations is lower. 
Concerning the latter, Estonian furniture firms are generally reactive to the design setting of 
competitors and only 20 firms in furniture industry employ designers; among them 5 compa-
nies are exporters.   
The role of government is seen in directing the R&D policy towards traditional industrial sec-
tors (including furniture), but also improving the educational system and promoting coopera-
tive arrangements.   
2.4. Hungary  
National Framework conditions  
Given the importance of sectoral characteristics, only a few overall conclusions can be drawn 
here. First, business R&D expenditures are very low in Hungary: 0.3% of GDP (in 2004), 
which is less than one third of the EU-25 average. Second, BERD is highly concentrated: 
pharmaceuticals industry accounts for more than one third of the total (34.4% in 2004). Case 
study evidence suggests that BERD is concentrated in terms of size and ownership: the bulk 
of BERD is spent by large, foreign-owned companies.12   
                                                     
12
 These data at a national or sectoral level are not publicly available, either  but can be purchased. 
 Final Report  
Private sector R&D in the new Member States
Page 29 of 76 
The four sectoral case studies confirm the dominant role of foreign-owned firms in RTDI ac-
tivities, too. Foreign-owned firms tend to be large, and thus the decisive share of BERD is 
performed by large enterprises. Using EUROSTAT data, the share of large firms (with 250 or 
more employees) was 96% of total R&D expenditures (2003), and 78% of total R&D person-
nel in manufacturing industry (2004).  
Manufacture of pharmaceuticals (NACE 24.4)  
The pharmaceuticals industry has been one of the best performing industries considering its 
overall performance and the specified R&D indicators since the transition of the Hungarian 
economy. Between 2001 and 2003, R&D expenditure in the pharmaceuticals industry in-
creased by 20 percent/year on average and R&D intensity averaged around 11% and 20% in 
terms of sales revenues and sectoral GDP. This is by far the highest R&D intensity value with 
respect to both indicators in the Hungarian manufacturing industry.  
The share of pharmaceuticals in the national GDP has grown to 0.5% by 2003, thanks to a 
healthy growth in its production value (from 840 mio. EUR in 1999 to 1537 mio. EUR in 2003).  
The private R&D expenditures in NACE 24.4 amounted to 82.6 mio. EUR in 2004, up from 
43.7 mio. EUR in 1998. The share of R&D expenditures of pharmaceuticals industry in the 
total BERD is close to 28% and exceeds 34% of the private R&D expenditures in the manu-
facturing industry.  
The number of researchers has been fluctuating around 1600-1700 since 1998. The total 
number of researchers was 1771 (head counts) in 2004, which represents around 20% of the 
total number of researchers in the private sector.  
According to the major conclusions of the sectoral case studies, pharmaceuticals industry is 
the most R&D intensive sector in Hungary, which is in line with the global trends of this sector. 
The sectoral research system has been radically restructured during the past fifteen years as 
foreign pharmaceuticals manufacturers became majority owners in most companies, and they 
pursue global R&D strategies. In Hungary, they focus on the development of generic drugs. 
Thus, the number of research projects has decreased, but the allocation of R&D expenditures 
became more efficient.  
FDI became a major determinant of R&D at the Hungarian companies. R&D plays an increas-
ingly important role in maintaining and improving the companies
 competitive positions. It is 
even more so in the case of pharmaceutical companies, whose long-term competitiveness 
depends on their ability to innovate and develop original molecules. Companies mainly spe-
cialising in the production of generics cannot maintain a competitive edge over producers 
from the Far East, and recently introduced EU environmental protection regulations also pose 
difficulties for their operations.  
The foreign investors have significantly restructured the R&D system of their Hungarian affili-
ates. In most cases, R&D at the Hungarian companies became a sub-system in the global 
R&D programme of the parent companies, which determines on the global scale what type of 
research is to be performed by the Hungarian companies. As a result, research at the Hun-
garian manufacturers is restricted to areas specified in the global R&D strategy, and thus 
original research performed only in specific areas. New product development of the domestic 
companies decreased, as well as the number of patent applications for original products, 
which is also due to the introduction of product patents (replacing process patents). The tran-
sition from the process-patent to a product-patent system meant that Hungarian manufactur-
ers had to introduce a dramatically new approach to research. The range of products has also 
decreased in many cases, because the parent company has replaced Hungarian products by 
its own products. Another visible effect is that the cooperation between domestic companies 
and universities became more limited, and it is performed mainly in the field of developing 
analytical tests.  
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Manufacture of parts and accessories for motor vehicles and their engines (NACE 34.3) 
and Manufacture of electrical equipment for engines and vehicles (NACE 31.61) 
Two sectors, NACE 34.3 and NACE 31.61 are analysed together, because they are closely 
related: although statistically they belong to different sectors, in essence both of them are 
parts of automotive industry, broadly defined. One of them has been selected for this project 
because of its high R&D-intensity (in the Hungarian context), that is, manufacture of parts and 
accessories for motor vehicles and their engines (NACE 34.3). The other one has been cho-
sen due to its fast growing R&D-intensity, namely, manufacture of electrical equipment 
(NACE 31.6). This latter sector covers the sub-sector called manufacture of electrical equip-
ment for engines and vehicles (NACE 31.61)  
The share of the automotive components industry in the national GDP has grown to 0.8% by 
2003, thanks to a healthy growth in its production value (from 1000 mio. EUR in 1998 to 2049 
mio. EUR in 2003).  
The private R&D expenditures in NACE 34.3 amounted to 12.5 mio. EUR in 2004, up from 4.2 
mio. EUR in 1998. The share of R&D expenditures of the automotive components industry in 
the total BERD amounts to 4.2%, that is, 5.2% of the private R&D expenditures in the manu-
facturing industry.  
The number of researchers has more than doubled since 1998. The total number of re-
searchers was 367 (head counts) in 2004, which represents around 4% of the total number of 
researchers in the private sector.  
The share of the other electric equipment industry essentially electrical equipment for en-
gines and vehicles in the national GDP has reached to 0.3% by 2003, thanks to a healthy 
growth in its production value (from 317 mio. EUR in 1998 to 1,092 mio. EUR in 2003).  
The private R&D expenditures in NACE 31.6 amounted to 2.9 mio. EUR in 2004, up from 0.4 
mio. EUR in 1998. The share of R&D expenditures of the electrical automotive components 
industry in the total BERD amounts to 1%, that is, 1.2% of the private R&D expenditures in 
the manufacturing industry.  
The number of researchers has increased 2.5 times since 1998. The total number of re-
searchers was 85 (head counts) in 2004, which represents around 1% of the total number of 
researchers in the private sector.  
Automotive industry has been traditionally less R&D intensive. Yet, innovation, R&D and en-
gineering skills are becoming decisive factors of success for automotive firms, given the fierce 
competition in this market. The challenges for R&D and innovation are improved products in 
terms of safety, comfort, and fuel efficiency. These product innovations are assisted, and, in 
the meantime, also pressed, by ever faster technological changes. Hungarian engineers have 
been endowed with these skills and knowledge. Results of the interviews suggest emerging 
co-operation between automotive firms on the one hand, and university departments as well 
as other R&D units on the other. More recently, some foreign investors have also realised the 
world-class knowledge of Hungarian scientists and engineers, and they are setting up either 
their in-house R&D units or joint research groups with universities. Again, besides profes-
sional excellence, there is a considerable cost advantage in this field, too. Further, in the sec-
ond half of the 1990s, R&D schemes were also applied to strengthen innovation capabilities 
of suppliers, and a new one was launched in 2006. 
The successful re-structuring of the Hungarian automotive industry is not only due to some 
push factors, i.e. the fierce competition among automotive companies and hence the pursuit 
of cost-cutting via re-location of their production, but it also thanks to pull factors, i.e. the at-
tractions of the Hungarian economic environment, broadly defined. Given the ever changing, 
and global nature of the automotive industry, no country can be complacent. On the contrary, 
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continuously renewed, concerted efforts and well-devised policy measures are needed to 
achieve further results.  
Manufacture of medical instruments (NACE 33.1)  
The share of the medical instruments industry in the national GDP has reached to 0.1% by 
2003, thanks to a healthy growth in its production value, albeit from a low absolute number 
(from 94 mio. EUR in 1998 to 194 mio. EUR in 2003).  
The private R&D expenditures in NACE 33.1 amounted to 1.5 mio. EUR in 2004, up from 0.8 
mio. EUR in 1998. The share of R&D expenditures of the medical instruments industry in the 
total BERD amounts to 0.5%, that is, 0.6% of the private R&D expenditures in the manufac-
turing industry.  
The number of researchers has increased by four times since 1998. The total number of re-
searchers reached 214 (head counts) in 2004, which represents around 2.4% of the total 
number of researchers in the private sector.  
The R&D-intensity of the sector is not only higher than that of the whole electrical and optical 
instruments sector but it also produces higher growth. These tendencies are in line with the 
changes that can be observed in the industry at the EU-25 level.  
The most important trends in the world s medical instruments industry play a determining role 
in the innovation activities of Hungarian companies. These trends include the increasing use 
of IT systems built into medical equipment, the revolution of digital imaging equipment and the 
expansion of the home-use appliances market. Besides R&D of the traditional equipment, 
Hungarian medical equipment manufacturers proved successful in the development and ap-
plication of these product families.  
Unfortunately, further data is not available for the analysis of the effects of R&D on the per-
formance of the Hungarian medical instruments industry. Studies and sectoral analyses that 
systematically analyse the relationship between R&D and company performance are not 
available.    
2.5. Latvia  
The current level of R&D in Latvia is comparatively low. In terms of the level of spending on 
R&D relative to the gross domestic product (0.4%) Latvian R&D intensity is one of the lowest 
in the EU. In fact, in the early 1990s, spending on R&D experienced a significant decrease 
from which it has not yet recovered. As a result, while GDP growth rates have been high, in 
recent years the highest in the EU, most economic activity still takes place in low value-added 
sectors.  
This situation can be partly explained by rapid economic restructuring following the abandon-
ment of the command economy. Prior to the reform, much of the applied R&D was concen-
trated in the research divisions of uncompetitive enterprises inherited from the USSR. Over 
the course of the reforms, many of these companies were closed down. Coupled with a dras-
tic fall of government funding for science, this caused a dramatic decline in R&D performance.  
Another reason for the currently insufficient private R&D effort is the lack of a coherent inno-
vation policy throughout most of the 1990s. Initial policy documents either did not concentrate 
on innovation, or else lacked concrete measures to be taken and were not backed by pledges 
of funding. Only in 2001 the government adopted the National Innovation Concept. On the 
basis of the concept the National Innovation Programme for 2003-2006 was later approved. 
The most recent document concerned with innovation is the National Development Plan for 
2007-2013. The main goal of the plan is to create a knowledge-based economy; correspond-
ingly, R&D activities are heavily stressed. 
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Manufacture of chemicals and chemical products (NACE 24)  
The chemical industry is one of Latvia s traditional industries. Almost half of its turnover is 
generated by pharmaceutical companies. In turn, the pharmaceutical sub-sector is dominated 
by two large firms. Currently, the turnover of the sector is growing after a brief decline follow-
ing the Russian financial crisis in 1998. Value added in chemicals and chemical products has 
grown to just over 50 mio. EUR in 2003 representing a share of 0.51% of GDP.   
It is an industry where R&D is traditionally emphasized, particularly among the pharmaceuti-
cal companies, as innovation is necessary to remain competitive in this sector. Compared 
with other industries, companies in NACE 24 spend a much higher percentage of their turn-
over on innovation with large pharmaceuticals producers contributing approximately 10% 
and employ proportionally more workers in R&D roles than most other Latvian firms. Smaller 
companies, on the other hand, spend much less, mainly due to high costs of research in this 
field. The recent trend also shows that the share of R&D expenses in turnover is growing. 
Thus expenditures on R&D have grown from nearly 1.7 mio. EUR in 2001 to nearly 2.4 mio. 
EUR in 2003. This represents nearly 63% of manufacturing R&D and just over 18% of all 
BERD.  
In addition, companies working in the chemicals sector have benefited from a relatively well-
developed local scientific base. This especially applies to larger producers, who frequently 
cooperate with research institutes. As a result, the largest pharmaceutical companies are able 
to maintain innovative potential and register new patents regularly.  
At the same time, lack of human resources is becoming an acute problem for enterprises in 
the industry, as the Latvian education system does not ensure a sufficient number of univer-
sity graduates specialising in the relevant fields. Nevertheless, the total number of staff in 
R&D has grown from 156 in 2002 to 234 in 2004 and of these the researcher head count is up 
from 119 to 126. The latter number represents just over 69% of researchers in manufacturing 
and nearly 23% of all private researchers.  
Additionally, the burden of administrative requirements, particularly those related to quality 
standards, is a significant obstacle for companies, as meeting these requirements demands 
investments which are diverted from R&D programmes.  
Other business services (NACE 74)  
The NACE category 74, other businesses services, includes miscellaneous services such as 
advertising, legal, audit, consulting services, etc. The turnover and the number of companies 
in this industry were rapidly growing in the 1990s, as the sector was practically non-existent 
prior to the 1990s. By 2003 value added in the sector was nearly 248 mio. EUR representing 
a share of 2.5% of GDP (up from 522 mio. EUR in 2001 or a share of just over 2.2% of GDP).  
R&D spending in the sector constitutes almost a half of the total private R&D spending. Al-
though it is rather variable thus in 2001 total R&D in this sector was 3 mio EUR, in 2002 it 
was nearly 6.7 mio. EUR and in 2003 just over 5.9 mio EUR. The latter represented nearly 
46% of all BERD and was about 57% more than BERD in manufacturing. This, however, 
could have been caused by the nature of NACE group 74, which contains companies not in-
cluded in other groups. Unfortunately, it is impossible to determine the pattern of R&D spend-
ing in different sub-groups of NACE 74, although these sub-groups are clearly very diverse.  
Still, based on survey data it can be said that companies in the sector generally regard inno-
vation as being important for boosting efficiency of operations, improving quality of services, 
or meeting regulatory requirements. At the same time, some companies express the view that 
available human resources are insufficient to ensure optimal R&D process. In 2002 1336 
people were employed in R&D representing nearly 57% of all private R&D employees,  Out of 
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the 1336 employees, 522 were researchers (46% of all private researchers). By 2004 these 
figures were respectively 219 (19%) and 93 (nearly 17%).  
Manufacture of textiles (NACE 17)  
The textiles sector is another industry with a long tradition in Latvia. Currently, however, it is 
endangered by rising labour costs. As a result, companies find it increasingly difficult to com-
pete with countries with cheap labour. Consequently, the sector has shrunk with value added 
in 2003 at just over 62 mio. EUR (0.63% of GPD) down from 108 mio. EUR (nearly 1.2% of 
GDP) in 2001.  
Investment going to innovation is increasing, possibly reflecting an attempt to offset the nega-
tive effects of international competition. Nevertheless, the industry still spends little on innova-
tion compared to other sectors. In addition, companies
 ability to engage in R&D is con-
strained by a very limited domestic scientific base. In contrast to sectors such as chemicals, 
there are no specialised research centres working in fields relevant for the textile industry, 
and as a result, firms are rarely able to use external expertise in their R&D effort. Thus in 
2003 only 0.219 mio. EUR was spent on R&D, which represents 5.8% of manufacturing R&D 
or nearly 1.7% of BERD.   
Furthermore, human resources represent another potential bottleneck. While existing workers 
are relatively highly qualified, only a handful of university students choose to specialise in 
relevant fields. Thus, companies are likely to face a problem of increasingly ageing staff in 
future, which may become another obstacle for their R&D process, and may further endanger 
their competitiveness. In 2003 there were just 13 researchers in the sector representing just 
over 7% of researchers in manufacturing and 1.85% of all private researchers. The sector 
reported just one backup worker in R&D in 2003.  
Manufacture of fabricated metal products (NACE 28)  
Manufacture of fabricated metal products is one of Latvia s fast-growing sectors, having 
nearly doubled its turnover between 1999 and 2003. Value added in 2003 was 53 mio. EUR 
or or 0.53% of GDP. Research and development, however, does not play a major role, taking 
up less than 0.5% of the sector s turnover. Those R&D activities that do take place are mostly 
performed by large companies in the sector. Probably the cost and risk of innovation are be-
ing too large for smaller firms. In 2003 R&D expenditures were 0.47 mio. EUR or just over 
12% of manufacturing R&D (3.6% of BERD).  
As in many other industries, innovative activities in this sector are limited by a lack of engi-
neering graduates, as the demand for them is much higher than the numbers that are avail-
able. In addition, many companies complain about recent graduates being insufficiently quali-
fied. In 2004 only 4 people were reported as working in R&D in the sector, none of whom 
were actual researchers.  
To ease the recruitment problem, many companies try to attract students at early stages of 
their university studies, offering jobs or internships. There is also substantial cooperation be-
tween enterprises and universities, in which the former offer scholarships to students or finan-
cial aid to the schools. Nevertheless, this collaboration has not been extended to more direct 
cooperation in the R&D process between firms and universities or research centres, particu-
larly due to high costs, insufficient scientific base, and lack of information.   
2.6. Lithuania  
The selected sectors represent traditional branches of the manufacturing industry in Lithuania 
and contribute significantly to the economic activity of the country. However, the analysis was 
restricted by the two factors. First, business R&D investments and therefore R&D employ-
ment are very low. Second, due to the limitations that are given for a small country such as 
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Lithuania, there is no reliable statistical evidence to support even this argument. Therefore the 
analysis is mainly based on evidence from case studies conducted.  
Lithuania is dominated by the traditional industries, basically competing on costs, and facing 
the challenge of increase of productivity which still remains below 50% of EU average. R&D 
activities are performed by few companies in each of the selected branches, and its quality 
and orientation differs widely.   
In the aftermath of the Russian crisis of 1998, the economy quickly recovered from the exter-
nal shock. GDP grew over 6% in 2001-2002 annually and 9.7% in 2003, however this was the 
peak after which the real GDP growth fell to 6.7% in 2004, and 7.5% in 2005. Although growth 
is expected to remain high for the next few years, the vital need for new growth resources is 
obvious. Productivity growth, reduction of energy use in production and knowledge-based 
innovations are key challenges for the Lithuanian economy growth in the next future. Analysis 
of the country competitiveness shows that Lithuania is still competing on costs, and the next 
challenge is upgrading productivity in industry and transforming low value added activities into 
high productivity and high value added industries.   
The bulk of Lithuanian R&D resources are concentrated in the public sector. Further concen-
tration is encouraged with funding mechanisms, which drives 90% of public funding to public 
R&D institutions. Competitive funding for R&D remains very low.  
Knowledge creation indicators such as public R&D expenditure, business R&D expenditure, 
and share of medium-high tech R&D remain far below the EU-25 level. Accumulated funds 
from all sources for R&D and higher education constituted 2.2% of GDP. According to official 
statistics, 381 mio. LT (1 EUR = 3.45 Litas) were allocated for R&D in 2003. 35.5% were used 
to finance fundamental research, 38% for applied research, and 26.5% for experimental de-
velopment.   
In 2002, R&D activities were performed by 67 enterprises, and 58 mio. LT were devoted for 
R&D activities in enterprise sector. The public sector was subsidising private R&D activities 
with 36 mio. LT in the same year.   
Despite the increased numbers of PhD graduates, in the period 1998 
 2003 numbers of re-
searchers decreased by 22%. The R&D sector therefore faces a aging problem in the near 
future. Today, in the age group of 25 - 34 there are 3 times less researchers than in EU, and 
5  7 times less than in Finland and Sweden.  
Restructuring of R&D sector and development of R&D based businesses is not only the eco-
nomic target for Lithuania, but also a tool for reducing brain drain of highly skilled people, es-
pecially in the priority areas  biotechnologies, lasers, ICT, mechatronics and nanosciences.  
The R&D potential lies in the development of logistic applications, automatisation of manufac-
turing processes, environmental innovation, as well as in the cross cutting high technology 
fields, such as biotech, lasers, mechatronics, material and nano sciences, and ICT.    
Besides some other RTDI-policy measures, the government introduced an indirect support of 
R&D by means of a new tax regulation which has been in force since 2005. This modification 
of the revenue act enables business entities to deduct expenses spent on R&D from their tax 
base. The impact on R&D activity and outcome remains to be evaluated.   
Manufacture of food products and beverages (NACE15)  
The Lithuanian food industry is one of the largest industries in the country in terms of contri-
bution to GDP, and the largest employer among all industrial sectors (40 thousand employ-
ees). It covers production of dairy, meet, cereal refining industries, production of sugar, bev-
erages, etc.  
The share of food products and beverages in the national GDP has always played an impor-
tant role. Although, as a consequence of the decline of Eastern export markets and general 
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deindustrialisation of the country, it declined from 3.9% of GDP in 2000 to 3.5% of GDP 
(1832. mio. EUR) in 2005 in 2005.  
Dairy products, meet and cereal industries are identified as the most competitive sectors. In 
2002 these comprised 17% of all industrial business entities. Although, the relative impor-
tance of the food industry decreased from 30% in 1999 to 24% in 2002, it remains the largest 
industrial sector with continually growing sales and exports. In terms of competitiveness and 
international exports, dairy industry is most successful, comprising 19% of total food sector 
employment (8,600 employees). In recent years, the sector has undergone a process of sig-
nificant market consolidation. Only 19 out of 37 enterprises had licences for EU trade in 2002. 
47% of total production was exported to USA, Netherlands, Russia, Latvia, and other coun-
tries.   
The sector basically faces the challenge of international competition. Likewise the sector is 
challenged by ensuring high level food safety standards, applying new and safe manufactur-
ing technologies, development of healthy and ecological products. Large enterprises run their 
own food safety research labs, but they are mainly responsible for quality control rather than 
research duties.  
The private R&D expenditures in NACE 15 - amounted to 1.7 mio. EUR in 2003, R&D expen-
ditures in this sector fell by 0.19% from 2000 to 2003, but increased by 50% in 2003, com-
pared to 2002.  The share of R&D expenditures of the food industry in the total BERD ex-
ceeds 7.2 %, which is more than 12.2 % of the private R&D expenditures in the manufactur-
ing industry. 
The number of researchers has been decreasing since 2000. The total number of researchers 
was 52 (FTE) in 2003, which represents more than 7.8% of the total number of researchers in 
the private sector in 2003 and about 11% of researchers in the manufacturing industry.  
R&D intensity in the food industry is driven by internationalisation and the need to meet inter-
national quality and food safety standards. R&D also focuses on new product development 
and the application of new packaging technologies. Development of ecological food products 
is a new trend involving agriculture and food research.   
R&D investment is focused on acquiring and adjusting new production technologies with the 
main aim of improving food quality and food safety. Development of new products in most of 
the cases is carried out by the internal staff in enterprises, or, in rare cases, in co-operation 
with research organisations. In the meat-industry, major technology developments were re-
lated to the acquisition of modern technologies via SAPARD support schemes. Product de-
velopment remains limited to the internal company resources or is increasingly supply-side 
driven.   
Manufacture of chemicals and chemical products (NACE 24)  
The share of chemicals and chemical products in the national GDP has always played an im-
portant role. It has kept its share of 1% of GDP in the period of 2000 to 2005. It produced 1% 
of GDP (581,922 mio. EUR) in 2005. The sector is highly diversified and not equally competi-
tive. Mineral and organic fertilisers are producing most value added. Genomic engineering 
firms are competing on the global high-tech markets. The sector exported 75% of total pro-
duction. Most of cost-competitiveness is based on the relative low costs for raw material, im-
ported from Russian Federation. Home chemical and pharmaceutical industries are weakly 
developed.   
Producers of fertiliser export 80% of total production, home chemicals (30%), pharmaceuti-
cals (30%), synthetic fibres (80%), bio-technology products (90%). The export markets of fer-
tilisers and biotechnologies are western, while those of pharmaceuticals and home chemistry 
eastern. The most important challenge faced by the chemical industry was the membership in 
the EU. To profit from the EU economically, higher environmental standards had to be met 
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which was achieved by large enterprises, but not by SME s. 
As in many other countries, Lithuania s chemical industry is among the largest R&D investors 
in the country. The sectors R&D investments comprised 29% of total BERD in 2003. The pri-
vate R&D expenditures in NACE 24 - amounted to 6.78 mio. EUR in 2003, R&D expenditures 
in this sector increased with 10 times from 2000 to 2003. The share of R&D expenditures of 
the chemical industry in the total BERD exceeds 7.2 %, which is more than 12.2 % of the pri-
vate R&D expenditures in the manufacturing industry. 
The total number of researchers was 77 (FTE) in 2003, which represents more than 11.6 % of 
the total number of researchers in the private sector in 2003 and about 16.8 % of researchers 
in the manufacturing industry.  
The biotechnology sector consists of four not highly interrelated specialised companies. In 
economic terms biotechnologies are of moderate importance today, since they only comprise 
0.1% of the national GDP and employ only 300 people. The potential of the sector highly de-
pends on public R&D infrastructure, research base and competencies, since the companies 
themselves are not capable to develop brand new applications and basically are running on 
the innovative solutions, which formed the base for their spin-off. However, new solutions and 
patents are needed in order to keep competitive in the future, and companies are not capable 
of developing significant novelties without strong public R&D infrastructure. This research in-
frastructure is well developed, and comprises several public research organisations: State 
Research Institute of Biotechnology (IBT), State Research Institute of Biochemistry, Institute 
of Chemistry and Institute of Botany. The Institute of Biotechnology was especially successful 
in developing spin offs - all 4 biotechnology companies came from this institute.   
The biotechnology sector is the most R&D intensive sector, however it is represented by a 
few companies only, generally spin-offs of the Institute of Biotechnologies, and is concen-
trated in one city (Vilnius). It is highly dependent on the development of biotechnology science 
and its progress in Lithuania. However, the biotechnology industry today does not comprise 
an important share in the industrial structure, therefore investments are limited. The new 
wave of growth should be reached by the implementation of Industrial Biotechnology Devel-
opment programme, approved by the Government in 2006.   
Manufacture of machinery and equipment (NACE 29)13  
Manufacture of machinery and equipment is one of the most important branches of Lithuanian 
industry, with a long tradition and widely developed industrial branches. Historically, the 
higher-education system is largely oriented towards this industrial sector.   
The share of manufacture of machinery and equipment in the national GDP was 0.6 % 
(250,747 mio. EUR) in 2005. Compared to 2000, it has increased with 0.1 % point. In the light 
of strong deindustrialisation, it is important to notice, that the sector has maintained it share of 
GDP.  
There are over 700 enterprises in Lithuania, which can be assigned to the sector of machin-
ery and equipment. It employs over 41 thousand people and creates 18% of GDP of total 
manufacturing. The sector s products represent 17% of total Lithuanian exports. Over 50% of 
employees are employed in large enterprises (over 250 employees), and sales of those en-
terprises make up for 60% of total sales of the sector.  
The industry was one of the most affected by the process of deindustrialisation. Due to the 
orientation toward basic, non-specialised products, and low quality standards, production vol-
umes in 1997 dropped by 84% compared to 1990.   
The private R&D expenditures in NACE 29 amounted to 0.96 mio. EUR in 2003, R&D expen-
ditures in this sector increased with 15% from 2000 to 2003. The share of R&D expenditures 
                                                     
13
  Data are available for the aggregate NACE 27 to 29 
 Final Report  
Private sector R&D in the new Member States
Page 37 of 76 
of the machinery and equipment industry in the total BERD exceeds 4.1%, which is more than 
6.9% of the private R&D expenditures in the manufacturing industry. 
The number of researchers has been decreasing since 1998. The total number of researchers 
was 64 (FTE) in 2003, which represents more than 9.6% of the total number of researchers in 
the private sector in 2003 and about 14 % of researchers in the manufacturing industry.  
Differently from other sectors, it is one of the few sectors, where not only public, but also pri-
vate research organisations exist GTV (mechatronics solutions), and a few other.  
The sector is hardly finding its way in the modern competitive landscape. Its development is 
also not supported by public R&D and knowledge centre. Therefore, the government plans to 
establish an excellence centre for mechatronics in Kaunas with the support of EU structural 
funds. It aims to connect the needs of enterprises and researchers in development of meas-
urement and medical equipment. The initiative was taken because of the high variety of in-
dustry and non-existence of a single strong enterprise that would be able to lead joint R&D 
efforts of the sector and perform significant modernisation of the sector. In general, local R&D 
activities are associated with the adoption of imported technologies to local needs and to re-
solving technology compatibility problems.   
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Manufacture of medical, precision and optical instruments, watches and clocks (NACE 
33)  
The share of manufacture of electrical and optical equipment (NACE 31 33) in the national 
GDP is 1.3%. The manufacture of medical, precision and optical instruments, watches and 
clocks comprised 80.9 mio. EUR in 2005. The sector consists of 40 enterprises. All of them 
are SME s. Only nine firms are high-tech and R&D oriented, primarily in laser technology. 
Over 95% of Lithuanian laser production is exported to the EU, Switzerland, Japan, USA. In 
total, products are exported to 100 countries. The sector employs 250 persons, 30 of them 
are scientists. The development of the laser technology industry in Lithuania is related to the 
foundation of an experimental manufacturing company in 1983 by the Science Institute of 
Physics Most of the Lithuanian light technology enterprises span off the Institute of Physics. 
Vilnius university also has generated a spin-off called Light conversion . There are also for-
eign capital initiated companies, such as "GEOLA".   
Major laser companies could build a potential cluster, as all related companies are situated in 
Vilnius and most of them in the Technology park  Sunrise valley . Still, joint R&D activities 
remain of an ad hoc type. The establishment of the excellence centre should lead to further 
R&D activities and investments.  
The private R&D expenditures in NACE 33 amounted to 0.78 mio. EUR in 2003, R&D expen-
ditures in this sector increased 4 times from 2001 to 2003. The share of R&D expenditures of 
the medical and optical equipment industry in the total BERD exceeds 3.4%, which is more 
than 5.7 % of the private R&D expenditures in the manufacturing industry. 
The number of researchers in the sector is one of the highest compared to other sector. The 
total number of researchers in the whole sector (NACE 31-33) was 135 (full time equivalent - 
FTE) in 2003, and the sub-sector of manufacture of medical, precision and optical instruments 
employed 70 researchers (FTE) The sector represents more than 7.1% of the total number of 
researchers in the private sector in 2003 and about 15.2% of researchers in the manufactur-
ing industry.  
A key factor that could impact future R&D activities is the development of the mechatronics 
cluster, and implementation of the national High-technology Development Programme. The 
development of mechatronic products and lasers are two of Lithuania s scientific research 
priorities and at the same time two of the high-technology priority areas.   
R&D co-operation in new technology and product development occurs within the Department 
of Quant Electronics of Vilnius University, and Institute of Physics. R&D funding originates 
from various initiatives, such as Eureka, COST, FP6, but also programmes supported by the 
NATO.   
2.7. Malta  
The dependency of the Maltese economy on two key sectors, tourism (a major contributor to 
output growth, employment creation and foreign exchange generation), and electronics in 
manufacturing (semi-conductor) industry and their vulnerability related to the global business 
cycle and shock events highlight the challenge of sustaining the present economic develop-
ment and quality of life.   
The Maltese economy became more services-oriented between 2001 and 2005 and less de-
pendent on industry and agriculture. Total manufacturing value added at factor cost fell how-
ever value added per capita registered a marginal increase reflecting lower employment lev-
els. The growth rate in value added per capita declined whilst real value added per capita 
(productivity) registered a subdued rise.  
The transition to services and to sectors with a closer fit to the current educational and skills 
profile of the country s knowledge-driven labour pool , including new high value-added sectors 
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such as financial services (12% of GDP), Freeport related activity, ICT, aviation maintenance 
and repair, business process outsourcing and the pharmaceutical industry (25 companies), 
indicates that the economy is in a state of flux, in search of that economic push that will see it 
go steadily forward .    
There is no doubt that Malta s current investment level in R&D, public and private, is minimal, 
both in absolute amounts and as a percentage of GDP, that they are constraining national 
efforts to attract and retain high-tech FDI and to move up the technological ladder.       
Until as recently as 2002, statistics on national spending on R&D were not available, resulting 
in a lack of awareness among policy makers of the extent to which the country was lagging 
behind in this critical area. Whilst progress has been achieved, much is yet to be achieved 
(see table 1). Although figures for 2005 have not yet been released, it is estimated that the 
national R&D investment for 2005 is in the region of 0.3% for public investment and a further 
0.3% for private investment, that makes a total of 0.6% of GDP spent on R&D based on pre-
liminary indications of a substantial increase in the business investment.   
R&D activity in the business sector is largely concentrated in 30-40 firms and is clustered 
around a number of specific sectors, mainly related to high value added manufacturing in ICT,  
manufacture of machinery, manufacture of chemicals and medical instruments, financial in-
termediation, food and beverage. The incentives offered are typically to finance capital in-
vestment that may well explain why procurement of new equipment is by far the more popular 
way of acquiring new technologies.  
National Framework Conditions  
The low level of R&D activity which features in Maltese industry is a consequence of a dual 
economy; the number of indigenous SMEs with a low level of in-house research capacity.  
Poor R&D activity in the public sector is concentrated around a number of research institutes 
and innovation centres linked to the Ministries.  
Malta Enterprise is currently engaged in a number of R&D policy development actions and 
measures including Innovation Policy Development, Technology Transfer, Networking for In-
novation and promoting innovation management techniques.  
Malta Enterprise is currently operating 22 schemes to support FDIs and local enterprise, with 
12 schemes extending to cover R&D and innovation, but only one scheme, the Research and 
Development Tax Credit, introduced last year, supports R&D activity exclusively. Innovative 
start-ups are supported through the Business Incubation Centre where they benefit from 
managerial assistance as well as small grants and access to schemes to facilitate investment 
in capital assets.   
The experiences of the chosen case studies indicate that the presence of a director influenc-
ing employee with international experience and a post-graduate degree in the subject is the 
soundest way of ensuring the required migration into a valid R&D function within the enter-
prise. However, the family influence on this migration is deemed as typically negative in any 
of the indigenous companies. Incentives are required to encourage companies to use such 
PhDs in their R&D crossover whilst at the same time support the owners in dealing with the 
resistance emanating from their long serving conservative staff.    
Publishing and Printing (NACE 22)  
The publishing and printing sector s share in total value added fell to 6.3% of the total manu-
facturing in 2004 from 6.9% in 2003 and 8.1% in 2002.  
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The private R&D expenditures through the acquisition of new production equipment in NACE 
22 in 2004 was 12.7 mio EUR.  There were no previous annual figures recorded and thus a 
comparison is not possible. This amounts to 0.3% of the 2004 GDP.  
Research staff totalled 2 out of a total estimated employment of 2019 within 217 companies. 
There are no previous records available for comparison, too.  
The sector s personnel costs per capita registered an annual average growth rate of 9.7% 
between 2001 and 2004, exceeding the average for the total manufacturing industry by 14.2% 
in 2004. Gross operating surplus rose by 25.9% in 2002, and fell subsequently in the following 
two years to nearly half the level recorded in 2001. Following a 22.3% rise in the sector s 
value added at factor cost per capita in 2002, a decline of 14.2% was recorded in 2003, fol-
lowed by a decline of nearly the same magnitude in the following year.  
The total number of employees in the manufacture of pulp and paper products (including pub-
lishing and printing) was 1,875 representing a decrease of 46 over the previous year.  Conse-
quently, at the end of September 2005, the share of the manufacture of pulp and paper prod-
ucts (including publishing and printing) sector in manufacturing stood at 7.7%, unchanged 
from the rate recorded during September 2004. Most of the companies within this sector em-
ploy less than 9 (84% of companies) and only two employ more than 250.  
The only areas of R&D recorded in this sector is through the direct acquisition of machinery 
and equipment that included advanced machinery, computer hardware/software specifically 
purchased to implement new or significantly improved products (goods/services) and/or proc-
esses. Some investment on R&D training was also indicated. In this sector there were no 
R&D expenditures within the enterprises (intramural), either as current, capital or labour ex-
penditures for R&D performance. There also was no commissioned R&D performed by other 
units (extramural R&D, including other enterprises within the group) or other public or private 
research organizations on R&D (extramural).  
The only significant investment on acquisition of machinery and equipment is by an FDI print-
ing enterprise that may skew the statistics. Furthermore there is an abnormally high number 
of companies listed under NACE 22.22 (printing not elsewhere classified) that could be inter-
preted as poor classification. There were 2 companies in NACE 22.22 that received govern-
ment financial aid to invest in capital equipment that was registered as being commensurate 
to research funding.   
Factors important for the industry include increase in quality, reduction of waste, increase in 
productivity, better capital utilisation, and training.  
The data indicates that smaller sized companies are not investing in R&D. Data also implies 
that indigenous companies are smaller companies and invest less in R&D. The larger ones 
seem more prone to investment particularly with the aid of the Malta Enterprise financial as-
sistance. However the R&D investment seems solely limited to the acquisition of the latest 
machinery as the way for technology upgrade.   
Food, beverages and tobacco (NACE 15)  
The food, beverages and tobacco products sector s share in total value added reached 16.8% 
of the total manufacturing in 2004 from 16.6% in 2003 and 15.3% in 2002.  
The private R&D expenditures have been mainly dominates by the acquisition of new produc-
tion equipment in NACE 15 in 2004 and was at 3 mio. EUR. There were no previous annual 
figures recorded and comparison is not possible. This amounts to 0.07% of the 2004 GDP.  
Research staff totalled 35 out of a total estimated employment of 4,704 within 646 companies. 
There are no previous records available for comparison. 
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R&D in the food sector also seems slightly more varied than just technological development 
through equipment procurement alone, even if procurement still remains the most significant 
factor. Data implies that the food sector has a healthy local market particularly amplified dur-
ing the tourist seasons. R&D efforts reported indicate a wider take-up even with the smaller 
and indigenous enterprises.  
The contribution of the food, beverages and tobacco sector to total value added remained the 
second largest in the industry. The sector s share in total value added fell marginally to 15.3% 
in 2002 from 15.6% a year earlier. However this decline was reversed in the following year 
when the share rose to 16.6% in 2003. In 2004, the food, beverages and tobacco products 
sector s contribution in total value added rose by a further 0.2 percentage points, to 16.8%.   
R&D is predominantly performed in two sub-sectors: NACE 15.89 (food not elsewhere classi-
fied) and 15.90 (beverages). However bread (NACE 15.81), fruit and vegetables n.e.c. (NACE 
15.33) and wines (15.93) also seem to invest in R&D staff even though financial investment 
was not recorded.  
The greatest source of technology acquisition is through the acquisition of machinery and 
equipment. However there is also some investment in training/marketing/design as well as 
extramural research.   
Manufacturing of machinery and equipment (NACE 29)  
The manufacturing of machinery and equipment sector s share in total value added reached 
1.6% of the total manufacturing in 2004 from 1.5% in 2003 and 1.2% in 2002.  
The private R&D expenditures mainly through intramural R&D in NACE 29 in 2004 was at 
0.38 mio EUR, which amounts to 0.01% of the 2004 GDP. There were no previous annual 
figures recorded. .  
Research staff totalled 14 out of a total estimated employment of 571 within 57 companies. 
There are no previous records available for comparison.  
During 2002 to 2005, total exports declined by 198 mio. EUR (86.1 mio. Lm) to 1,369 mio. 
EUR (595.3 mio. Lm). This represents a decline of 12.6%. The machinery and transport 
equipment sector contributed to 9.9 percentage points of the decline in total exports. Another 
3.1 percentage points was the result of the decline in fuel exports.   
If one were to exclude exports of fuel and machinery and transport equipment sectors, it is 
interesting to note that exports in the first nine months of 2003, 2004 and 2005 remained sta-
ble at around 494 mio EUR (215 mio Lm). This occurred despite the trend decline in exports 
of clothing, traditionally the second major exporting sector. This indicates that exports in other 
sectors compensated for the decline in exports of clothing. During the period under review, a 
significant increase of 12 mio EUR (5.4 mio Lm) in exports of semi-manufactures was also 
recorded.   
Notably different from the food and the printing sectors is that most of the R&D carried out in 
this sector is attributed to intramural activities. The sector is after all focused on the building of 
machinery so it follows that machinery and equipment procurement is not cited as being their 
source of R&D. The largest number of researchers as well as the largest investment in R&D 
was noted as within the sub-sector of non-domestic cooling and ventilation equipment.   
Employment showed a decrease although productivity is shown to be increasing through in-
creasing per capita sales, wages and exports.   
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Financial intermediation (NACE 67.2, 66.1)  
There are no figures available to compare this financial services sector with that of the manu-
facturing.  
The private R&D expenditures comprise mainly the acquisition of new equipment in NACE 
66.1 and 67.2 in 2004 was at 1.1 mio EUR. There were no previous annual figures recorded 
and thus comparison are not possible again. This amounts to 0.03% of the 2004 GDP.  
No research staffs were noted out of a total estimated employment of 5530 within 221 com-
panies.   
R&D&I in this section was attributed to the acquisition of machinery and equipment with the 
most investment being carried out in central banking.  This indicates that the data supplied 
included public investment.   
The experiences of the chosen case studies indicate that the presence of a director influenc-
ing employee with international experience and a post-graduate degree is the soundest way 
of ensuring the required migration into a valid R&D function within the enterprise. However, 
the family influence on this migration is deemed as typically negative in any of the indigenous 
companies. Incentives are required to encourage companies to use the knowledge of PhDs in 
their R&D crossover whilst at the same time support the owners in dealing with the resistance 
emanating from their long serving conservative staff. This seems also particularly applicable 
to the financial services. Although the figures show that the industry is rapidly growing, some 
data indicates that it really is the longer established financial related companies that are grow-
ing.  And these have the same conservative outlooks of the long-serving, now senior, staff 
who shun any progress into new technologies.   
2.8. Poland  
The process of privatisation of the Polish economy has been conducted since 1988. It was 
influenced by 3 major streams: i) establishing of more than 2 millions of private active enter-
prises (among which the largest group consist of micro firms in services), ii) privatisation of 
former state owned enterprises by different formal procedures of privatisation such as sale to 
foreign investor, to domestic investor, IPO on Stock Exchange, sale to employees, mass pri-
vatisation, and iii) debt restructuring creditor companies as well as FDI in green field projects.   
Main sources of expenditure for innovation activity in Poland in the private sector were based 
on own funds and bank credits. These two sources constitute together 95.3% of financial 
sources in this sector. Contribution of bank financing (16.5%) is almost two times higher than 
in public sector (8.5%) and differs according to ownership form. The foreign funds however 
contribute in smaller scale in financing of private sector (1% against 1% in public sector).  
Almost all firms with R&D expenditures in machine industry in Poland are characterized by 
growth of sales. Foreign investor owned firms have better relation of R&D investments to 
sales. Increasing the R&D intensity to the level of the corporation imply spill-over effects on 
the regional level as well as country level. National firm R&D investments could give competi-
tive position on the global market (e.g. coal mining machines).   
The labour costs in Poland are still few times lower than in USA and Western Europe and at 
the same time there is plenty of skilled and well-educated labour force. These conditions may 
have attracted the largest foreign investors in Polish aviation sector like General Electric, 
United Technologies Holding S.A., EADS CASA, Pratt & Whitney Canada, Goodrich, Snecma 
and Avio. Those companies are willing to invest in R&D.   
The automotive sector is interested in developing its own R&D entities because there is a 
huge demand on R&D in Poland. The first ones exist established by Delphi and TRW and the 
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others are to be established soon. The increase of employment in R&D activity of the sector 
was about 50% between 2003 and 2004. That proves that it is not possible to develop pro-
duction facilities and launch new products without investing in R&D activities.   
Private firms developed by the innovative entrepreneurs in NMSs are able to construct corpo-
rate management structure, understandable motivational system, invest in R&D and thanks 
that became competitive on the European and global market. This opportunity is the chance 
for diminishing the R&D concentration as well as to introduce new dynamics in the ERA.   
Manufacturing of Machinery and Equipment n.e.c. (NACE 29)  
In 2005, the share of NACE 29 in the value of sold production of the whole manufacturing in-
dustry was about 4.4% and amounted to 26,038 mio. PLN (6,816 mio. EUR), which was 
111.5% of the value in 2004.  
The intramural R&D expenditures amounted to 180 mio. PLN (47.3 mio. EUR), which was 
more than 10% of the total intramural R&D expenditures in the whole manufacturing industry 
and 118.2% of the expenditures from 2004. The intramural R&D expenditure from own 
sources (equivalent of BERD) amounted to 153 mio. PLN (25.75 mio. EUR) which was more 
then 12% share in the whole industry expenditures (1,255 mio. PLN = 328.7 mio. EUR).   
The total number of employees in R&D activities in enterprise sector in NACE 29 was 2117 
persons, which represent more than 12% of the total number of employees in R&D activities 
in the whole manufacturing industry (16,846 persons) and about 83% of the number in 2004.   
The expenditures for R&D in manufacturing of machinery and equipment are less stable than 
in other industries. They are very demand oriented. Structural changes of the industry influ-
ence the scale of R&D expenditures. The sector spent 77 mio. EUR in 1999, the year with 
highest R&D expenditure so far. After that period R&D investments decreased every year to 
the level of 21.5 mio. EUR in 2002. In the last years relatively fast growth could be observed. 
The level of R&D expenditures in 2004 is almost 40 mio. EUR.   
The Polish industry of manufacturing of machinery and equipment is the 6th largest sector in 
terms of employees among EU-25 and the largest sector among the NMSs. In 2003 it em-
ployed more than 192 thousands persons. Altogether, there were 13,840 enterprises in 2004 
of which 243 firms are still state owned. The sector mainly produces machinery for the power 
and coal mining industry. The largest enterprise in the sector is Alstom Power, which is the 
main R&D performer. Alstom s main factory is located in a region with high unemployment 
and without specialized scientific centers. Mobile R&D teams develop strong links with spe-
cialized technical universities in Lower Silesia, a region which long tradition in R&D.  
Poland is one of the leading producers of machines for coal mining in the world. This sub-
sector is characterized by high R&D intensity as patenting activity and firms are traditionally 
cooperating with technical universities.   
There is no evidence for a direct impact between R&D intensity and sectoral growth. How-
ever, almost all firms with R&D expenditures are characterized by growth of sales. Foreign 
owned firms have better relation of R&D investments to sales. Firms specialized in coal min-
ing machine are examples of winner companies thanks to the boom on the global markets. 
Though, the high growth of sales not always means relative growth of R&D investments in 
this sector. However, the level of investments is stable.  
Manufacture of Pharmaceutics, Medicinal Chemicals and Botanical Products (NACE 
24.4)  
In 2005, the share of NACE 24.4 in the value of sold production of the whole manufacturing 
industry was above 1% and amounted to 6 377.86 mio. PLN (1 669.6 mio. EUR), which was 
105.5% of the value in 2004. The intramural R&D expenditures amounted to 149 mio. PLN 
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(39.1 mio. EUR), which was more than 8% of the total intramural R&D expenditures in the 
whole manufacturing industry and 108% of the expenditures from 2004. The intramural R&D 
expenditure from own sources (equivalent of BERD) amounted to 148 mio. PLN (38.8 mio. 
EUR) which was almost 12% share in the whole industry expenditures (1,255 mio. PLN = 
328.7 mio. EUR).   
The total number of employees in R&D activities in enterprise sector in NACE 29 was 1027 
persons, which represent more than 6% of the total number of employees in R&D activities in 
the whole manufacturing industry (16,846 persons) and only about 85% of the number in 
2004.   
The Pharmaceutical sector in Poland is characterised by very high outlay on R&D activities 
and the great majority (92.8%) of this outlay comes from enterprises
 own sources. Addition-
ally the expenditure on R&D in this sector systematically grows for the last 6 years and it can 
be seen that those expenses are mainly (in 93%) used for acquisition of new machinery and 
appliances. This indicates that there is great tendency on modernising the existing infrastruc-
ture in pharmaceutical companies.  
The noticeable rise of R&D investments level in NACE 24.4 does not follow general trend in 
Polish R&D activity. Between 1999 and 2004 R&D investments fell by 20% in the whole 
manufacture sector, whereas in the same period there was a noticeable rise of 150% in 
NACE 24.4.   
One of the biggest current problems of the pharmaceutical sector in Poland is its low level of 
privatisation and rather slow progress in selling the biggest state owned pharmaceutical com-
panies to private owners. All the preparations, before the process of privatisation of the big-
gest companies started, took about 4 years, even though there was high interest of local and 
foreign investors.   
Along with the accession of Poland to EU there occurred the problem of adaptation of Euro-
pean law and fulfilling its restrictions and standards. As the majority of local producers were 
concentrated on production of generic drugs there were some possible barriers, for example 
occurring from extension of exclusive data period that was intended to protect the rights of the 
drug inventor for several more years. Even more problems for local producers was implied by 
the regulations imposing the obligation of presenting very exact and detailed documentation 
for the production methods and quality of substrates used in every part of produced drugs in 
accordance to EU standards. An effect of the EU law restrictions is that the majority of Polish 
pharmaceuticals are exported to Eastern Europe, Middle East and other countries with milder 
quality and documentation restrictions. Still over 60% of drugs sold in Poland is imported.  
One of the NACE 24.4 characteristics is the rapid growth of foreign investment beginning from 
the year 1998 when the privatisation of the sector started. Between 1999 and 2004 the num-
ber of R&D units in pharmaceutical sector has decreased on 8% compared to 14% in the 
whole industry, and the reduction of employees between 1999 and 2002 was only 3.2%, com-
pared to over 25% in the whole industry. The percentage of R&D employees in NACE 24.4 
amounted 7.8%. While in the whole manufacturing sector the number of R&D employees 
dropped radically about 36%, in NACE 24.4 there was 56% rise in researchers employed.   
Manufacture of Other Transport Equipment (Aircrafts) (NACE 35.3)   
In 2005, the share of NACE 35.3 in the value of sold production of the whole manufacturing 
industry was only 0.14% and amounted to 834 mio. PLN (218.5 mio. EUR), which was 107% 
of the value in 2004.  
The intramural R&D expenditures amounted to 60 mio. PLN (15.9 mio. EUR), which was 
more than 3% of the total intramural R&D expenditures in the whole manufacturing industry 
and about 94% of the expenditures from 2004. The intramural R&D expenditure from own 
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sources (equivalent of BERD) amounted to 24.7 mio. PLN (6.5 mio. EUR) which was almost 
2% share in the whole industry expenditures (1,255 mio. PLN = 328.7 mio. EUR).   
The total number of employees in R&D activities in enterprise sector in NACE 35.3 was 922 
persons, which represent more than 5% of the total number of employees in R&D activities in 
the whole manufacturing industry (16,846 persons) and only about 88% of the number in 
2004.   
Poland has a long history in the area of aeronautics. The tradition of the Polish aircraft starts 
in 1910 with foundation of the Aviata aircraft factory in Warsaw in 1910. Before the First 
World War another four aircraft factories had been founded in Poland: in Warsaw, Lublin, Bi-
ala Podlaska and Poznan, and one state-owned in Warsaw. After the Second World War and 
until 1989 Polish aircraft production was meant mainly for defence purposes and as such had 
many advantages like tax incentives and priority in material acquisition. After the transition 
this sector had many problems with accommodating to competitive conditions. It has suffered 
severely from the collapse of its traditional markets, because it was locked into outdated 
technologies and the beginning of the privatisation process was quite slow. But thanks to 
benefits from production of other civil equipment, such as agricultural aircraft and gliders, 
most of the companies managed to find foreign investors, mainly from the US. There is hope 
that the basis of an innovative aviation cluster is emerging.  
R&D expenditure is strongly influenced by the public support. R&D investment in the aviation 
sector from the public sector is higher than private and foreign investment. Financing from 
public sources is 54% and 25% from domestic enterprises. Statistics between 1999 and 2004 
show that the number of R&D units in NACE 35.3 has decreased only by 1 and the number of 
employees in R&D activities has slowly decreased and then rose to almost the same level. 
But it is worth noticing that in this figures the number of researchers increased while the num-
ber of technicians and other R&D units employees decreased accordingly.   
The aviation industry is being perceived as a thematic priority of innovative policy in Poland 
and in the whole Europe. The polish market is the biggest in Central Europe and places itself 
among the biggest in the whole of Europe. In addition to the fact, that the aircraft sector is one 
of the prioritised branches of the industry in Europe it gives Polish companies great opportu-
nity for development through cooperation with the world's largest manufacturers. The Aircraft 
Transport in Poland is carried out both by public entities and private companies. There are 
now about 55 aircraft related firms in Poland covering both the civil and military markets and 
employing some 16,000 people.   
The boom in aviation companies, especially in southern Poland occurred when Pratt & Whit-
ney became a strategic investor in WSK Rzeszow. Most of the production is exported, mainly 
to United States, Germany, Italy, Greece, Canada, Spain, Republic of South Korea and Viet-
nam. The labour costs in Poland and the availability of skilled and well-educated labour force 
attracted the largest foreign investors like General Electric, United Technologies Holding S.A., 
EADS CASA, Pratt & Whitney Canada, Goodrich, Snecma and Avio. Those companies are 
willing to invest in R&D.   
Manufacture of Transport Equipment (Motor Vehicles, Trailers and Semi-trailers) 
(NACE 34)  
In 2005, the share of NACE 34 in the value of sold production of the whole manufacturing in-
dustry was above 10% and amounted to 60,634 mio. PLN (15,8723 mio. EUR), which was 
106.7% of the value in 2004.  
The intramural R&D expenditures amounted to 193 mio. PLN (50.5 mio. EUR), which was 
more than 11% of the total intramural R&D expenditures in the whole manufacturing industry 
and above 147% of the expenditures from 2004. The intramural R&D expenditure from own 
sources (equivalent of BERD) amounted to 178.5 mio. PLN (46.7 mio. EUR) which was more 
than 14% share in the whole industry expenditures (1,255 mio. PLN = 328.7 mio. EUR).  
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The total number of employees in R&D activities in enterprise sector in NACE 34 was 1,249 
persons, which represent more than 57 of the total number of employees in R&D activities in 
the whole manufacturing industry (16,846 persons) and about 107% of the number in 2004.   
The level of R&D expenditures as a percentage of total sales has reached 0.2% in 2003. Due 
to the dynamic development of the sector the share remained stable, based on a 55.4% in-
crease of expenditures on R&D in 2004. Most foreign car manufacturers, or Tier 2 and 3 sup-
pliers producing in Poland carry out their R&D activities outside of Poland. Delphi Automotive 
Systems and TRW are the first foreign investors who invested in R&D in Poland by creating 
R&D Centers in Krakow and Cz stochowa. The number of R&D employees almost doubled 
from 2003 to 2004. This proves that there is a dynamic process taking place in R&D activity in 
the sector.  
About 80% of production of the industry is exported. Poland became an important producer of 
diesel engines, which are assembled to such passenger cars like Opel, Volkswagen, Skoda, 
Seat, Audi, Fiat, Honda, Isuzu and Toyota. Receivers for produced spare parts or accessories 
are such well known companies like Daimler- Chrysler, BMW, Jaguar or Ferrari. 
Volkswagen and Fiat have started in Poland production of their brand new models (Caddy 
and Panda). Volvo and MAN have decided to increase their investments in Poland. Thanks to 
them, Poland is going to become the largest bus and coach producer in Europe.  
Manufacturers are mostly private companies with foreign ownership; the state holds a minor-
ity share in only one firm. FDI in the sector is significantly higher than in the whole industry. 
About 20% of FDI in industry are accumulated in the transport equipment sector.   
There is no clear evidence of the impact of R&D on transport equipment sector at the mo-
ment. Rather it can be proved that very poor R&D activities forces manufacturers to buy tech-
nology abroad. However, due to the dynamic development of the automotive market opportu-
nities are used by many Polish producers by which demand for research activities in technical 
universities as well as specialized institutes may be rising. Spill-over effects of the develop-
ment of automotive production and market can be observed in the whole economy based on 
FDI and private Polish innovative firms including tyre-manufacturing (Bridgestone, Michelin) 
and furniture producers (Inter Groclin with a market share of 5% of the European).   
2.9. Slovakia  
High economic growth tends to be associated with R&D expenditure. Slovakia provides an 
interesting exception from this correlation. The rapid economic growth and rise in per capita 
GDP happened alongside deep fall in R&D expenditure, employment and infrastructure. Slo-
vak experience, however, does not contradict to the assumption on a positive links between 
R&D expenditure and economic performance, if the effects of R&D spill-overs and technology 
diffusion are taken into account. Slovakia accounted for the highest rates of the purchase of 
technology equipment in the EU-25 area. Most of the technology diffusion was related to 
branches of the MNCs (Samsung, Volkswagen, Siemens, etc.), which accounted for high 
rates of R&D spending and top-notch technologies. Slovak branches of MNCs contribute to 
parent companies turnovers and R&D spending and, in turn, profit from technology diffusion. 
In the year 2000, the Slovak economy accounted for significant increases in labour productiv-
ity. Data on productivity in domestic and foreign sectors indicate that MNCs were by far more 
productive than domestic firms. Hence, the relationship between R&D and innovation spend-
ing on one hand and productivity on the other hand is valid also for Slovakia.  
National Framework Conditions  
Data by the 2005 European Innovation Scoreboard indicate that, with some notable excep-
tions, Slovakia ranked to the poorest innovation performers in the EU-25 area. Low spending 
on R&D was the major weakness of the National Innovation System in Slovakia. There has 
been a negative trend in R&D spending since 1989, when support to R&D peaked with 3.88 
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percent and subsequently decreased to 0.5 % of GDP in 2005. Slovakia accounted for very 
high innovation expenditure by companies (160% of the EU-25 average) and ICT expenditure 
(95% of the EU-25 average), which was related to purchase of high-tech equipment by 
branches of MNCs. FDIs were the reason for high levels of employment in mid/high-tech 
manufacturing (121% of the EU-25 average) and new to market product sales (239% of the 
EU-25 average). Slovakia failed to address some most serious problems in innovation per-
formance, namely shares of business and public expenditure on R&D in GDP (38% and 25% 
respectively of the EU-25 average), University R&D financed by business sector (5% of the 
EU-25 average) and early stage venture capital (6% of the EU-25 average). The poor finan-
cial base of R&D system was reflected in a very low commercial output. Rates of patenting 
activity were only 3% of those in the EU-25 area.  
By 2006, the Slovak National Innovation System consisted of a number of government, pri-
vate and non-profit organisations. Most of these organisations (including private ones) were 
controlled and/or supported by the government and its agencies and initiatives. Major respon-
sibilities within the National Innovation System were assigned to the Ministry of Education and 
Ministry of Economy. The Ministry of Education concentrated its role on the support of basic 
and applied research. Applied research also was supported via the public procurement and 
carried out via (private) industry research institutes. The Ministry of Economy managed a 
network of innovation support agencies which concentrated on implementation of various in-
novation policy measures, many of which were heavily dependent on EU funds.   
Most innovation policies in Slovakia overlapped with S&T policies, which were designed and 
implemented by the Ministry of Education. The Ministry, however, lacked financial and human 
resources for managing industry research, and was not able to elaborate and implement poli-
cies aimed at commercialisation of R&D. Weak support for applied research was reflected in 
extremely low commercial output of the Slovak R&D sector. The Ministry of Economy and the 
National Agency for the Development of Small and Medium Enterprises (NADSME) designed 
and implemented a number of particular industry-oriented innovation policy measures, but 
were not able to formulate a coherent innovation policy framework. In general there is only a 
modest support to innovation activities compared to very generous assistance to major for-
eign low- and medium-tech investors (car producers in particular). The release of the Strategy 
of Competitiveness Development in Slovakia up to 2010 (the Lisbon Strategy for Slovakia) 
and preparation of the new Law on Organisation of State Support to Research and Develop-
ment (the Law No 172/2005) were major issues in debates on R&D and innovation policy in 
Slovakia in the period from 2004 to 2005. The Competitiveness Strategy is completed by four 
Action Plans, of which the Action Plan for R&D and Innovation accounts for the largest 
amount of financial means allocated. It indicates that government is serious about its plan to 
change Slovakia from a low-cost, low-value added economy to a knowledge-based one.   
Manufacture of motor vehicles and transport equipment (NACE 34)  
The share of manufacture of motor vehicles and transport equipment industry in the national 
GDP has increased from 1.9% in 2000 to 2.0% (655.5 mio. EUR) in 2004. Low numbers of 
reporting organisation disabled publishing data on R&D in this industry. The CIS 3 data (cov-
ering period 2001-2003) are used as a proxy. Thus, the share of manufacture of motor vehi-
cles and transport equipment industry in the total BERD in manufacturing can be estimated to 
some 10 % (about 5.14 mio. EUR). There are no data on researcher numbers published for 
this industry, too. The car industry has already become a top sector in Slovak economy. It will 
even increase in importance when Hyundai-Kia and Peugeot-Citroen will start their production 
in 2006. By 2005 the industry was dominated by Volkswagen and its suppliers. All these were 
branches of foreign multinationals. None of these assembly and/or production plants reported 
R&D activities in Slovakia. The overall R&D capacities in this industry, however, are quite low 
by international standards. The car and car components productions in Slovakia seemed to 
profit much more from technology diffusion from existing R&D units abroad rather than from 
domestic R&D activities.  
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Manufacture of base metals and fabricated metal product (NACE 27-28)  
This industry is one of the oldest and most important Slovak industries. The industry enjoyed 
huge increases in labour productivity. In period 2000-2004 employee numbers dropped, but 
sales increased by one half, while amount of total value added and value added per em-
ployee doubled.  
The share of the manufacture of base metals and fabricated metal products industry in the 
national GDP has increased from 3.4% in 2000 to 4.1 % (1,342.4 mio. EUR) in 2004. The pri-
vate R&D expenditures in NACE 28 only (no data on NACE 27 due to individual data protec-
tion) amounted to 0.78 mio. EUR in 2004. There also were no data on BERD development in 
period 2000-2004. Individual data protection in some industries disabled computing BERD in 
total manufacturing industry. If the CIS 3 data (covering period 2001-2003) are used as a 
proxy, the share of the manufacture of base metals and fabricated metal products industry in 
the total BERD in manufacturing can be estimated to some 4.3 % (2.17 mio. EUR). However, 
there are no data on development of researcher numbers in this industry, due to individual 
data protection.  
Manufacture of rubber and plastic products (NACE 25)  
The share of rubber and plastic products industry in the national GDP has increased from 
0.8% in 2000 to 1.0 % (326.0 mio. EUR) in 2004. The private R&D expenditures in NACE 24 
amounted to 7.9 mio. EUR in 2004. The private R&D expenditures in this sector increased 
from 4.11 to 7.57 mio EUR in period 2000-2004. The share of R&D expenditures of the rubber 
and plastic products industry in the total BERD exceeded 11.4% in 2004. Individual data pro-
tection in some industries disabled computing BERD in total manufacturing industry. If the 
CIS 3 data (covering period 2001-2003) are used as a proxy, share of the rubber and plastic 
products in industry in the total BERD in manufacturing can be estimated to some 15 %. The 
number of researchers has been decreasing since 2000. The total number of researchers 
(FTE) dropped from 171 in 2000 to 140 in 2004, which represents more than 4.0% of the total 
number of researchers in the private sector in NACE 25 in 2004 (there are no data on re-
searcher numbers in total manufacturing sector). The industry R&D actually consists of the 
firms Matador and VÚSAPL. Matador has strong research department and, on Slovak stan-
dards, performs good quality company research. The R&D activities enable Matador to flexi-
bly react on changing demand on the market for tyres.   
Manufacture of chemicals, chemical products and man-made fibres (NACE 24)  
The share of manufacture of chemicals, chemical products and man-made fibres industry in 
the national GDP has fallen from 1.3% in 2000 to 0.6 % (202.8 mio. EUR) in 2004. The pri-
vate R&D expenditures in NACE 24 amounted to 7.4 mio. EUR in 2004. The private R&D ex-
penditures in this sector fell by 1.25 times from 9.27 to 7.20 mio. EUR in period 2000-2004. 
The share of R&D expenditures of the manufacture of chemicals, chemical products and 
man-made fibres industry in the total BERD exceeded 11.2% in 2004. Individual data protec-
tion in some industries disabled computing BERD in total manufacturing industry. If the CIS 3 
data (covering period 2001-2003) are used as a proxy, share of the manufacture of chemi-
cals, chemical products and man-made fibres industry in the total BERD in manufacturing can 
be estimated to some 15 %. The number of researchers has been decreasing since 2000. 
The total number of researchers (FTE) dropped from 332 in 2000 to 127 in 2004, which 
represents more than 3.7% of the total number of researchers in the private sector in NACE 
24 in 2004 (there are no data on researcher numbers in total manufacturing sector). Despite 
recent decreases in BERD and researcher numbers, this sector accounts for probably one of 
the best research infrastructure among Slovak manufacturing industries. Thus, the industry 
experienced a range of difficulties, which heavily impacted its competitiveness (company re-
structuring, rising costs of inputs, implementation costs of the REACH legislative, etc.). The 
cost-cutting involved reduction of the R&D base. In 2004 and 2005 some key business play-
ers were bought by foreign (mostly Czech) investors and became parts of international busi-
ness groups. The process of company restructuring may be ended in this way and there 
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should be more resources for strategic investments, including R&D. Some firms (e.g. Zentiva) 
have already expressed strong interest in company R&D, which was seen as key to business 
success.   
2.10. Slovenia  
National Framework Conditions 
The importance of technology in general and R&D in particular is recognized by the Govern-
ment in the National Research and Development Programme 2001-2006, the new National 
Research and Development Programme 2006-2010 and the Development Strategies and is 
incorporated in a number of R&D related support strategies like three program lines of the 
Research Programme as well as of the Technology Transfer Initiative.   
Moreover, additional emphasis is put on STI policy related aspects like privatization, pro-
curement, training, financial market conditions, structure of the tax system and the IPR sys-
tem to potentially foster R&D involvement of business enterprises. The quality, accessibility 
and outreach of the prevailing research infrastructure complement the pool of factors or poli-
cies proliferating R&D activities.   
Privatization tendencies, particularly strong after 1992, led to the transformation of ownership 
structure and a more market and profit-oriented approach to entrepreneurship. Increasing 
international competition and the need to satisfy consumer wants and needs necessitated a 
more technology-oriented approach to business activity.   
Procedures concerning public procurement contracts are set out in the Public Procurement 
Act 2004 and help enhance R&D engagement in case of tight cooperation between private 
and public sector entities on technology-related issues determined by public demand.   
Training and education undoubtedly represent key aspects to R&D involvement and short-
ages of basic ingredients to R&D activities significantly hamper such activities. With stagnat-
ing enrollment and graduation rates, the weak Slovenian tertiary education system becomes a 
potential bottleneck to (high-quality) R&D involvement.   
The banking sector appears inadequately developed to meet the needs for high and risky 
venture capital to finance R&D activities and private enterprises need to resort to company 
funds.  
Tax credits or tax allowances are frequently applied measures to foster investments in R&D 
activities. Slovenia allows for the deduction of R&D expenditures and grants tax allowances to 
innovative companies operating in technology parks and deduction of PhD recruits
 salaries 
during the first six months of employment. The effect of said measures are however difficult to 
analyze.   
Protection of Intellectual Property Rights is guaranteed by the creation of the Slovenian Intel-
lectual Property Office in 1992. Patent application is however still relatively low, partly due to 
high application costs and alternative strategies availed of to protect innovations.  
The research infrastructure is dominated by the public research arena, predominantly engag-
ing in basic and curiosity-driven research. Cooperation with business firms is still weak, limit-
ing the creation and taking advantage of potential knowledge spillovers.   
Sectoral Results  
All in all, R&D expenditures and R&D personnel increased between the mid 1990s and 2004. 
Total Business R&D expenditures which represent approximately 40 to 60% of overall R&D 
expenditures in 1994 and 2004, respectively, show an almost threefold increase from 
90.4 mio. EUR in 1994 to 254.1 mio. EUR in 2004. Between 1994 and 2004, total R&D em-
ployment in the business sector steadily increased from 4,005 FTE in 1994 to 4,945 FTE in 
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2004. In 1994 and 2004, the sector represents 40 to 56% of overall R&D employment in 
terms of FTE.   
All industry analyses emphasize the dominant role of in-house R&D expenditures and expen-
ditures on acquisition of machinery/equipment. The majority of R&D expenditures are spent 
on applied research followed by experimental research. Only the Pharmaceutical industry re-
ports higher R&D expenditures for experimental research as compared to applied research. 
Without exception, R&D expenditures are funded within the national business sector and 
company funds.    
Manufacture of Pharmaceuticals (NACE 24.4)  
Manufacture of Pharmaceuticals - a traditionally very R&D intensive industry - reports one of 
the highest R&D intensities in the Slovenian Manufacturing Industry of 8.84% in 2001 with 
remarkable increases of 19.4% between 2001 and 2003. Approximately 3.3% of national 
GDP are generated within this single industry alone.   
While initially spending 18.9 mio. EUR on R&D-related activities in 1994, the industry reports 
a sixfold increase in expenditures between 1994 and 2004 with 104.6 mio. EUR in 2004. 
Among the industries considered, the Pharmaceuticals industry has the highest share of in-
dustry R&D expenditures to total Business R&D expenditures with 20.9% in 1994 and even 
41.1% in 2004. Starting from 391 employees in R&D-related activities in 1994 (in terms of 
FTE), the industry doubled R&D-related employment to 758 in 2004. In 1994, the industry 
employed approximately 10% of overall Business R&D personnel, while its employment share 
increased to 15% in 2004. Among the four industries considered, the small Pharmaceuticals 
industry represents the most important employer of Business sector R&D personnel.   
After 1999, industry R&D expenditures for applied and experimental research towards new 
product developments experienced remarkable expansions. The industry is dominated by two 
big generic producers which spend approximately 10% of their annual sales on R&D activities 
but do not actively engage in R&D cooperation activities. The vast number of medium sized 
and small firms serves to render input generation or output distribution services to the two key 
business players. Given the nature of the industry output as well as for reasons of competi-
tiveness, profitability and survival, continuous R&D activities and implementation of new of 
modified products are key success factors and technological change becomes a supply-side 
driven phenomenon. A positive correlation between R&D involvement (proxied by R&D ex-
penditures) and the reported export rate is apparent for all interviewed enterprises. Exposure 
to international competition necessitates a technology-based differentiation strategy and 
therefore fosters R&D activities.  
Manufacture of Machinery and Equipment (NACE 29)  
Manufacture of Machinery and Equipment which experienced tremendous increases in R&D 
intensity of 22.5% between 2001 and 2003 generates approximately 2% of national GDP.   
With respect to industry R&D expenditures, a threefold increase is observable between 1994 
and 2004, with 3.8 mio. EUR in 1994 and 14.1 Mio EUR in 2004. In 1994, 4.25% of overall 
Business R&D expenditures emerged from this particular industry. Between 1994 and 2004, 
the percentage contribution only slightly increased by 1.3 percentage points. With a dramatic 
drop observable in 2003, the industry s R&D personnel only negligibly grew between 1994 
and 2004 from 260 in 1994 to 266 R&D employees in 2004. In the period under consideration, 
the share of industry R&D personnel to overall Business R&D personnel dropped by over one 
percentage point.   
The industry is particularly active in the field of applied research to foster commercialization of 
product or process developments and sources its funds from within the business sector from 
company funds. R&D activities are concentrated in a small number of big enterprises with 
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strong export-orientation and abundance in financial and human resources. Said inputs rep-
resent key success factors for the generation and commercialization of new product and 
process developments. Scientifically motivated R&D cooperation seems to be of minor impor-
tance for R&D activities while cooperation with customers and competitors are regarded vital 
vehicles for R&D involvement. Suppliers are also considered important partners in R&D co-
operation projects, provided they managed to develop own technological capabilities. High 
taxes as well as legal regulations are considered significant factors hampering R&D activities.   
Manufacture of Electrical Machinery and Apparatus (NACE 31)  
Manufacture of Electrical Machinery and Apparatus reports remarkable increases of R&D in-
tensity of 17.7% between 2001 and 2003. Approximately 1.3% of national GDP stem from this 
particular industry.   
With its significant slump in R&D expenditures in 1997 and slow recovery thereafter, the in-
dustry reports an increase of R&D expenditures from 10.9 mio. EUR in 1994 to only 15.8 mio. 
EUR in 2004. Until 2004, R&D expenditures did not reach the pre-slump level of 16.9 mio. 
EUR. With respect to R&D employment, the industry experienced a dramatic drop in 1997 
and reports 587 employees (in FTE) in 1994 and only 422 employees in 2004. Until 2004, 
R&D employment did not reach the pre-slump level of 660 employees. While the industry rep-
resented a prime employer in 1994 with approximately 15% of all business R&D personnel 
employed in respective industry, its dominance vanished to about 9% in 2004.   
The majority of R&D expenditures are used for applied research for sake of commercializa-
tion. Industry output represents production inputs for other industries particularly the auto-
mobile industry.   
Customer needs are important sources of new product and process developments and inter-
nationally increasing competition, - particularly from China and India -, represent key factors 
fostering R&D involvement. R&D co-operations with local or foreign customers or producers 
as well as with academia and public research organizations are widespread strategies. In-
creasing tax-burden levied on employees renders R&D an increasingly difficult and expensive 
activity, hence financing of R&D activities is of crucial importance. Additionally, insufficient 
human resource potentials are considered deterrents to R&D involvement.   
Manufacture of Medicine, Precision and Optical Instruments (NACE 33)  
In terms of increases in R&D intensity, Manufacture of Medicine, Precision and Optical In-
struments outperforms the other industries considered and reports the most significant and 
dramatic increase of 27% between 2001 and 2003. Its contribution to national GDP is how-
ever relatively low with 0.7% only.   
Starting from 2.7 mio. EUR in 1994, industry R&D expenditures show a sixfold increase by 
2004 to 12.2 mio. EUR. Its share of industry to total Business R&D expenditures almost dou-
bled between 1994 and 2004. In the same period, the industry experienced a tremendous 
surge in 1997, followed by rather stable employment figures thereafter and more than dou-
bled its R&D-related employment from 141 employees in 1994 and to 344 in 2004. While the 
industry initially employed 3.5% of overall Business sector R&D personnel in 1994, R&D em-
ployment increased to approximately 7% of overall Business sector R&D employment.  
The necessity to commercialize products and processes renders applied research the most 
important R&D activity so that overall industry R&D expenditures are strongly dominated by 
in-house expenditures on applied and experimental research. The majority of R&D funding 
stems from within the business sector and is dominated by company funds.   
International competition and the need to withstand its growing intensity, paired with informa-
tion on consumer needs and the availability of human resources for R&D activities are seen to 
positively affect overall R&D involvement. Growing R&D costs, particularly determined by 
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growing costs of R&D personnel, are increasingly viewed as hampering factors to R&D in-
volvement in Slovenia.       
3. Sectoral Synthesis   
3.1. Motor vehicles and related Industries14  
Motor vehicle production is classified under NACE 34. However, the focus on one NACE sec-
tor only does not completely reflect the whole picture of the automotive industry. A very wide 
range of products are used to assemble a motor vehicle practically all industrial sectors 
supply the automotive industry , and thus readily available statistics are usually too narrow in 
terms of coverage. In other words, quite a few automotive suppliers are classified as leather, 
rubber, plastics, paint, glass, cable or metal producing and processing companies, foundries, 
electrical and electronics companies, etc. We still need statistical data, and hence a number 
of sectors are closely related to the motor vehicle industry: 
manufacture of motor vehicles (NACE 34.10); 
manufacture of bodies (coachwork) for motor vehicles (NACE 34.20),  
manufacture of parts and accessories for motor vehicles and their engines (NACE 
34.30);  
manufacture of electrical equipment for engines and vehicles (NACE 31.61); 
manufacture of rubber tyres and tubes (NACE 25.11).  
Below, the development of the NACE 34 sector (Manufacturing of motor vehicles, trailers and 
semi-trailers) and its R&D dynamics will be analysed in the selected NMSs. Furthermore, 
manufacture of electrical equipment for engines and vehicles (NACE 31.61) and manufactur-
ing of rubber and plastic parts (NACE 25) are considered as related industries.  
The sector of car manufacturing was in focus of the national research teams in Czech Repub-
lic, Hungary, Poland and Slovakia. As manufacture of rubber and plastic parts (NACE 25) is 
related to the automotive sector, the sector helps to extend the value chain by producing tyres 
within the countries. Some information on R&D in the tyre industry in the Czech Republic and 
Slovakia is provided. Furthermore, in the Hungarian sectoral case study Manufacture of elec-
trical equipment for engines and vehicles (NACE 31.61) is also included.    
3.1.1. Pattern of R&D  
There is a big difference in the importance of the automotive sector in the national economies 
in terms of value added. The share of the sector in the whole economy is between 1.5% and 
2.7% in terms of value added and will increase in the future (especially in Slovakia) (see 
Figure 1). The share of private R&D expenditure also varies significantly between countries.   
In the Czech Republic, the automotive sector contributed 2 bn. EUR or 2.7% to the gross 
value added of the economy and 13% to the gross value added of the manufacturing industry 
in 2004. In the same year 7% of Czech employees worked in the sector. The relative impor-
tance of the sector is 2.5% in Hungary and Slovakia, that is, the same level as in the Czech 
Republic. Only in Poland the sector is less important as it contributes 1.5% to the national 
gross value added. In absolute terms, the value added is still below that of Austria, a small 
state in the EU. 
                                                     
14
 This section has benefited from the analysis of the country reports by A Havas, presented at the validation work-
shop held in May 2006. 
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Figure 1: Value added by the automotive sector (NACE 34) 
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The Czech Republic has the highest figures among the NMSs in terms of nominal private 
R&D expenditures and R&D staff employed in the automotive industry. The sector s R&D ex-
penditure was around 170 mio. EUR, with slightly decreasing expenditures from 2002-2003 in 
Euro-terms, or stagnation when it is considered in local currency. This decrease cannot be 
considered as a trend as R&D expenditures (in Euros) remained relatively stable relative to 
GDP from 2001 to 2004 (see Table 2). R&D expenditure as a percentage of GDP is above 
the EU average in NACE 34 in the Czech Republic. In Hungary, Poland and Slovakia it is be-
low that level. But, unlike in the Czech Republic, growth rates in R&D expenditure in these 
countries were between 54% and 114% over a two to four year period.  
From 2002 to 2004 only Poland shows a significant increase in R&D personnel of more than 
one third. Although such a dramatic increase always requires prudent interpretation, FDI in-
vestment played an important role for the increase due to the establishment of new R&D cen-
tres (like the ones by Delphi and TRW). For Slovakia no data are available due to confidenti-
ality restrictions. In contrast, the absolute level of R&D personnel in NACE 34 stayed more or 
less stable in the Czech Republic and in Hungary. 
In the former Czechoslovakia, at the end of the 1980s, almost all automotive companies had 
their own R&D department. This radically changed after 1990. The situation was heavily influ-
enced by the way these companies have been privatised. The most important and most suc-
cessful privatisation in the Czech automotive industry was the one of Skoda Auto.  Due to the 
investment by VW, the number of R&D employees increased from approx. 600 in 1991 to 
1420 in 2005. Many other privatised companies were not as lucky as Skoda Auto, and they 
were forced to either close down or considerably restrict their own R&D activities. 
It is likely that R&D investment will also rise in other firms within the sector, with increasing 
expenditures in both investment and human resources. First, only manufacturing sites were 
built, now also R&D centres are being established. For instance, Siemens Automotive Sys-
tems Ltd., Robert Bosch Ltd. and Behr Czech Ltd. are among the companies that decided to 
establish R&D centres in 2004. New automotive product development projects are also being 
more and more secured by R&D centres in the Czech Republic even for the foreign head-
quarters.  
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Data for the tyre industry are only available at the aggregate level, NACE 25. R&D expendi-
tures in NACE 25 are quite low and the number of R&D employees has been stagnating dur-
ing the last 5 years. Compared to the situation in 1995, significantly less R&D personnel were 
employed in this sector in the Czech Republic. R&D employment (FTE) also fell in Slovakia, 
from 171 in 200 to 140 in 2004. Increasing tyre production might help raise R&D employment 
again in both countries.  
In Hungary NACE sector 31.61 was significantly below the national average of the manufac-
turing industry in 2000-2001, if R&D-intensity is measured by the share of R&D expenditures 
in value added, but closer to that average when R&D employment is taken as a measure. 
This simple exercise suggests that R&D expenditures per R&D employees were much lower 
in this sub-sector than the national average in the given period. One should also bear in mind, 
however, that data are missing from the EUROSTAT database for 2002-2004, and this sub-
sector has been selected for our study exactly for the high growth rate of R&D expenditures: 
almost a 7-times higher amount in 2004 compared to 2001. Thus, available data do not permit 
to draw firm conclusions as far as the R&D-intensity of this sector is concerned.  
NACE 34.1 presents a similar case: lower R&D-intensity than the manufacturing industry av-
erage when it is measured in expenditures, but a higher one when employment is taken into 
account.  
In contrast, NACE 34.3 is way above the national manufacturing average (2 and 5 times 
higher intensity), if either measure is taken. In this case, both CSO and EUROSTAT data 
point to the same conclusions. Given the strong performance of this sub-sector, the automo-
tive industry at a 2-digit level is close to the Hungarian manufacturing industry average when 
R&D expenditures are taken into account, and 4 times above that average, if employment 
figures are taken as an indicator.  
In Poland, the share of R&D expenditures in transport equipment manufactures at current 
costs is much bigger than the total industry average. Much more R&D activity were out-
sourced (to foreign specialised laboratories) or spent on salaries and other current costs. 
Capital expenditures for R&D are less than in the total industry average. The relation between 
R&D expenditures and total sales has reached 0.2% in 2003 and 2004 (despite a dynamic 
55% increase of expenditures on R&D), what is still far from the developed countries
 aver-
age.  
The number of R&D employees increased by about 48% in 2004 compared to 2003, that is, 
from 786 to 1,168. Especially the number of researchers was almost doubled from 406 to 
786. This increase gives some indication that the demand for R&D increases in the sector.  
In Slovakia, the low numbers of organisations reporting R&D in manufacture of motor vehi-
cles (1 organisation) and manufacture of other transport equipment (3 organisations) by 2004 
prevented publishing data on R&D employment and expenditures in the industry. The 2001-
2003 CIS 3 Survey enables a glimpse on the issue. Firms in the sector reported R&D invest-
ments of 5.1 mio. EUR. The sector ranked to the most R&D intensive in Slovakia (3 times of 
the country average). 
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Table 2: Overview of R&D intensity, increases in R&D intensity, and sectoral share in 
national GDP 
Country NACE 
code Sector  
R&D intensity 
private R&D in-
vestment as % 
of sectoral GDP 
(2003 or 2004) 
Increase in 
R&D inten-
sity (%)   
Sectoral 
GDP as  
% of na-
tional GDP 
(2003 or 
2004) 
34 
Manufacture of motor 
vehicles, trailers and 
semi-trailers 
8.8% 5% (stable)(2001-2004) 2.7% 
31 
Manufacture of electrical 
machinery and appara-
tus n.e.c. 
1.8% 104% (2001-2004) 1.8% 
Czech 
Republic
25 Manufacture of rubber 
and plastic products 0.9% 
91% 
(2001-2004) 1.6% 
34.3 
Manufacture of parts 
and accessories for mo-
tor vehicles and their 
engines 
2.8% 114% (2001-2003) 0.8% 
Hungary 
31 Manufacture of other 
electric equipment 3.5% 
54% 
(2001-2003) 0.3% 
Poland 34 
Manufacture of  motor 
vehicles, trailers and 
semi-trailers 
1.3% 55% (2003-2004) 1.3% 
34 
Manufacture of  motor 
vehicles, trailers and 
semi-trailers 
1.7%  2.2% 
Slovakia 
25 Manufacture of rubber 
and plastic products 1.1% 
10% 
(1998-2004) 1% 
Sources: EUROSTAT and National Statistical Offices   
3.1.2. Determinants of R&D investment  
The automotive sector is a dynamic sector in many NMSs, albeit with differing levels of R&D 
intensity. The development of the automotive sector over the last years took country-specific 
paths due to individual historical determinants. The Czech Republic and Hungary had a long 
tradition in car manufacturing before World Word 2, but these specialisation patterns changed 
considerably due to the division of labour between the member states of Council of Mutual 
Economic Assistance (CMEA), which comprised a market of 400 million people. As an exam-
ple, the Soviet-Hungarian specialisation agreement from 1964 stipulated that Hungary would 
specialise in producing buses for the entire CMEA. Skoda was practically the only producer of 
cars in the NMSs with its own R&D unit. All other car manufacturers produced cars with li-
cences from western companies. These historical developments are, to some extent, still per-
ceivable in the structures of the sector.15 
                                                     
15  For more details on the history of the automotive industry in Central European countries, including recent 
developments, see e.g. Havas [2000a], [2000b], Pavlinek, [2002a], [2002b], [2003], [2005] 
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Today, two main arguments for investors in this sector are cost arguments vis-à-vis the old 
member states of the EU and the emerging opportunities to get a foot into the enlarged Euro-
pean market. The first argument is true for all investors; the second argument is mainly rele-
vant for manufacturers from Asia. In most cases investments follow either a low end / high 
volume strategy or a high end / low volume strategy. Other arguments are the hungry cus-
tomers in the NMSs, geographic proximity and a test-bed functions for organisational inno-
vations. (Havas [2000a]).  
The structure of the automotive industry is organised hierarchically: at the top of the pyramid 
there are the vehicle manufacturers, supported by suppliers structured in three tiers. The 
tasks of first tier suppliers (T1) include not only manufacturing of certain parts and compo-
nents but product design as well, either together with their assemblers or on their own.16 As 
for manufacturing of a given part, though, usually more than one supplier is chosen, and 
hence several suppliers are competing for orders. First-tier suppliers have also built their net-
work, usually consisting of 20-60 firms. These second-tier suppliers, in turn, rely on thousands 
of small and medium-sized enterprises, producing basically simple, labour-intensive products 
given their wage advantages compared to larger firms. T1 suppliers provide training for their 
network on quality assurance techniques, just-in-time logistics, as well as on technological 
developments, and assist and check the introduction of various technological, organisational 
and managerial organisations.  
This general organisational pattern of the industry is having significant impacts in the NMSs. 
A number of foreign-owned T1 suppliers have also set up plants in the NMSs, either via 
green-field plants, or by taking over domestic firms. Most of the domestic companies, how-
ever, are T2 and T3 suppliers, with some exceptions.  
Foreign direct investment is the main determinant of the expansion of the sector. Invest-
ments are either secured by take-over of existing firms or in some cases by joint ventures. 
Investments are either brown-field or green-field types of investments. 
Asian car companies seem to follow their customers: they establish new factories in the 
NMSs which allows them to sell their cars on a growing market in the NMSs, and get closer to 
the EU-15 markets. As these firms can draw upon their Asian networks of suppliers only to a 
limited extent (given the geographical distance, or as in the case of Slovakia are hindered to 
do so by national interest groups), local suppliers in the NMSs have the business opportunity 
to expand. Some of their former Asian suppliers do follow these car companies in Central 
Europe, too, setting up subsidiaries, and thus eliminating the disadvantages of geographical 
distance.  
Important FDI projects have been for instance in the Czech Republic the acquisition of Skoda 
by VW, while in Hungary Suzuki, General Motors and Audi established their operations by 
green-field investments. Fiat and Daewoo took over Polish firms and General Motors set up a 
green-field investment in Poland. PSA Peugeot Citroen and Hyundai Kia are setting up green-
field investments in Slovakia.  
In Slovakia, automotive industry has been dominated by Volkswagen and its suppliers. Slo-
vak suppliers to the automobile industry have managed, within a relatively short period of 
time, to apply European standards of quality, productivity, logistics, environment and labour. 
There are more than 260 automotive suppliers and subcontractors in Slovakia. The top ten 
include: Bosch, Delphi, Johnson Controls, Visteon, Lear, Magna, Valeo, TRW Automotive and 
Dana. The sector contributed 19% to the total merchandise exports in 2002 and employed 
more than 25 thousand people (ILO [2005]). 
Slovakia currently manufactures over 250 thousand cars per year. In 2003 and early 2004 
both PSA Peugeot Citroen and Hyundai-Kia announced their plans to build large final assem-
bly plants in Slovakia. This investment will nearly triple automotive output by the end of the 
                                                     
16
 In the latter case they might well work with other firms and various R&D institutes, of course. The point is, that the 
assembler only defines the main parameters of a given part or component, e.g. its size and required technical per-
formance, and leaves the whole design process to its supplier. 
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decade and remains the key driver of the Slovak economy. These developments may as well 
lead to an increase in R&D intensity in the future.  
The automotive industry is one of the most important branches of the Czech economy, too. 
Similarly, as in other advanced countries, it very noticeably influences trade balance: 85% of 
cars were exported, making up for 21% of total Czech exports (Havas [2006]). The sector at-
tracts foreign investments and improves the situation on the local labour market (> 80 thou-
sand jobs (ILO [2005]). After 1989 the Czech automotive industry as well as other branches 
of the economy  went through a long and important restructuring period. Today, the sector is 
fully comparable with those in many advanced countries, and controlled by private enter-
prises. Most of the companies are managed by strong foreign owners, predominantly from 
Germany. Under such conditions the continuing economic improvement is apparent not only 
in the individual companies, but also in the whole automotive branch.   
The Hungarian automotive sector comprises around 36 thousand employees and is an im-
portant factor in the trade balance: 17% of the economy s total merchandise exports in 2002. 
(ILO [2005]). After half-a-century of CMEA-wide division of labour, car production has re-
emerged in Hungary in the early 1990s. Suppliers have also invested heavily in Hungary. 
Moreover, their motivation has not been simply to follow car assemblers. On the contrary, to 
serve them from nearby plants is only a minor part of the explanation. Their principal reason 
for setting up subsidiaries in Hungary has been cost-cutting. The only major local clients for 
them are not car assemblers but the engine and gear box manufacturing plants of Audi, GM 
Opel and ZF, hence the vast majority of their output is exported and is attributed to the sub-
sector NACE 34.3.  
At present, in Poland there are about 345 producers with 92.5 thousand employees in com-
panies of manufacture of transport equipment. The main producers of passenger cars and 
vans in Poland are Fiat Auto Poland S.A. in Bielsko-Biala, FSO S.A. in Warsaw, Opel Polska 
in Gliwice Sp. z o.o., Volkswagen Poznan Sp. z o.o. in Poznan and Intrall in Lublin. The main 
producers of trucks and buses and coaches in Poland are: MAN Star Truck Sp. z o.o. in Sta-
rachowice, Zak ady Samochodowe JELCZ S.A. in Jelcz-Laskowice, Autosan S.A. in Sanok, 
Solaris Bus & Coach Sp. z o.o. w Bolechowie, Solbus Sp. z o.o. w Solcu Kujawskim, MAN 
Pojazdy U ytkowe Polska Sp. z o.o. in Poznan, Volvo Poland Sp. z o.o. in Wroclaw and 
Scania-Kapena Sp. z o.o. in S upsk. Delphi and TRW are the two first enterprises in the sec-
tor setting up their own R&D units in Poland.  
Production in manufacture of rubber and plastic products is to a large extent related to the 
rapidly developing car industries in Slovakia, the Czech Republic and elsewhere in Central 
and Eastern Europe. Tyres, vibration control parts and plastic car components are main prod-
ucts in this sector in Slovakia. The sector is one of the most dynamic industries in the Czech 
manufacturing sector since the second half of the 1990s. Its position in the manufacturing 
structure has significantly improved. This enormous increase has resulted from a close link-
age to the rapidly increasing automotive sector, as well as the electrical industry, food indus-
try and building industry that creates the core of the Czech industrial structure today. The 
2000-2004 was a period of rapid growth in the sector. Volume of sales, total value added and 
value added per employee doubled. R&D in NACE 25 is mainly driven by foreign companies 
operating in the Czech market, enormous growth of automotive and electrical machinery and 
a growing foreign demand. In Slovakia, R&D is dominated by one large domestic firm.   
3.1.3. Framework conditions  
Framework conditions that can have an impact on R&D investment are of varying influence 
on R&D intensities. Unlike in the pharmaceutical sector where environmental regulations or 
quality standards play a central role, the automotive industry is less influenced by national or 
EU regulations, apart from regulations on emission but that mainly affect the parent firms, 
who are in charge of designing engines.  The car industry also has to implement the REACH 
legislative on chemical products. Chemical industry is one of major suppliers for manufacture 
of cars. Estimates by the Slovak Ministry of Economy identify costs of some 70 mio. EUR in 
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the next seven years to implement REACH. But given total turnover of 5.8 bn. EUR (2004), 
the REACH costs should not endanger competitiveness of the car industry in Slovakia.  
Apart from legal regulations, standardisation plays a role for the sectoral production system. 
Standardisation is very much related to the tier-system. This normally supports enterprises 
which are able to influence standardisation. Moreover, FDI-based intra-firm knowledge spill-
over help to reduce related R&D efforts to a minimum.   
Tax incentives or tax credits are another type of rather indirect RTDI policy measures which 
are not specifically designed for the sector in question, but might be an incentive for MNCs to 
investigate the capacities for R&D activities in the NMSs. The impact of such measures has 
not yet been evaluated.  
The public support in setting up technology parks (purchase of land, arranging administrative 
procedures, building basic infrastructure) which will be also subsidised by EU structural funds 
in the future might be an additional incentive to attract R&D units. 
Human resources 
The availability of highly qualified R&D personnel seems to be an ever increasingly important 
factor for the expansion of R&D units in the NMSs. 
The productivity growth within the NACE 34 sector in the Czech Republic is higher than the 
labour costs growth, which is important for attracting FDI and keeping the sector competitive 
against other countries. The only problem with the human resources in the Czech Republic is 
to find the right people for the right job due to the fact that more and more automotive compa-
nies are setting up their factories in the Czech Republic.   
Some recently published labour market analyses point out the lack of suitably qualified per-
sonnel for R&D. Lack of qualified employees and university graduates with technical back-
ground was one of the reasons which led Skoda Auto towards the decision to build the uni-
versity campus Na Karmeli .  
Research infrastructure  
Universities focused on transport and engineering play a very important role for future suc-
cess of the Czech automotive R&D. They educate qualified staff and co-operate with the 
automotive companies on various R&D projects, respectively carry out research according to 
the industry customer requests. So far there is a communication gap among universities and 
their engagement into specific research tasks. There are many obstacles in co-operation 
among companies and R&D institutions, such as the focus of the universities on academic 
research instead of research with applicable results, administrative barriers, etc. Moreover, 
universities are also often criticised for insufficient reactions regarding specific company s re-
quests concerning graduates knowledge.   
3.1.4. Impact of R&D  
The direct impact of R&D activities is reported in only very rare cases. Although on a very 
high aggregated level, studies (e.g. as cited by ILO 2005) show a clear correlation between 
R&D activities and economic performance, it is hard to trace and evaluate the impact of pri-
vate R&D in the automotive sector.   
Doubtless, there is a large impact of technologies and processes that were brought to the 
NMSs by FDI. Productivity rates are rising in the sector in most countries which can be ex-
plained by intra-firm knowledge transfer. At the firm level, the diffusion of new management 
methods and organisational techniques can be identified, which is also caused by the strong 
influence of FDI.  
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Another impact is the growth of the supplier industry. One reason for growth is FDI by Asian 
firms that want to get a local base inside the EU. They much more rely on establishing new 
links with local suppliers in order to comply with the local content rules, than the European 
firms that can more easily stick with their existing suppliers, as the EU local content is not an 
issue for them (Havas 2000a). It is yet to be seen if the recent investment of Hyundai-Kia 
would confirm this observation or it would have to be amended. In any case, indigenous sup-
pliers are likely to be forced to step up their R&D efforts  in a number of cases by setting up 
R&D units from the scratch, and in all cases via more intense co-operation with universities 
and R&D institutes to be able to compete in the global market. Most likely R&D will play a 
role in the efforts to extend the value chain in the car manufacturing within the NMSs. One 
should not overestimate, though, the potential of R&D-induced growth in low- or mid-tech 
suppliers industries.  
Innovation, however, should play a crucial role in enhancing indigenous suppliers competi-
tiveness, in order to secure their market share, and thus other sources of knowledge and in-
novation need to be exploited. Absorptive capabilities and innovation management skills, 
hence, should be considerably strengthened at a firm level. Carefully designed policies can 
certainly assist this upgrading and also need to promote the development of the wider institu-
tional framework such as communication and networking among firms (e.g. large businesses 
and SMEs, among SMEs), as well as academia-industry co-operation, and ultimately the 
strengthening of clusters.  
3.2. Pharmaceutical Industries  
In the following chapter the development of the pharmaceutical sector (NACE 24.4) and its 
R&D dynamics in selected NMSs will be analysed. The pharmaceutical sector is one of the 
most R&D intensive and dynamic sectors per se and thus an interesting case study. The sec-
tor has been studied by the national research teams in Poland, Hungary and Slovenia. More-
over, the chemical sector (NACE 24) has been analysed in Latvia and Slovakia which also 
delivers some fragmented information about the pharmaceutical sector.   
In Table 3, the R&D intensity of the pharmaceutical sector (NACE 24.4) or of the aggregated 
NACE 24 is listed, as well as the relative increase over a certain period of time. This listing 
gives an overview of the importance of R&D in the sector in the various countries. R&D inten-
sity is highest in Hungary (19.2%), followed by Slovenia (8.8%) which also shows an increase 
in intensity over a three year period from 2001 to 2003. Furthermore the share of the sectoral 
GDP as a percentage of the national GDP is given to indicate the importance of the sector in 
the country. It shows that the pharmaceutical sector has the highest share in the Slovenien 
economy (3.3%) and a share below 1% in the other countries. Given the limited data, it can 
be said that pharmaceutical sector plays a large role in private R&D only in Slovenia and to 
some extent (with significantly lower importance of the sector in the national economy) in 
Hungary.  
3.2.1. Pattern of R&D  
The transformation of the pharmaceutical sector has been dominated by the privatisation of 
former state own large enterprises and by FDI. This led to a restructuring of R&D labs within 
larger organisations. In some countries restructuring lead to a concentration of R&D in fewer 
R&D sites. This, for instance has happened in Hungary in the last few years. However, in 
general, the number of firms has not changed significantly. The number of firms slightly dimin-
ished in Hungary in Poland, while it slightly grew in Slovakia.  
For international country comparison it is enlightening to compare R&D expenditure in abso-
lute monetary terms. The absolute figures of R&D expenditure (see Figure 2) show that Hun-
gary and Slovenia are the most important R&D performers in the NMSs competing on the 
global market. In the much larger economy of Poland and in the Czech Republic enterprises 
invest only half the amount that is spent by the MNCs in Hungary. The other countries con-
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sidered in the sectoral comparison are not easily to be perceived as sites for private R&D in-
vestment.   
Figure 2: R&D expenditure in pharmaceutical industry or the chemical industry in 
NMSs (in mio. EUR) 
0 20 40 60 80 100
Hungary (24.4)
Slovenia (24.4 )
Czech Republic (24)
Poland (24.4)
Slovakia (24)
Lithuania (24)
Latvia (24)
Cyprus (24)
sectoral BERD [mio. EUR]
2002
2003
Source: EUROSTAT   
Apart from Slovenia and Hungary, the National Innovation Systems are not very much ori-
ented towards the pharmaceutical sector. The data on R&D personnel show that the Slove-
nian pharmaceutical sector is more capital intensive than in Hungary. In 2002, 25% of the 
R&D personnel in Hungary were spending 35% of national BERD, whereas 15% of Slovenia s 
R&D personnel were spending 30% of national BERD. One reason might be that labour pro-
ductivity in Slovenia is higher than in Hungary, but it might also be explained by country spe-
cific structures between the enterprises. The temporal comparison shows that in smaller 
countries larger changes in R&D investment and employment can be observed. Again, it is 
not easy to estimate the share of the pharmaceutical sector in the aggregated figures at 
NACE two-digit level.  
Over the last 10 years the pharmaceutical sector has been growing with respect to total size 
(in terms of sales and value added). This holds true for R&D expenditures and R&D employ-
ees in most countries studied here. Some countries showed a drawback (e.g. Latvia in 1999) 
but have recovered recently. A more general decline in economic activity in the chemical in-
dustry can be observed in Slovakia.   
The following trends in pattern of R&D can be observed in the three countries studied with 
available data for the NACE three-digit level:   
Hungary s pharmaceutical sector has grown faster than the entire chemical sector in the last 
few years. It is the most R&D intensive sector in Hungary. Between 2001 and 2003, R&D ex-
penditures grew about 20% annually. Total sales and value added also grew remarkably be-
tween 1997 and 2004. The growth was fuelled by massive increases in productivity, which led 
to a decreased number of employees in this period, too.   
The pharmaceutical sector in Poland invested increasingly in R&D between 1999 and 2004, 
which is in complete contrast to the general R&D investment trend of the whole industry dur-
ing that period. The number of employees grew in the same period. Although, the number of 
R&D-performing units decreased in the same period.  
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The development in R&D performance in Slovenia s pharmaceutical sector is the one with 
the most significant increases. The R&D expenditures almost sevenfold between 1992 and 
2004, even though only two firms are active in R&D. Both firms, namely Krka and Lek, are 
subsidiaries of MNC.  
For five more countries at least some pharmaceutical specific pattern of R&D can be drawn:   
For Cyprus data are only available at NACE two digit level. The employment related to R&D 
expenditure in the chemical sector reached 1.3 mio. EUR in 2003 while the capital expendi-
ture was 573 thousand EUR. The main type of research activity that has been observed is 
mainly experimental research, followed by applied research. However no information is avail-
able on the specificities of the pharmaceutical sector.  
The R&D expenditures in the Czech chemical industry significantly reached 50 mio. EUR in 
2004. Expenditures were decreasing in the first half of the 1990s due to the privatisation, 
however, during the period 1995-2004 it doubled and a considerable increase was evident 
particularly in 2004. The pharmaceutical industry is an important part of the chemical sector in 
the Czech Republic. The intramural private R&D expenditures in the pharmaceutical industry 
(NACE 24.4) amounted to almost 62% of R&D expenditures in NACE 24 and the share of 
NACE 24.4 increased significantly in recent years (49% in 2003).  
In Latvia, the chemical sector has recovered after a decline in 1999. The turnover in 2003 
was about the same as in 1997, half of which came from the pharmaceutical sector. Over the 
last few years, R&D expenditure grew faster than the sectors turnover, and the share of R&D 
in sectoral GDP rose to 1.9% (2003). Like in most other NMSs, the sector is dominated by a 
few large companies, which are the ones performing most R&D.  
As in many other countries, Lithuania s chemical industry is among the largest R&D inves-
tors in the country. The sectors R&D investments comprised 29.2% of total BERD in 2003. It 
employed 77 researchers. The development of the pharmaceutical industry is very weak. 
Lithuania exports (30% of sales) are directed towards eastern markets. No information is 
available how many of the 77 researchers in the sector are working in the pharmaceutical in-
dustry.  
Slovakia s chemical sector is the oldest one, though; the pharmaceutical sector only repre-
sents a small part of the NACE 24 category. Among the 10 largest chemical firms only one 
pharmaceutical firm is represented. The pharmaceutical branch is thus underrepresented 
within the chemical sector. As mentioned before, the chemical sector had some problems in 
the past with a decline in value added. As a consequence R&D expenditures as well as R&D 
employment declined.  
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Table 3: Overview of R&D intensity, increases in R&D intensity, and sectoral share in 
national GDP 
Country NACE 
code Sector  
R&D intensity  
private R&D  
investment as % 
of sectoral GDP 
(2003 or 2004) 
Increase in 
R&D inten-
sity (%)   
Sectoral 
GDP as  
% of na-
tional GDP 
(2003 or 
2004) 
Cyprus 
24 
Manufacture of  
Chemicals and Chemi-
cal Products 
3.8% 113% (2001-2003) 0.5% 
Czech 
Republic 24 
Manufacture of chemi-
cals and chemical 
products 
4.6% 65% (2001-2004) 1.4% 
Hungary 24.4 
Manufacture of phar-
maceutics, medicinal 
chemicals and botanic 
products 
19.3% -5% (2001-2003) 0.5% 
Latvia 24 
Manufacture of chemi-
cals and chemical 
products 
1.9% 50% (2001-2003) 0.6% 
Lithuania 24 
Manufacture of chemi-
cals and chemical 
products 
5.3% 974% (2002-2003) 1.0% 
Poland 
24.4 
Manufacture of phar-
maceutics, medicinal 
chemicals and botanic 
products 
n.a. 39% (2003-2004) n.a. 
Slovakia 
24 
Manufacture of chemi-
cals, chemical prod-
ucts and man-made 
fibres 
1.1% -17 0.8% 
Slovenia
24.4 Manufacture of  Pharmaceuticals 8.8% 
19% 
(2001-2003) 3.3% 
  
3.2.2. Determinants of R&D investments  
The success of FDI is the most decisive factor of the development of the pharmaceutical sec-
tor and of R&D investments in the NMSs. On the one hand, R&D investment is depending on 
the general framework conditions such as the socio-political environment, and on the other 
hand, it is depending on the capacity and potential of the pharmaceutical firms, which had to 
deal with the transformation from state-owned into privately owned organisations.   
The short list of key firms in each country confirms the strong concentration of the sector in 
the NMSs. In most countries the largest firms are now subsidiaries of foreign MNCs. The 
Hungarian sector, for instance, is now nearly totally influenced by foreign MNCs. About 80% 
of the industry is owned by foreign investors. However, in Slovenia, for instance, the largest 
firm is still partly national as it span of from a merger of a Czech and Slovakian firm. 
                                                     
17
 Unknown, because of the individual data protection. 
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In general, as can be observed, for instance, in Hungary, FDIs have opened the doors for in-
ternational co-operations via the networks of the multi-national parent companies. The foreign 
owners have restructured the R&D system, and reduced the number of R&D projects. At the 
same time the product range was also narrowed. Hungarian R&D affiliates thus had to spe-
cialise in certain fields of product development and manufacturing. As a critical side effect, 
this also limits the co-operation with domestic universities. Co-operation was mainly taking 
place in the field of analytical testing, which is now reduced due to the specialisation of the 
industry.  
In the last decades the R&D strategy of the majority of pharmaceutical firms in the NMSs was 
mainly based on the production of generic products. Following this business and innovation 
strategy most pharmaceutical companies carrying out applied R&D, even though, the devel-
opment of new drugs and the ability to develop or discover new molecules is becoming in-
creasingly important to remain competitive in the long run. Cases in Hungary, Slovakia and 
the Czech Republic show that firms were not only successful in improving production proc-
esses but also in mastering the product innovation challenge. In one of the company case 
studies, the firm (anonymous) invests 8.6% of its turnover in R&D. It serves as an example of 
a highly successful pharmaceutical company, which develops original drug molecules and 
generic products.   
Like in other countries, Polish companies
 prime strategy was and still is the development of 
generic drugs. In contrast to other industrial sectors, privatisation in the pharmaceutical sector 
has gone slower in the last few years, which is certainly the reason why the pharmaceutical 
sector has still problems in its performance. In general, the companies have problems with 
quality management (safety). For instance, it is still not possible to export to the EU market, 
because of the lack of documentation of quality procedures. Thus, most products are sold to 
countries with lower standards such as in Eastern Europe and the Middle East. There seems 
to be a need for further foreign capital in the future to improve R&D capabilities and to master 
the quality level standards required internationally.   
A case of a dynamic pharmaceutical firm which masters the transition characterised by re-
structuring and privatisation is Zentiva Hlohovec. Zentiva Hlohovec is the fourth largest Slo-
vakian firm in the chemical sector with an R&D ratio of 4.1%. It is a merger of the former Slo-
vakian Slovakofarma and the Czech Leciva and is now the biggest Central and Eastern Euro-
pean producer of pharmaceuticals. It is successfully listed in the Prague Stock exchange and 
has a newly developed portfolio of branded generics . Some of the R&D efforts formerly car-
ried out in Slovakia have been now transferred to the headquarters in Prague. The company 
has developed new products (new generic molecules) and built up R&D, manufacturing and 
marketing capabilities successfully. The firm sells its products mainly to Central European 
countries and the Russian Federation. At the end of 2005 240 researchers were employed. In 
contrast to problems with regulation mentioned by other firms, Zentiva has strong and good 
relationships with the regulatory authorities in each of the company s core markets.  
Most drugs are mainly developed for large or global markets. However, specific national mar-
ket demand conditions, e.g. by close co-operations with hospitals, universities, key scientists, 
etc. could create some niche markets and thus help to explore national competitive advan-
tages. However, the strength of domestic markets could not be identified as an important fac-
tor in the pharmaceutical sector. Thus, favourable internal market conditions have not been 
determinants or enabling factors for a dynamic development of the pharmaceutical sector.   
Finally, start-up activities are another important determinant of R&D dynamics. Even though 
the data sources are limited and assumptions have to be made with some prudence, start-ups 
have generally been very weak across the countries studied. In all countries the pharmaceuti-
cal sector is dominated by a few large (foreign) firms. Start-up activities in this sector are very 
challenging due to the high risk and the huge amount of capital required.  
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3.2.3. Framework conditions  
Regulations, in particular patent rights and the registration of new drugs are important factors 
for the development of the pharmaceutical sector in the NMSs. In order to master these chal-
lenges, the pharmaceutical companies had to improve their quality management procedures. 
The REACH (Registration, Evaluation and Authorisation of Chemicals) program, is however, 
considered as hindering the R&D and innovation process. The implementation of REACH has 
been a major challenge for the development of the sector, as, for instance stressed by the 
Slovak report. The regulation might harm competitiveness in the short run, but will set incen-
tives for innovation at the same time on the long run.  
Many Polish companies were not able to cope with the demanding new conditions of the EU 
market, which requires quality standards that are not reached by most enterprises in the Pol-
ish industry. In general, recently introduced environmental protection regulations have ham-
pered the development of the sector. Due to these difficulties, Poland has achieved to post-
pone the EU deadline until the end of 2008. Moreover, the Good Manufacturing Practice 
(GMP) standards are required to achieve the highest level of safety within the sector.   
The importance of quality management and safety processes is also stressed in a company 
case study in Slovakia. The case study provides an example of a company that has success-
fully used the European Mutual Recognition Procedure (MRP) in order to gain market regis-
tration for key products (marketing authorizations) in the EU. The company is also member of 
the safety data processing networks and management (EudraVigilance) to maintain its high 
quality level.   
The research infrastructure (universities and research organisations) plays a minor role in the 
different countries as concerns the development of the pharmaceutical sector as co-operation 
partner. In general, the links to the national research infrastructure seem to be rather weak in 
many countries. The two largest Slovenian pharmaceutical companies are engaged in the 
development and production of generic products but have so far hardly been linked to the na-
tional research infrastructure, e.g. via co-operations with universities. Some firms, such as the 
Hungarian case study firm, have even signed co-operation agreements with foreign laborato-
ries, which was possible since the company has long experience in doing co-operation with 
international partners. Co-operations are generally seen as a strategy to share risk in the 
pharmaceutical sector, as, for instance stressed by a Hungarian firm studied.  
Nevertheless, there are also some examples of firms which have successfully exploited the 
national research capacity. The largest Latvian pharmaceutical company, which was privat-
ized in 1997, is now listed at the stock exchange. It has successfully introduced new products 
in the last years, spends about 10% of revenues in R&D and co-operates with national and 
foreign research institutions, hence, has mastered the transformation process. However, 
other Latvian companies are not engaged in co-operations with research institutes. Some his-
torically closer links between industry and research institutes can be observed also in Lithua-
nia, though, in particular in the area of biochemistry. There are some internationally very suc-
cessful pharmaceutical companies, which specialised in niche markets. Moreover, in Lithua-
nia some spin-off activities can be observed (biochemistry).  
Thus, at the moment, the public R&D infrastructure is obviously not very favourable for phar-
maceutical companies in the NMSs. The Slovakian report for instance, concludes, R&D in-
frastructure in many Slovak industries reminded of technical museums rather than modern 
research facilities. However, at least from the perspective of some of successful companies, 
the general framework conditions are regarded as favourable with respect to the future devel-
opment potential.   
At the moment human resources seem to be the most critical hampering factors for the further 
development of the sector. Interviews in Latvian firms, for instance, reveal that the lack of 
qualified scientists hinders the further expansion of R&D activities. Potential candidates are 
often insufficiently qualified. Many qualified scientists go abroad (brain drain). Ageing of the 
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researchers is another related problem in the Baltic countries. The Hungarian study con-
cludes: The Company needs to have the best brains and not technicians . To some extent 
this is also due to the lower attractiveness of natural sciences among students. In Latvia, 
however, the number of students has grown which is a good precondition for the future devel-
opment. It remains un-answered here, whether or not universities will be able to train as many 
qualified students as demanded by the industry.   
3.2.4. Impact of R&D  
Due to a lack of data, fast changing framework conditions and restructuring of the sector in 
the last few years, a deeper assessment of a direct impact of R&D activities on economic per-
formance is not feasible at the moment.   
The assessment of the impacts of R&D is generally difficult. Most likely, increasing R&D in-
vestments have fostered growth and kept companies competitive in many cases. International 
investors have played a central role in that respect. In general, investments in R&D have 
helped to increase productivity, in particular with respect to the production of generic prod-
ucts. In some cases even the development of new pharmaceuticals was reported.   
In some cases, firms with a long established development and competence track (not only 
with generic products but also newly developed molecules) were able to keep production in 
the country and further develop their R&D strategy. Another result of the study is that newly 
established firms, spin-offs and start-ups play hardly any role in the R&D performance of the 
NMSs.   
Even though the pharmaceutical sector obviously enhanced its competitiveness in the past, in 
general, perspectives appear to be rather unfavourable. It remains unclear, if the sectors in all 
NMSs will be able to grow in the future under the given framework conditions. The main chal-
lenges will be to be innovative in terms of being able to develop new molecules, to closer co-
operate with domestic research institutes, and to develop the necessary qualification of hu-
man resources to match the needs of the sector.   
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III. Conclusions  
1 Cross-Cutting Issues 
As shown by the sectoral case-studies in this project, the patterns of private R&D investment 
in NMSs are very heterogeneous. This heterogeneity is to a significant extent a reflection of 
the respective national and sectoral R&D histories , i.e. a result of path-dependencies. Spe-
cifically in the former communist countries, it becomes obvious that the division of specialized 
industries between the countries of the economic alliance is still influencing the importance of 
private R&D investment in the different sectors. This is most obvious in the case of the auto-
motive industries and is still reflected in today s economic structure and the private R&D ex-
penditure in the sector. A significant and broadly based domestic R&D capacity has been 
maintained in the Czech Republic, building on the continuous presence of Skoda as a major 
automotive manufacturer. In other countries, industrial R&D capacities have been re-
established rather recently, mostly with a very specific mission within the global R&D strategy 
of the mother company. Other countries like Slovenia, never had a significant share in the 
automotive sector, or were specialised in niches like Hungary.  The heterogeneity of the sec-
toral case studies is also partly determined by the size of the countries. Countries like Malta 
or Cyprus hardly show any R&D activities. Larger countries like Poland, Czech Republic have 
a longer tradition in R&D activities.  
Moreover, the current situation is still very much in flux; the processes of industrial transfor-
mation and integration in the global economy have not yet settled. These general observa-
tions imply that any recommendations to policy should be based on a sectorally and nationally 
differentiated interpretation of patterns of private R&D investment. This is consistent with the 
recent trend in research and innovation policy research to stress the integration of RTDI-
policies into stronger industrial or sectoral policies (Malerba 2004). Although such a more dif-
ferentiated perspective seems to be appropriate from a conceptual point of view, it turned out 
to be very difficult at least in some countries to underpin it with statistical data. In some 
countries (Malta, Cyprus, Lithuania and others) this is simply a matter of data availability, in 
others the interpretation of data is not unequivocal due to problems of confidentiality (e.g. 
SK), inappropriate international statistical standards (e.g. in services) and in the smaller 
NMSs it is a matter of scale of the sector (Malta, Cyprus, Lithuania, Latvia, Estonia).  
In spite of this call for a differentiated and cautious interpretation of private R&D investment 
data, some cross-cutting observations can nevertheless be made. First of all, FDI tends to 
play a very significant role in many sectors (automotive, pharmaceuticals), implying a more or 
less tight embedding of the R&D investment in a NMSs in the overall R&D strategy of a multi-
national firm. This development while being generally perceived as very positive has a 
number of double-edged impacts on the evolution of the R&D base in a country. On the one 
hand, foreign investment tends to contribute to the upgrading of the managerial knowledge 
and organisational competences as well as diffusion of new technologies. New techniques 
and practices are being introduced and the collaboration with local partners and suppliers al-
lows spreading these new approaches more widely. On the other hand, the embedding in a 
global company s R&D strategy often entails a narrowing of the scope of the R&D work per-
formed in the country concerned. This, in turn, has consequences for the spectrum of R&D 
collaboration with domestic universities and research centres. It is also worth noting the type 
of R&D that is being performed by enterprises in the NMSs. It is less basic research oriented 
than in countries with headquarters and is much more focused towards specific niches (e.g. 
pharmaceuticals in Hungary), as well as adaptation-oriented in the sense that restructuring 
and modernisation of the economy is still taking place to a noticeable extent (e.g. R&D in fi-
nancial intermediaries in Estonia). Moreover, due to the internal competition between R&D 
locations of a multi-national company, there is a risk that these activities may be moved else-
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where, if the conditions for R&D or the overall R&D strategy of the company change. The 
maintenance of private sector R&D activities by way of FDI thus comes at the price of uncer-
tainty about the sustainability of this investment. However, in the end, the extent to which 
R&D might become footloose depends on the quality and continuous improvement of the 
factors and conditions due to which R&D-investment were initially set up (and maintained!) in 
a specific location.  
The sectoral case studies have shown that the reasons for foreign investment in R&D can be 
manifold. Of outstanding importance for foreign investment in R&D seems to be a combina-
tion of three factors: the quality of the human resource and competence base, the labour 
costs, and the access to local markets. The availability of highly qualified R&D personnel is 
widely acknowledged as strength of many NMSs, in many cases building on a long-standing 
industrial tradition in the respective sector (e.g. Czech automotive industry, pharmaceutical 
industry in Hungary and Slovenia). However, growing R&D investment be it in the private sec-
tor or in the public sector is likely to exhaust the capacities of the local labour markets in 
terms of qualified staff in the foreseeable future. In some cases a lack of scientific staff for 
R&D is already reported. This is caused by brain drain and over-ageing (e.g. Estonia, Latvia, 
Lithuania). The intention of most NMSs to invest the foreseen EU structural funds into R&D 
infrastructure and innovation projects, will also create a pressure on the countries education 
system to provide the research staff that contribute in a sustainable way to the creation of 
knowledge. While this problem may be overcome in the medium to long term by reinforcing 
efforts to educate a new generation of engineers and scientists, it may lead to a scarcity of 
qualified personnel in those locations where already now substantial further investment in 
manufacturing and/or R&D is planned (e.g. in the automotive industry in the Slovak Republic). 
The least that can be concluded from this observation is that it is not very likely that the NMS 
will be able to provide a labour reserve of knowledge workers to compensate for foreseeable 
shortages in the EU-15 countries.  
Labour costs have been a major advantage and reason for FDI in the New Member States, in 
production even more than in R&D. Some sectoral studies show that national economic poli-
cies are already faced with the diminishing competitive advantage by means of growing 
wages (e.g. in Estonia). Although this factor was not reported to be that important in the sec-
toral studies, this factor is frequently named as important.  
As a third key factor, home markets, tend to play a particularly important role with respect to 
the local embedding of R&D. While some foreign R&D investment was motivated by the ease 
of access to the large internal European market, in some sectors the national markets are 
also an important argument for investment. This holds, for instance, in the pharmaceutical 
industry where specific conditions and relationships prevail with hospitals, universities and 
key scientists, thus offering opportunities that are favourable to the creation of niche markets, 
which, however, have been exploited only in rare cases. A different situation can be observed 
for IT services in Estonia, where the combination of qualified personnel and demand for an 
upgrading of service quality was conducive to the establishment of a strong national R&D 
market.   
A sustainable embedding of R&D might not always be guaranteed in the case of FDI. Local-
ised R&D could on the one hand lead to local value added. On the other hand, FDI might 
skim the cream of high-potential researchers in labs that produce footloose R&D for value 
added elsewhere in the world.   
The access to a well-developed innovation infrastructure is of particular relevance when it 
comes to the question of how to ensure the embedding of foreign R&D investment in the na-
tional research and innovation systems. Through institutionalised co-operation arrangements 
with foreign investors and the building of networks, mutual learning processes and dependen-
cies can be created that contribute to the upgrading of the research and innovation landscape 
of a country. Unfortunately, very few examples of this type of embedding and networking can 
be observed so far.  
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As compared to these three key factors, it is difficult to assess the role of favourable frame-
work conditions (e.g. tax incentives). While they certainly matter for specific decisions, the 
interviews conducted in the course of the project tend to suggest that their importance seems 
to be over-estimated. If available, specific incentives are welcome, but the main determinants 
of foreign investment lie, as noted above, elsewhere.  
In spite of the emphasis put on foreign private R&D investment, the domestic private R&D 
performers should not be overlooked. Most case studies concentrated on larger firms that are 
often part of  MNCs. Hardly perceivable by statistical methods, here and there, there seem to 
start-up some R&D intensive enterprises in the biotech-sector (e.g. in Lithuania). However, 
hardly any sector specific information is available on the dynamics of R&D intensive start-ups 
in the NMSs.  
From this analysis, a number of issues arise that cut across as critical for the future and thus 
requiring particular policy attention:  
The consideration of national and sectoral innovation systems to ensure the embed-
ding of R&D; 
The future development of the human resource base as a pre-condition for perform-
ing R&D and thus for attracting R&D investment; 
The continuous improvement of the innovation infrastructure (universities, research 
centres, etc.), not only as sources of qualified R&D personnel, but also as potential 
partners for industrial R&D; 
A growing attention to the role of services, either as stand-alone research-intensive 
activities (e.g. KIBS) or as support services to R&D performed in other sectors (e.g. 
standardisation, IT services); 
Improving the innovation climate by structural measures rather than by financial in-
centives. This concerns, for instance, also the strengthening of the relationships be-
tween different innovation actors, private and public ones. There are already some 
examples of private firms getting engaged in funding of R&D centres or university in-
stitutes; 
Bundling of national R&D capacities (e.g. through national technology platforms) and 
seeking a better co-ordination with European initiatives.  
2 Future Research Needs 
This study has been of an exploratory nature and was not meant to deeply investigate all as-
pects that would have been worth investigating. However, it was going into sufficient depth to 
identify a number of research needs for the future. These can be subsumed under five main 
headlines:  
Data availability (to be based on analysis of availability matrix)  
Internationally comparable data are available on sectoral level for more countries than ex-
pected prior to the project. The EUROSTAT database provides good raw material for data 
analysis. It is however not always clear which data are available at which level and in which 
part of the EUROSTAT database. Additional efforts by EUROSTAT to further improve the us-
ability of the database would be welcome for the kind of projects we conducted.  
Another major issue is to facilitate deeper, more sophisticated analyses by making available 
data currently stored in different data sets: census, R&D and innovation surveys. Only these 
micro level data can provide a basis for sound, meaningful econometric analyses of the inter-
relationships between R&D, innovation, other characteristics and firm and their ultimate per-
formance. Of course, confidentiality of individual firm data should be maintained, but as the 
practice of various countries, e.g. that of Canada, shows it is possible. The European Com-
mission based on a detailed discussion with the national authorities, the EUROSTAT, busi-
nesses and legal experts might consider developing a set of guidelines to facilitate these 
types of analyses, which seem to be useful for policy-makers (both at an EU and national 
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level), businesses as well as advancing academic research on innovation processes, ulti-
mately underpinning more reliable policies and strategies.   
Broadening and deepening the empirical base 
The sectoral and company case-studies conducted in the context of this project could not 
provide more than a first impression of the richness of the patterns, determinants and impacts 
of private R&D investment in the NMSs. For a more systematic investigation of the subject 
matter, both a broadening and a deepening of sectoral studies would be needed, in order to 
capture the high degree of specificity of national and sectoral characteristics. Three priorities 
can be mentioned in this respect: 
There were some apparent gaps in the selection of sectors investigated. This refers 
in particular to the service sector where only a few and very heterogeneous segments 
could be investigated.  
While some sectors like automotive and pharmaceutical were quite well covered in 
this study, it will be imperative to ensure better comparability of sectoral case-studies 
by focusing in a follow-up activity on just a few sectors. 
The number of company case-studies was by far too small to draw any generalised 
conclusions, given the considerable intra-sectoral differences, e.g. in terms of size, 
ownership, managerial capabilities, level of technological development/ sophistica-
tion, leading to significant gaps in performance and prospects. 
Empirical studies are needed to investigate in more detail the science-industry rela-
tionships and historical patterns of co-operation between research institutes and in-
dustry. Such studies would deliver information why in some countries and sectors the 
relationships are exploited while in others not, and, hence, would allow to develop 
specific research and innovation policy measures.   
As regards the deepening of the investigation, in particular the impacts of private R&D in-
vestment will require further analysis.   
Impacts of private sector R&D 
Little information is available on the impacts of private sector R&D, either at firm or sectoral 
level. Only very few studies could be identified that provide information on impacts, indicating 
a need for further research. In general, the role and impact of private sector R&D would have 
to be analysed in the context of company strategies, differentiating at least some basic types 
of companies (e.g. MNCs and domestic niche players) and their respective strategies.  
As a first hypothesis with respect to basic types of company R&D strategies, the following four 
types could be suggested as a tentative indication from the case studies conducted:  
A companies, these are autonomous domestic players that manage to initiate and 
implement their own R&D strategies and operate on domestic and/or international 
markets (e.g. financial intermediaries in Estonia, biotech niche players in Lithuania). 
B companies, these are firms that are embedded in global R&D networks and are 
mostly subsidiaries of foreign companies in the case of NMSs  (e.g. automotive, 
pharma ). 
C companies, these are firms that perform adaptation-oriented R&D in order to 
adapt existing products and services to local market needs and regulations (e.g. tele-
com equipment providers, IT services). 
D companies, these are firms with invisible R&D which is embodied in services or 
a cross-cutting activity in a firm s organisational units (e.g. service providers, SMEs).  
In order to refine and substantiate this typology, additional research work would be required, 
based on detailed company case studies focusing on motivations for R&D, its embedding in 
wider firm strategies, the respective roles of intra- and extramural R&D and in general the lo-
cal embeddedness of R&D activities as reflected in ties with the wider research infrastructure 
(universities, clusters, etc.) and spill-over effects. These kinds of data should provide an indi-
cation of the efficiency of different types of R&D investment for the upgrading of the innova-
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tion system. Due to the lack of statistical data, such a case study based approach would be 
particularly interesting in small countries.   
Impacts of policy measures 
Finally, from a policy perspective, there are five main issues that would require further investi-
gation in order to better assess the role and the impact of different types of policy measures: 
The impact of targeted policy measures to attract and embed foreign R&D invest-
ment:  
Several New Member States have taken targeted measures (e.g. tax and investment 
incentives) to attract FDI. These are not targeted to increase private R&D investment. 
Although targeted measures have been quite successful in raising FDI, it is unclear 
whether these incentives are sufficient to ensure that this investment will stay and not 
move elsewhere once the conditions have changed. In other words, the key question 
concerns the sustainable embedding of private R&D investment in the innovation sys-
tems of the NMSs.  
The impact of targeted measures to leverage private R&D funding:   
Rather than addressing specifically foreign firms, efforts have also been made to 
strengthen domestic private investment in R&D and innovation, e.g. facilitating ac-
cess to venture capital, supporting spin-offs, etc. 
The role of publicly funded innovation infrastructures for attracting and embedding 
private R&D investment:   
Another policy lever with respect to private R&D investment consists of the upgrading 
of the innovation infrastructure, i.e. the creation of at least partly publicly funded 
research and research-facilitating organisations (technology transfer centres, compe-
tence centres, etc.). In a wider sense, investment in the university system also falls 
under this category, thus adding the educational and human resource dimension. 
The role of national platforms and clusters:   
As a co-ordination measure, the building of sectoral or technology-specific platforms 
is about to be implemented in some NMSs (e.g. Poland). There are potential benefits 
to be reaped by these measures, for instance in terms of international visibility, 
economies of scale, and influence on European level agenda-setting, but there is still 
a need to develop models and approaches for how to implement these platforms.     
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V. Acronyms / Glossary   
Acronym/ Term Description 
BERD Business enterprise expenditure on R&D  
bn. billion 
CMEA Council of Mutual Economic Assistance  
CSO  Hungarian central statistical office 
GDP Gross domestic product 
FDI Foreign direct investment 
FTE Full time equivalent - employment 
KIBS  Knowledge intensive business services 
NMSs New Member States of the EU 
mio. million 
MNC Multi national company 
MRP European Mutual Recognition Procedure  
R&D Research and development 
REACH EU standard - Registration, Evaluation and Authorisation of Chemicals 
T1, 2, 3 Tier one to three suppliers in the value chain of car manufacturing 
USSR Soviet Union 
CY Cyprus 
CZ Czech Republic 
EE Estonia 
LV Latvia 
LT Lithuania 
HU Hungary 
MT Malta 
PL Poland 
SK Slovakia 
SI Slovenia 
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VI. Annexes  
Availability Matrices for NMSs  
The following tables include all data sources and publishing organisations that were used to 
provide the availability matrixes for the new member states. For each data source a source 
number is given to identify the data sources in the availability matrices.  
Cyprus 
Source number  
in the availability matrix  
1,2 
Data Source  1: Research and Development Statistics (2001, 2002, 2003),  
2:Industrial statistics  
Publishing organisation  Statistical Office of Cyprus, Ministry of Finances  
Source number  
in the availability matrix  
3 
Data Source  National Accounts 
Publishing organisation  Ministry of Finance, Dept. of Statistics 
Source number  
in the availability matrix  
4 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
Czech Republic 
Source number  
in the availability matrix  
1 
Data Source  Research and Development Indicators for the CR 2004 
- http://www.czso.cz 
(http://www.czso.cz/eng/edicniplan.nsf/p/9601-05) 
Publishing organisation  Czech Statistical Office  
Source number  
in the availability matrix  
2 
Data Source  Research and Development Indicators in the CR 2003  
- http://www.czso.cz 
(http://www.czso.cz/eng/edicniplan.nsf/p/9601-04) 
Publishing organisation  Czech Statistical Office 
Source number  
in the availability matrix  
3 
Data Source  Research and Development Indicators in the CR 2002 
- http://www.czso.cz 
(http://www.czso.cz/csu/edicniplan.nsf/p/9601-03) 
Publishing organisation  Czech Statistical Office  
Source number  
in the availability matrix  
4 
Data Source  Research and Development Indicators in the CR 1995 - 2002  
- http://www.czso.cz 
(http://www.czso.cz/csu/edicniplan.nsf/p/9610-04) 
Publishing organisation  Czech Statistical Office 
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Source number  
in the availability matrix  
5 
Data Source  Technical Innovation in the Czech Republic 2002-2003 (CIS 
3)  - http://www.czso.cz 
(http://www.czso.cz/eng/edicniplan.nsf/p/9605-04) 
Publishing organisation  Czech Statistical Office 
Source number  
in the availability matrix  
6 
Data Source  Technical Innovation in the Czech Republic 1999-2001 (CIS)  
- http://www.czso.cz 
(http://www.czso.cz/eng/edicniplan.nsf/p/9605-03)) 
Publishing organisation  Czech Statistical Office 
Source number  
in the availability matrix  
7 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
Estonia 
Source number  
in the availability matrix  
1 
Data Source  R&D Yearbook 2003 (published in 2005) and on-line data-
base www.stat.ee (2006) 
Publishing organisation  Statistical Office of Estonia 
Source number  
in the availability matrix  
2 
Data Source  Community Innovation Survey (CIS 4) 
Publishing organisation  Statistical Office of Estonia 
Source number  
in the availability matrix  
3 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
Hungary 
Source number  
in the availability matrix  
1 
Data Source  Kutatás és fejlesztés/ Research and Development (annual 
bilingual publication) 
Publishing organisation  Central Statistical Office 
Source number  
in the availability matrix  
2 
Data Source  Innováció 1999-2001 / Innovation 1999-2001 (CIS 3 
compatible) 
Publishing organisation  Central Statistical Office 
Source number  
in the availability matrix  
3 
Data Source  Innováció 2003 / Innovation 2003 (CIS light compatible) 
Publishing organisation  Central Statistical Office 
Source number  
in the availability matrix  
4 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
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Latvia 
Source number  
in the availability matrix  
1 
Data Source  Research and Development Statistical Data Collection 
Publishing organisation  Central Statistical Bureau of Latvia 
Source number  
in the availability matrix  
2 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
Lithuania 
Source number  
in the availability matrix  
1 
Data Source  Lithuanian Statistics on Science and Technology (Research 
activities), B27 
Publishing organisation  Statistical Office of the Lithuanian Republic - www.std.lt,   
EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Source number  
in the availability matrix  
2 
Data Source  Community innovation survey 
Publishing organisation  Statistical Office of the Lithuanian Republic, www.std.lt, Euro-
pean Statistics on Science and Technology 
Source number  
in the availability matrix  
3 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
Malta 
Source number  
in the availability matrix  
1 
Data Source  Innovation Survey (Extended Community Innovation Survey) 
Publishing organisation  National Statistics Office, Malta 
Source number  
in the availability matrix  
2 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
Poland 
Source number  
in the availability matrix  
1 
Data Source  Science and Technology Yearbook (Nauka i technika) 
Publishing organisation  Central Statistical Office (Glowny Urzad Statystyczny) 
Source number  
in the availability matrix  
2 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
Slovakia 
Source number  
in the availability matrix  
1, 2 
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Data Source  1: The R&D Yearbook and 2: Selected Data on R&D Organi-
sations in Slovakia 
No. 1 and 2 (Sources 1 and 2 largely overlap. Since 2005 
Source 2 is cancelled and all information relaed to R&D will 
be published in Source 1) 
Publishing organisation  Statistical Office of the Slovak Republic  
Source number  
in the availability matrix  
3 
Data Source  (Community innovation survey) 
Publishing organisation  Statistical Office of the Slovak Republic  
Source number  
in the availability matrix  
4 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
Slovenia 
Source number  
in the availability matrix  
1 
Data Source  Survey on Research and Development 
Publishing organisation  Statistical Office of the Republic of Slovenia 
Source number  
in the availability matrix  
2 
Data Source  Community Innovation Survey 
Publishing organisation  Statistical Office of the Republic of Slovenia 
Source number  
in the availability matrix  
3 
Data Source  EUROSTAT Internet Database - epp.eurostat.cec.eu.int 
Publishing organisation  EUROSTAT 
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